biosample_id	individual_id	callset_ids	pgx_legacy_sample_id	legacy_ids	description	histological_diagnosis_id	histological_diagnosis_label	icdo_morphology_id	icdo_morphology_label	icdo_topography_id	icdo_topography_label	sampled_tissue_id	tnm	stage	grade	age_iso	death	followup_state_id	followup_state_label	followup_time	recurrence	recurrence_time	geoprov_city	geoprov_country	geoprov_iso_alpha3	geoprov_lat	geoprov_long	cnv_fraction	cnv_del_fraction	cnv_dup_fraction	cell_line	experiment_id	series_id	platform_id	cell_line_id	cell_line_label	external_references__id___PMID	external_references__label___PMID	external_references__id___geo:GSM	external_references__label___geo:GSM	external_references__id___geo:GSE	external_references__label___geo:GSE	external_references__id___geo:GPL	external_references__label___geo:GPL	external_references__id___cellosaurus	external_references__label___cellosaurus	external_references__id___arrayexpress	external_references__label___arrayexpress	external_references__id___cbioportal	external_references__label___cbioportal	followup_state__id	followup_state__label	data_use_conditions__id	data_use_conditions__label
pgxbs-kftva60l	pgxind-kftx267h	pgxcs-kftvlit1		PGX_AM_BS_NETL-04	Large cell neuroendocrine carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Oberschleissheim	Germany	DEU	48.25	11.56												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftva60s	pgxind-kftx267p	pgxcs-kftvliuz		PGX_AM_BS_NETL-08	atypical carcinoid tumor [lung]	NCIT:C45551	Lung Atypical Carcinoid Tumor	pgx:icdom-82493	Atypical carcinoid tumor	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Oberschleissheim	Germany	DEU	48.25	11.56												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftva60y	pgxind-kftx267x	pgxcs-kftvliwy		PGX_AM_BS_NETL-12	atypical carcinoid tumor [lung]	NCIT:C45551	Lung Atypical Carcinoid Tumor	pgx:icdom-82493	Atypical carcinoid tumor	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Oberschleissheim	Germany	DEU	48.25	11.56												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftva610	pgxind-kftx267z	pgxcs-kftvlixf		PGX_AM_BS_NETL-13	Carcinoid tumor	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Oberschleissheim	Germany	DEU	48.25	11.56												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftva612	pgxind-kftx2681	pgxcs-kftvlixw		PGX_AM_BS_NETL-14	Carcinoid tumor	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Oberschleissheim	Germany	DEU	48.25	11.56												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftva61k	pgxind-kftx268n	pgxcs-kftvlj37		PGX_AM_BS_NETL-25	Carcinoid tumor	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Oberschleissheim	Germany	DEU	48.25	11.56												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftva61n	pgxind-kftx268q	pgxcs-kftvlj46		PGX_AM_BS_NETL-27	Carcinoid tumor	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Oberschleissheim	Germany	DEU	48.25	11.56												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftva6da	pgxind-kftx26ms	pgxcs-kftvlmp5		PGX_AM_BS_AdSqLu-bjo-05	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftva6df	pgxind-kftx26my	pgxcs-kftvlmqk		PGX_AM_BS_AdSqLu-bjo-08	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftva6dk	pgxind-kftx26n4	pgxcs-kftvlmrz		PGX_AM_BS_AdSqLu-bjo-11	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftva6dl	pgxind-kftx26n6	pgxcs-kftvlmsh		PGX_AM_BS_AdSqLu-bjo-12	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftva6ea	pgxind-kftx26o0	pgxcs-kftvlmzl		PGX_AM_BS_AdSqLu-bjo-27	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftva6eg	pgxind-kftx26o7	pgxcs-kftvln1g		PGX_AM_BS_AdSqLu-bjo-31	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftva6ei	pgxind-kftx26o9	pgxcs-kftvln1y		PGX_AM_BS_AdSqLu-bjo-32	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvghzv	pgxind-kftx27w0	pgxcs-kftvlxuf		PGX_AM_BS_NCBISKYCGH-1609	Small cell carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Berlin	Germany	DEU	52.52	13.41												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgi03	pgxind-kftx27w9	pgxcs-kftvlxws		PGX_AM_BS_NCBISKYCGH-1614	Small cell carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Berlin	Germany	DEU	52.52	13.41												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgi0a	pgxind-kftx27wh	pgxcs-kftvlxyn		PGX_AM_BS_NCBISKYCGH-1618	Small cell carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Berlin	Germany	DEU	52.52	13.41												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgiid	pgxind-kftx28ih	pgxcs-kftvm3cn		PGX_AM_BS_NCBISKYCGH-2249	Small Cell Carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Heidelberg	Germany	DEU	49.41	8.69												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiin	pgxind-kftx28it	pgxcs-kftvm3fh		PGX_AM_BS_NCBISKYCGH-2255	Small Cell Carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Heidelberg	Germany	DEU	49.41	8.69												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiis	pgxind-kftx28iz	pgxcs-kftvm3gv		PGX_AM_BS_NCBISKYCGH-2258	Small Cell Carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Heidelberg	Germany	DEU	49.41	8.69												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgioe	pgxind-kftx28pu	pgxcs-kftvm550		PGX_AM_BS_24174329-clc-S00001	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgioi	pgxind-kftx28py	pgxcs-kftvm55x		PGX_AM_BS_24174329-clc-S00003	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgioq	pgxind-kftx28q8	pgxcs-kftvm588		PGX_AM_BS_24174329-clc-S00009	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgipv	pgxind-kftx28rl	pgxcs-kftvm5jx		PGX_AM_BS_24174329-clc-S00035	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiqu	pgxind-kftx28sq	pgxcs-kftvm5vr		PGX_AM_BS_24174329-clc-S00062	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgisf	pgxind-kftx28un	pgxcs-kftvm6bm		PGX_AM_BS_24174329-clc-S00099	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgisi	pgxind-kftx28ur	pgxcs-kftvm6cj		PGX_AM_BS_24174329-clc-S00101	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgist	pgxind-kftx28v4	pgxcs-kftvm6fs		PGX_AM_BS_24174329-clc-S00111	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgit0	pgxind-kftx28vc	pgxcs-kftvm6ho		PGX_AM_BS_24174329-clc-S00116	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgit1	pgxind-kftx28ve	pgxcs-kftvm6i5		PGX_AM_BS_24174329-clc-S00117	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgit4	pgxind-kftx28vi	pgxcs-kftvm6j2		PGX_AM_BS_24174329-clc-S00119	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgito	pgxind-kftx28w6	pgxcs-kftvm6on		PGX_AM_BS_24174329-clc-S00134	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgitt	pgxind-kftx28wc	pgxcs-kftvm6q1		PGX_AM_BS_24174329-clc-S00137	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiui	pgxind-kftx28x6	pgxcs-kftvm6z8		PGX_AM_BS_24174329-clc-S00155	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiv1	pgxind-kftx28xu	pgxcs-kftvm74w		PGX_AM_BS_24174329-clc-S00167	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiv6	pgxind-kftx28y0	pgxcs-kftvm76b		PGX_AM_BS_24174329-clc-S00170	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgivj	pgxind-kftx28yg	pgxcs-kftvm7a2		PGX_AM_BS_24174329-clc-S00178	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgiw7	pgxind-kftx28za	pgxcs-kftvm7h3		PGX_AM_BS_24174329-clc-S00193	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiwk	pgxind-kftx28zp	pgxcs-kftvm7kv		PGX_AM_BS_24174329-clc-S00201	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgiwr	pgxind-kftx28zx	pgxcs-kftvm7mr		PGX_AM_BS_24174329-clc-S00205	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgix2	pgxind-kftx290b	pgxcs-kftvm7q2		PGX_AM_BS_24174329-clc-S00213	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgix5	pgxind-kftx290f	pgxcs-kftvm7r0		PGX_AM_BS_24174329-clc-S00215	large cell carcinoma [lung]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgix9	pgxind-kftx290j	pgxcs-kftvm7rz		PGX_AM_BS_24174329-clc-S00222	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgixh	pgxind-kftx290t	pgxcs-kftvm7ub		PGX_AM_BS_24174329-clc-S00228	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiy1	pgxind-kftx291i	pgxcs-kftvm82s		PGX_AM_BS_24174329-clc-S00243	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiy8	pgxind-kftx291q	pgxcs-kftvm84o		PGX_AM_BS_24174329-clc-S00248	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiyd	pgxind-kftx291w	pgxcs-kftvm863		PGX_AM_BS_24174329-clc-S00251	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiyn	pgxind-kftx2928	pgxcs-kftvm88x		PGX_AM_BS_24174329-clc-S00232	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiys	pgxind-kftx292d	pgxcs-kftvm8ac		PGX_AM_BS_24174329-clc-S00262	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgiyt	pgxind-kftx292f	pgxcs-kftvm8as		PGX_AM_BS_24174329-clc-S00264	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiz5	pgxind-kftx292u	pgxcs-kftvm8e6		PGX_AM_BS_24174329-clc-S00273	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgiz8	pgxind-kftx292y	pgxcs-kftvm8f5		PGX_AM_BS_24174329-clc-S00276	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgizw	pgxind-kftx293q	pgxcs-kftvm8lz		PGX_AM_BS_24174329-clc-S00293	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgizx	pgxind-kftx293s	pgxcs-kftvm8mh		PGX_AM_BS_24174329-clc-S00297	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgizz	pgxind-kftx293u	pgxcs-kftvm8my		PGX_AM_BS_24174329-clc-S00299	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj02	pgxind-kftx293y	pgxcs-kftvm8nw		PGX_AM_BS_24174329-clc-S00309	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj0j	pgxind-kftx294i	pgxcs-kftvm8sm		PGX_AM_BS_24174329-clc-S00323	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj0l	pgxind-kftx294k	pgxcs-kftvm8t5		PGX_AM_BS_24174329-clc-S00284	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj0r	pgxind-kftx294s	pgxcs-kftvm8v1		PGX_AM_BS_24174329-clc-S00332	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj0w	pgxind-kftx294y	pgxcs-kftvm8wg		PGX_AM_BS_24174329-clc-S00338	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj1c	pgxind-kftx295i	pgxcs-kftvm916		PGX_AM_BS_24174329-clc-S00349	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj1g	pgxind-kftx295m	pgxcs-kftvm924		PGX_AM_BS_24174329-clc-S00351	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj1k	pgxind-kftx295s	pgxcs-kftvm93j		PGX_AM_BS_24174329-clc-S00355	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj1u	pgxind-kftx2964	pgxcs-kftvm98c		PGX_AM_BS_24174329-clc-S00361	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj1w	pgxind-kftx2966	pgxcs-kftvm98v		PGX_AM_BS_24174329-clc-S00363	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj1z	pgxind-kftx296a	pgxcs-kftvm99u		PGX_AM_BS_24174329-clc-S00365	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj2f	pgxind-kftx296u	pgxcs-kftvm9ep		PGX_AM_BS_24174329-clc-S00350	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj2k	pgxind-kftx2970	pgxcs-kftvm9g4		PGX_AM_BS_24174329-clc-S00399	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj3r	pgxind-kftx298g	pgxcs-kftvm9s9		PGX_AM_BS_24174329-clc-S00426	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj4n	pgxind-kftx299k	pgxcs-kftvma1p		PGX_AM_BS_24174329-clc-S00448	adenosquamous carcinoma [lung]	NCIT:C9133	Lung Adenosquamous Carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj4v	pgxind-kftx299t	pgxcs-kftvma42		PGX_AM_BS_24174329-clc-S00453	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj52	pgxind-kftx29a1	pgxcs-kftvma5x		PGX_AM_BS_24174329-clc-S00457	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj55	pgxind-kftx29a5	pgxcs-kftvma6v		PGX_AM_BS_24174329-clc-S00459	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj6g	pgxind-kftx29br	pgxcs-kftvmamk		PGX_AM_BS_24174329-clc-S00490	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj6l	pgxind-kftx29bw	pgxcs-kftvmanz		PGX_AM_BS_24174329-clc-S00493	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj6t	pgxind-kftx29c6	pgxcs-kftvmaqb		PGX_AM_BS_24174329-clc-S00498	adenosquamous carcinoma [lung]	NCIT:C9133	Lung Adenosquamous Carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj6w	pgxind-kftx29ca	pgxcs-kftvmar9		PGX_AM_BS_24174329-clc-S00501	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj77	pgxind-kftx29co	pgxcs-kftvmauj		PGX_AM_BS_24174329-clc-S00507	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj7b	pgxind-kftx29cs	pgxcs-kftvmavh		PGX_AM_BS_24174329-clc-S00509	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj7r	pgxind-kftx29db	pgxcs-kftvmb06		PGX_AM_BS_24174329-clc-S00521	carcinoid [lung]	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj89	pgxind-kftx29dx	pgxcs-kftvmb5c		PGX_AM_BS_24174329-clc-S00538	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgj8e	pgxind-kftx29e3	pgxcs-kftvmb6r		PGX_AM_BS_24174329-clc-S00584	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj8g	pgxind-kftx29e5	pgxcs-kftvmb78		PGX_AM_BS_24174329-clc-S00602	large cell neuroendocrine with small cell carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgj8m	pgxind-kftx29ed	pgxcs-kftvmb94		PGX_AM_BS_24174329-clc-S00635	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgj9v	pgxind-kftx29fv	pgxcs-kftvmbnp		PGX_AM_BS_24174329-clc-S00689	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgja1	pgxind-kftx29g3	pgxcs-kftvmbpm		PGX_AM_BS_24174329-clc-S00696	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjaq	pgxind-kftx29gx	pgxcs-kftvmbwn		PGX_AM_BS_24174329-clc-S00718	large cell neuroendocrine with small cell carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjau	pgxind-kftx29h3	pgxcs-kftvmby2		PGX_AM_BS_24174329-clc-S00721	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjb7	pgxind-kftx29hj	pgxcs-kftvmc1t		PGX_AM_BS_24174329-clc-S00736	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjbk	pgxind-kftx29hz	pgxcs-kftvmc5i		PGX_AM_BS_24174329-clc-S00747	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjbp	pgxind-kftx29i5	pgxcs-kftvmc6x		PGX_AM_BS_24174329-clc-S00752	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjbs	pgxind-kftx29i9	pgxcs-kftvmc7u		PGX_AM_BS_24174329-clc-S00825	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjck	pgxind-kftx29j6	pgxcs-kftvmcfu		PGX_AM_BS_24174329-clc-S00933	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjcn	pgxind-kftx29ja	pgxcs-kftvmcgs		PGX_AM_BS_24174329-clc-S00795	large cell neuroendocrine with small cell carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjd5	pgxind-kftx29jw	pgxcs-kftvmclz		PGX_AM_BS_24174329-clc-S00837	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjdn	pgxind-kftx29kh	pgxcs-kftvmcta		PGX_AM_BS_24174329-clc-S00934	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjds	pgxind-kftx29kn	pgxcs-kftvmcup		PGX_AM_BS_24174329-clc-S00938	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjdt	pgxind-kftx29kp	pgxcs-kftvmcv6		PGX_AM_BS_24174329-clc-S00803	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjdv	pgxind-kftx29kr	pgxcs-kftvmcvn		PGX_AM_BS_24174329-clc-S00941	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjdw	pgxind-kftx29kt	pgxcs-kftvmcw5		PGX_AM_BS_24174329-clc-S00943	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgje0	pgxind-kftx29kx	pgxcs-kftvmcx2		PGX_AM_BS_24174329-clc-S00945	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgje6	pgxind-kftx29l5	pgxcs-kftvmcyx		PGX_AM_BS_24174329-clc-S00954	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjf1	pgxind-kftx29m8	pgxcs-kftvmd7u		PGX_AM_BS_24174329-clc-S01023	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjfb	pgxind-kftx29mk	pgxcs-kftvmdam		PGX_AM_BS_24174329-clc-S01048	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjg9	pgxind-kftx29nq	pgxcs-kftvmdke		PGX_AM_BS_24174329-clc-S01085	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjgk	pgxind-kftx29o3	pgxcs-kftvmdnn		PGX_AM_BS_24174329-clc-S01093	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjgm	pgxind-kftx29o6	pgxcs-kftvmdo4		PGX_AM_BS_24174329-clc-S01096	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjgo	pgxind-kftx29o8	pgxcs-kftvmdol		PGX_AM_BS_24174329-clc-S01097	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjh3	pgxind-kftx29oq	pgxcs-kftvmdsr		PGX_AM_BS_24174329-clc-S01110	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjiu	pgxind-kftx29qv	pgxcs-kftvmed2		PGX_AM_BS_24174329-clc-S01166	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjiz	pgxind-kftx29r1	pgxcs-kftvmeeg		PGX_AM_BS_24174329-clc-S01169	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjj0	pgxind-kftx29r3	pgxcs-kftvmeey		PGX_AM_BS_24174329-clc-S01170	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjja	pgxind-kftx29re	pgxcs-kftvmehr		PGX_AM_BS_24174329-clc-S01188	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjjb	pgxind-kftx29rg	pgxcs-kftvmei8		PGX_AM_BS_24174329-clc-S01189	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjjl	pgxind-kftx29rs	pgxcs-kftvmel1		PGX_AM_BS_24174329-clc-S01196	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjkb	pgxind-kftx29sp	pgxcs-kftvmesk		PGX_AM_BS_24174329-clc-S01226	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjkd	pgxind-kftx29sr	pgxcs-kftvmet1		PGX_AM_BS_24174329-clc-S01227	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjkm	pgxind-kftx29t3	pgxcs-kftvmevv		PGX_AM_BS_24174329-clc-S01234	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjkv	pgxind-kftx29td	pgxcs-kftvmey7		PGX_AM_BS_24174329-clc-S01244	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjl0	pgxind-kftx29tj	pgxcs-kftvmezl		PGX_AM_BS_24174329-clc-S01248	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjlm	pgxind-kftx29u9	pgxcs-kftvmf7m		PGX_AM_BS_24174329-clc-S01271	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjm2	pgxind-kftx29ut	pgxcs-kftvmfc9		PGX_AM_BS_24174329-clc-S01288	adenosquamous carcinoma [lung]	NCIT:C9133	Lung Adenosquamous Carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjma	pgxind-kftx29v3	pgxcs-kftvmfel		PGX_AM_BS_24174329-clc-S01297	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjmf	pgxind-kftx29v9	pgxcs-kftvmffz		PGX_AM_BS_24174329-clc-S01302	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjmk	pgxind-kftx29vf	pgxcs-kftvmfhe		PGX_AM_BS_24174329-clc-S01306	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjmm	pgxind-kftx29vh	pgxcs-kftvmfhv		PGX_AM_BS_24174329-clc-S01310	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjnf	pgxind-kftx29wh	pgxcs-kftvmfq7		PGX_AM_BS_24174329-clc-S01335	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjni	pgxind-kftx29wl	pgxcs-kftvmfr5		PGX_AM_BS_24174329-clc-S01342	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjns	pgxind-kftx29wx	pgxcs-kftvmftz		PGX_AM_BS_24174329-clc-S01315	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjnw	pgxind-kftx29x1	pgxcs-kftvmfux		PGX_AM_BS_24174329-clc-S01359	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjnx	pgxind-kftx29x3	pgxcs-kftvmfve		PGX_AM_BS_24174329-clc-S01357	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjo2	pgxind-kftx29x9	pgxcs-kftvmfwt		PGX_AM_BS_24174329-clc-S01363	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjo7	pgxind-kftx29xf	pgxcs-kftvmfy7		PGX_AM_BS_24174329-clc-S01368	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjom	pgxind-kftx29xx	pgxcs-kftvmg2e		PGX_AM_BS_24174329-clc-S01383	large cell carcinoma [lung]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjos	pgxind-kftx29y5	pgxcs-kftvmg4a		PGX_AM_BS_24174329-clc-S01398	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjow	pgxind-kftx29y9	pgxcs-kftvmg58		PGX_AM_BS_24174329-clc-S01402	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjp4	pgxind-kftx29yj	pgxcs-kftvmg7l		PGX_AM_BS_24174329-clc-S01407	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjp7	pgxind-kftx29yn	pgxcs-kftvmg8j		PGX_AM_BS_24174329-clc-S01366	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjpz	pgxind-kftx29zl	pgxcs-kftvmgiq		PGX_AM_BS_24174329-clc-S01477	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjq9	pgxind-kftx29zx	pgxcs-kftvmgll		PGX_AM_BS_24174329-clc-S01493	carcinoid [lung]	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjqi	pgxind-kftx2a09	pgxcs-kftvmgog		PGX_AM_BS_24174329-clc-S01499	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjqq	pgxind-kftx2a0k	pgxcs-kftvmgqs		PGX_AM_BS_24174329-clc-S01505	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjr6	pgxind-kftx2a13	pgxcs-kftvmgvf		PGX_AM_BS_24174329-clc-S01516	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjri	pgxind-kftx2a1h	pgxcs-kftvmgyp		PGX_AM_BS_24174329-clc-S01524	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjrr	pgxind-kftx2a1t	pgxcs-kftvmh1k		PGX_AM_BS_24174329-clc-S01533	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjse	pgxind-kftx2a2l	pgxcs-kftvmh85		PGX_AM_BS_24174329-clc-S01555	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjsg	pgxind-kftx2a2n	pgxcs-kftvmh8m		PGX_AM_BS_24174329-clc-S01556	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjsl	pgxind-kftx2a2t	pgxcs-kftvmha1		PGX_AM_BS_24174329-clc-S01565	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjsn	pgxind-kftx2a2v	pgxcs-kftvmhah		PGX_AM_BS_24174329-clc-S01566	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjtf	pgxind-kftx2a3t	pgxcs-kftvmhkj		PGX_AM_BS_24174329-clc-S01587	carcinoid [lung]	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjtv	pgxind-kftx2a4d	pgxcs-kftvmhp7		PGX_AM_BS_24174329-clc-S01605	carcinoid [lung]	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgju6	pgxind-kftx2a4r	pgxcs-kftvmhsh		PGX_AM_BS_24174329-clc-S01643	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjud	pgxind-kftx2a4z	pgxcs-kftvmhuc		PGX_AM_BS_24174329-clc-S01620	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjui	pgxind-kftx2a54	pgxcs-kftvmhvq		PGX_AM_BS_24174329-clc-S01626	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjuj	pgxind-kftx2a56	pgxcs-kftvmhw7		PGX_AM_BS_24174329-clc-S01627	large cell neuroendocrine carcinoma [lung]	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjul	pgxind-kftx2a58	pgxcs-kftvmhwo		PGX_AM_BS_24174329-clc-S01628	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjv0	pgxind-kftx2a5q	pgxcs-kftvmi0v		PGX_AM_BS_24174329-clc-S01661	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjv2	pgxind-kftx2a5s	pgxcs-kftvmi1c		PGX_AM_BS_24174329-clc-S01639	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjv4	pgxind-kftx2a5u	pgxcs-kftvmi1t		PGX_AM_BS_24174329-clc-S01640	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjve	pgxind-kftx2a66	pgxcs-kftvmi4l		PGX_AM_BS_24174329-clc-S01646	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjvh	pgxind-kftx2a6a	pgxcs-kftvmi5i		PGX_AM_BS_24174329-clc-S01648	carcinoid [lung]	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjvi	pgxind-kftx2a6c	pgxcs-kftvmi5z		PGX_AM_BS_24174329-clc-S01649	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjvn	pgxind-kftx2a6i	pgxcs-kftvmi7e		PGX_AM_BS_24174329-clc-S01652	carcinoma [lung]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjvp	pgxind-kftx2a6k	pgxcs-kftvmi7v		PGX_AM_BS_24174329-clc-S01653	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjvu	pgxind-kftx2a6q	pgxcs-kftvmi99		PGX_AM_BS_24174329-clc-S01656	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjvv	pgxind-kftx2a6s	pgxcs-kftvmi9p		PGX_AM_BS_24174329-clc-S01657	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjvz	pgxind-kftx2a6w	pgxcs-kftvmian		PGX_AM_BS_24174329-clc-S01635	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjw7	pgxind-kftx2a76	pgxcs-kftvmid0		PGX_AM_BS_24174329-clc-S01664	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjwa	pgxind-kftx2a7a	pgxcs-kftvmidy		PGX_AM_BS_24174329-clc-S01678	large cell carcinoma [lung]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgjwz	pgxind-kftx2a84	pgxcs-kftvmiky		PGX_AM_BS_24174329-clc-S01721	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjxk	pgxind-kftx2a8u	pgxcs-kftvmisx		PGX_AM_BS_24174329-clc-S01747	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvgjxx	pgxind-kftx2a9a	pgxcs-kftvmiwo		PGX_AM_BS_24174329-clc-S01772	squamous cell carcinoma [lung]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Koeln	Germany	DEU	50.93	6.95												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvglau	pgxind-kftx2bwz	pgxcs-kftvmxmx		PGX_AM_BS_21684623_NSCLC-got-2106LNC	Non-small cell carcinoma [lung]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Heidelberg	Germany	DEU	49.41	8.69												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvglaw	pgxind-kftx2bx1	pgxcs-kftvmxne		PGX_AM_BS_21684623_NSCLC-got-2106LNT	Non-small cell carcinoma [lung]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Heidelberg	Germany	DEU	49.41	8.69												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvglay	pgxind-kftx2bx3	pgxcs-kftvmxnw		PGX_AM_BS_21684623_NSCLC-got-2106TC	Non-small cell carcinoma [lung]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Heidelberg	Germany	DEU	49.41	8.69												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvglaz	pgxind-kftx2bx5	pgxcs-kftvmxoc		PGX_AM_BS_21684623_NSCLC-got-2106TT	Non-small cell carcinoma [lung]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Heidelberg	Germany	DEU	49.41	8.69												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvglb1	pgxind-kftx2bx7	pgxcs-kftvmxot		PGX_AM_BS_21684623_NSCLC-got-2427TC	Non-small cell carcinoma [lung]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Heidelberg	Germany	DEU	49.41	8.69												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvglb3	pgxind-kftx2bx9	pgxcs-kftvmxpa		PGX_AM_BS_21684623_NSCLC-got-2427TT	Non-small cell carcinoma [lung]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Heidelberg	Germany	DEU	49.41	8.69												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgnh0	pgxind-kftx2ek2	pgxcs-kftvnkvg		PGX_AM_BS_20164920_00-20T	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgnkl	pgxind-kftx2eok	pgxcs-kftvnlyd		PGX_AM_BS_20164920_97-16T	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgnkw	pgxind-kftx2eoy	pgxcs-kftvnm1p		PGX_AM_BS_20164920_97-47T	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgnlm	pgxind-kftx2epv	pgxcs-kftvnmb6		PGX_AM_BS_20164920_99-32T	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgnlq	pgxind-kftx2epz	pgxcs-kftvnmc3		PGX_AM_BS_20164920_99-53T	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgnoq	pgxind-kftx2etn	pgxcs-kftvnn6v		PGX_AM_BS_20164920_Daffy1T	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgnr1	pgxind-kftx2ewi	pgxcs-kftvnnwl		PGX_AM_BS_20164920_H23	non-small cell lung carcinoma [cell line H23]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgo3l	pgxind-kftx2fby	pgxcs-kftvnrmi		PGX_AM_BS_20164920_S003619T	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgo49	pgxind-kftx2fct	pgxcs-kftvnrth		PGX_AM_BS_20164920_S003608T	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgo4l	pgxind-kftx2fd8	pgxcs-kftvnrws		PGX_AM_BS_20164920_S003618T	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgoa1	pgxind-kftx2fk1	pgxcs-kftvntl4		PGX_AM_BS_20164920_SM-12WC	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgoak	pgxind-kftx2fkq	pgxcs-kftvntqp		PGX_AM_BS_20164920_SM-12Y5	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgplp	pgxind-kftx2h7n	pgxcs-kftvo7z1		PGX_AM_BS_19607727_PulmSCC-12	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgxr8	pgxind-kftx2rds	pgxcs-kftvqquh		PGX_AM_BS_LungSCC-cho-Sq1	Squamous cell carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Seoul	Republic of Korea	KOR	37.57	126.98												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgxra	pgxind-kftx2rdu	pgxcs-kftvqqv0		PGX_AM_BS_LungSCC-cho-Sq10	Squamous cell carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Seoul	Republic of Korea	KOR	37.57	126.98												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvgyjq	pgxind-kftx2rzb	pgxcs-kftvqwbb		PGX_AM_BS_NSCLC-yak-L-24	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Bursa	Turkey	TUR	40.19	29.08												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvh1e5	pgxind-kftx2viq	pgxcs-kftvrs3g		PGX_AM_BS_BroCa-fos-M0	Carcinoma in situ [left main bronchus]	NCIT:C27467	Stage 0 Lung Cancer	pgx:icdom-80102	Carcinoma in situ, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge UK	United Kingdom	GBR	52.21	0.12												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh1e7	pgxind-kftx2vit	pgxcs-kftvrs3y		PGX_AM_BS_BroCa-fos-M19	Carcinoma [bronchial, after carcinoma in situ of left main bronchus]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge UK	United Kingdom	GBR	52.21	0.12												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3vn	pgxind-kftx2ymw	pgxcs-kftvsjs3		PGX_AM_BS_LuCa-AC-05	Adenocarcinoma [lung, stage III]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3vp	pgxind-kftx2ymy	pgxcs-kftvsjsl		PGX_AM_BS_LuCa-AC-06	Adenocarcinoma [lung, stage II]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3vu	pgxind-kftx2yn4	pgxcs-kftvsju1		PGX_AM_BS_LuCa-AC-09	Adenocarcinoma [lung, stage IV]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3vy	pgxind-kftx2yna	pgxcs-kftvsjvi		PGX_AM_BS_LuCa-AC-12	Adenocarcinoma [lung, stage II]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3w0	pgxind-kftx2ync	pgxcs-kftvsjw0		PGX_AM_BS_LuCa-AC-13	Adenocarcinoma [lung, stage I]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3w5	pgxind-kftx2yni	pgxcs-kftvsjxf		PGX_AM_BS_LuCa-AC-16	Adenocarcinoma [lung, stage IV]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3wj	pgxind-kftx2yo0	pgxcs-kftvsk1r		PGX_AM_BS_LuCa-AC-25	Adenocarcinoma [lung, stage II]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3wl	pgxind-kftx2yo2	pgxcs-kftvsk28		PGX_AM_BS_LuCa-AC-26	Adenocarcinoma [lung, stage II]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3ws	pgxind-kftx2yoa	pgxcs-kftvsk45		PGX_AM_BS_LuCa-AC-30	Adenocarcinoma [lung, stage III]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3x6	pgxind-kftx2yos	pgxcs-kftvskaq		PGX_AM_BS_LuCa-SQCC-39	Squamous cell carcinoma [stage II]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3xo	pgxind-kftx2ypf	pgxcs-kftvskg1		PGX_AM_BS_LuCa-SQCC-50	Squamous cell carcinoma [stage III]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3xx	pgxind-kftx2ypr	pgxcs-kftvskiy		PGX_AM_BS_LuCa-SQCC-56	Squamous cell carcinoma [stage III]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3y6	pgxind-kftx2yq1	pgxcs-kftvsklc		PGX_AM_BS_LuCa-SQCC-61	Squamous cell carcinoma [stage IV]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3y9	pgxind-kftx2yq5	pgxcs-kftvskmb		PGX_AM_BS_LuCa-SQCC-63	Squamous cell carcinoma [stage III]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3yd	pgxind-kftx2yq9	pgxcs-kftvskna		PGX_AM_BS_LuCa-SQCC-65	Squamous cell carcinoma [stage III]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh3ye	pgxind-kftx2yqb	pgxcs-kftvskns		PGX_AM_BS_LuCa-SQCC-66	Squamous cell carcinoma [stage IV]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Hong Kong	China	CHN	22.29	114.16												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh4xc	pgxind-kftx2zxx	pgxcs-kftvsvhl		PGX_AM_BS_AEB-14595748-AC9	Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Graz	Austria	AUT	47.07	15.45												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh5i5	pgxind-kftx30ns	pgxcs-kftvt1xg		PGX_AM_BS_NeuEndLung-C23	Carcinoid tumor	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bochum	Germany	DEU	51.48	7.22												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh5ii	pgxind-kftx30o8	pgxcs-kftvt21a		PGX_AM_BS_NeuEndLung-N1	Large cell neuroendocrine carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bochum	Germany	DEU	51.48	7.22												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh5iu	pgxind-kftx30oo	pgxcs-kftvt254		PGX_AM_BS_NeuEndLung-N17	Large cell neuroendocrine carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bochum	Germany	DEU	51.48	7.22												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh5iy	pgxind-kftx30os	pgxcs-kftvt263		PGX_AM_BS_NeuEndLung-N3	Large cell neuroendocrine carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bochum	Germany	DEU	51.48	7.22												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh5j1	pgxind-kftx30ow	pgxcs-kftvt271		PGX_AM_BS_NeuEndLung-N5	Large cell neuroendocrine carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bochum	Germany	DEU	51.48	7.22												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh5j4	pgxind-kftx30p0	pgxcs-kftvt280		PGX_AM_BS_NeuEndLung-N7	Large cell neuroendocrine carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bochum	Germany	DEU	51.48	7.22												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh5j9	pgxind-kftx30p6	pgxcs-kftvt29g		PGX_AM_BS_NeuEndLung-S1	Small cell neuroendocrine carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bochum	Germany	DEU	51.48	7.22												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh5ja	pgxind-kftx30p8	pgxcs-kftvt29x		PGX_AM_BS_NeuEndLung-S10	Small cell neuroendocrine carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bochum	Germany	DEU	51.48	7.22												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh5jc	pgxind-kftx30pa	pgxcs-kftvt2af		PGX_AM_BS_NeuEndLung-S2	Small cell neuroendocrine carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bochum	Germany	DEU	51.48	7.22												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh5jh	pgxind-kftx30ph	pgxcs-kftvt2bv		PGX_AM_BS_NeuEndLung-S5	Small cell neuroendocrine carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bochum	Germany	DEU	51.48	7.22												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh5ji	pgxind-kftx30pj	pgxcs-kftvt2cd		PGX_AM_BS_NeuEndLung-S6	Small cell neuroendocrine carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bochum	Germany	DEU	51.48	7.22												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh5jn	pgxind-kftx30pp	pgxcs-kftvt2dt		PGX_AM_BS_NeuEndLung-S9	Small cell neuroendocrine carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bochum	Germany	DEU	51.48	7.22												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh6so	pgxind-kftx329q	pgxcs-kftvtgei		PGX_AM_BS_BCCD-AC6	Pulmonary adenocarcinoma [Mixed AC, papillary, tubular, bronchioloalveolar, solid, mucinous, CGH in adenocarcinomacomponent]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Graz	Austria	AUT	47.07	15.45												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh6sq	pgxind-kftx329s	pgxcs-kftvtgez		PGX_AM_BS_BCCD-AC7	Pulmonary adenocarcinoma [Mixed AC, tubular, acinar, solid, CGH in adenocarcinomacomponent]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Graz	Austria	AUT	47.07	15.45												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh7rg	pgxind-kftx33h2	pgxcs-kftvtr6z		PGX_AM_BS_SqLC-chu-L-15	Squamous cell carcinoma [T2N1]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Oita	Japan	JPN	33.24	131.61												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh7s6	pgxind-kftx33hy	pgxcs-kftvtrgr		PGX_AM_BS_SqLC-chu-L-46	Squamous cell carcinoma [T1N0]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Oita	Japan	JPN	33.24	131.61												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh7sz	pgxind-kftx33iz	pgxcs-kftvtrpj		PGX_AM_BS_SqLC-chu-L-88	Squamous cell carcinoma [T2N0]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Oita	Japan	JPN	33.24	131.61												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh9bc	pgxind-kftx35ev	pgxcs-kftvu8hq		PGX_AM_BS_PulAdCa-09	pulmonary adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh9bg	pgxind-kftx35f1	pgxcs-kftvu8l5		PGX_AM_BS_PulAdCa-12	pulmonary adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh9bq	pgxind-kftx35fd	pgxcs-kftvu8o2		PGX_AM_BS_PulAdCa-18	pulmonary adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh9bv	pgxind-kftx35fk	pgxcs-kftvu8ph		PGX_AM_BS_PulAdCa-21	pulmonary adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvh9by	pgxind-kftx35fo	pgxcs-kftvu8qf		PGX_AM_BS_PulAdCa-23	pulmonary adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Helsinki	Finland	FIN	60.17	24.94												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvhb2n	pgxind-kftx37m7	pgxcs-kftvus7q		PGX_AM_BS_AdCysCa-03	adenoid cystic carcinomas [trachea, grade I, stage I]	NCIT:C6051	Tracheal Adenoid Cystic Carcinoma	pgx:icdom-82003	Adenoid cystic carcinoma	pgx:icdot-C33.9	Trachea	trachea						EFO:0030039	no followup status				Charlottesville	United States of America	USA	38.03	-78.48												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvhb3r	pgxind-kftx37nl	pgxcs-kftvusl6		PGX_AM_BS_SCLC-03	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Stockholm	Sweden	SWE	59.33	18.06												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhb3u	pgxind-kftx37np	pgxcs-kftvusm6		PGX_AM_BS_SCLC-05	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Stockholm	Sweden	SWE	59.33	18.06												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhb3x	pgxind-kftx37nt	pgxcs-kftvusn5		PGX_AM_BS_SCLC-07	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Stockholm	Sweden	SWE	59.33	18.06												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhb3z	pgxind-kftx37nv	pgxcs-kftvusnn		PGX_AM_BS_SCLC-08	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Stockholm	Sweden	SWE	59.33	18.06												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhb41	pgxind-kftx37nx	pgxcs-kftvuso6		PGX_AM_BS_SCLC-09	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					1	EFO:0030049	dead (follow-up status)				Stockholm	Sweden	SWE	59.33	18.06												EFO:0030049	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhb44	pgxind-kftx37o1	pgxcs-kftvusp7		PGX_AM_BS_SCLC-11	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Stockholm	Sweden	SWE	59.33	18.06												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhb46	pgxind-kftx37o4	pgxcs-kftvuspp		PGX_AM_BS_SCLC-12	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Stockholm	Sweden	SWE	59.33	18.06												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhb4a	pgxind-kftx37oa	pgxcs-kftvusr8		PGX_AM_BS_SCLC-15	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Stockholm	Sweden	SWE	59.33	18.06												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhb4c	pgxind-kftx37oc	pgxcs-kftvusrq		PGX_AM_BS_SCLC-16	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung					0	EFO:0030041	alive (follow-up status)				Stockholm	Sweden	SWE	59.33	18.06												EFO:0030041	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhc6p	pgxind-kftx3901	pgxcs-kftvv4ss		PGX_AM_BS_NSCLC-L45	squamous cell carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Toronto	Canada	CAN	43.7	-79.42												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvhc6r	pgxind-kftx3903	pgxcs-kftvv4t9		PGX_AM_BS_NSCLC-L56	adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Toronto	Canada	CAN	43.7	-79.42												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvhhr5	pgxind-kftx3fif	pgxcs-kftvwrn7		cfe0f0e4-d8bf-40ce-99f1-2bf99ceca18b	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhhu8	pgxind-kftx3flz	pgxcs-kftvwsl3		a7347072-546c-4370-9214-96a17a713b27	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.2	Middle lobe, lung	middle lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhhui	pgxind-kftx3fmb	pgxcs-kftvwsnz		0791e7aa-e97c-4dd0-9615-09ec7090f684	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhhzc	pgxind-kftx3frz	pgxcs-kftvwu4x		3073311b-5b00-4fd7-b1f6-1067d2e86564	Primary Tumor	NCIT:C5649	Acinar Lung Adenocarcinoma	pgx:icdom-85503	Acinar cell carcinoma	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhio8	pgxind-kftx3glz	pgxcs-kftvx1vs		32c4dcd3-8cc1-4a7d-b593-b8d0b7541c1b	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhiti	pgxind-kftx3ggc	pgxcs-kftvx3jk		5a9f5ccb-635d-440e-ad03-fde8f63a2233	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhiv0	pgxind-kftx3gtr	pgxcs-kftvx3zj		32a90a21-f9e2-4bca-b540-e4f517e26ac3	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhix4	pgxind-kftx3gw3	pgxcs-kftvx4nw		7a6f5405-a196-460c-bbe2-6c75ecaf0da0	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhj2w	pgxind-kftx3h2e	pgxcs-kftvx6fl		c7d727b6-47c6-4339-b9dd-5baf41527bd4	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhj3q	pgxind-kftx3h3c	pgxcs-kftvx6ob		cf14428a-1964-4f11-aa9a-d60c6631c2c6	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhj6n	pgxind-kftx3h6u	pgxcs-kftvx7lr		21b2f32e-ccea-4b20-86d3-6647e99825cf	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhjed	pgxind-kftx3hfv	pgxcs-kftvxa0c		49a0ab8a-f379-4394-accf-0b4b08d2dcc6	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhjjg	pgxind-kftx3hly	pgxcs-kftvxbkd		2a2ed3ec-57c9-4d2e-a03e-03b11b03950f	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhjpo	pgxind-kftx3hsv	pgxcs-kftvxdhs		7d3b0879-08ed-47ea-8ac2-770baafd042d	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhjsw	pgxind-kftx3hwi	pgxcs-kftvxehh		e447da47-227d-4956-9f46-ad1f81b73eba	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhk9v	pgxind-kftx3ifq	pgxcs-kftvxjto		635a73e9-d507-45ae-a533-deff382643c1	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhka2	pgxind-kftx3ify	pgxcs-kftvxjvn		5bae2e45-6dbc-458c-a66f-702eb1af7357	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkdf	pgxind-kftx3ijt	pgxcs-kftvxkyg		40459a56-482e-4c5a-832c-8d2ef9a83048	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkfg	pgxind-kftx3im8	pgxcs-kftvxlkb		69cfb7ce-0b44-4ea2-8fbd-c94eba042589	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkgy	pgxind-kftx3int	pgxcs-kftvxm2y		323d4a3b-38d8-4428-9135-437a839dc8e4	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkin	pgxind-kftx3iph	pgxcs-kftvxmkq		45885727-79fe-43d6-866e-1fe7ded4bfdc	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkls	pgxind-kftx3isn	pgxcs-kftvxnjy		51ef1033-e974-4b03-9d29-0f58366842d0	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkly	pgxind-kftx3isv	pgxcs-kftvxnlw		9de8d353-3442-41d8-8bfe-a08c4975eaca	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkr9	pgxind-kftx3fe6	pgxcs-kftvxp8m		68788942-0af1-4c4a-9f7b-d53a13ab7c68	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkvq	pgxind-kftx3j3b	pgxcs-kftvxqm8		1a929496-806b-42f7-a45d-5f66a73eedcd	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.2	Middle lobe, lung	middle lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkwz	pgxind-kftx3j4o	pgxcs-kftvxr22		f418ffe1-3f43-4155-ad1e-69aa27e5d614	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.2	Middle lobe, lung	middle lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkxv	pgxind-kftx3j5q	pgxcs-kftvxrbq		c85ed66e-c58b-45d9-82f6-8248b9e05338	Primary Tumor	NCIT:C2923	Bronchioloalveolar Carcinoma	pgx:icdom-82503	Bronchiolo-alveolar adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhky4	pgxind-kftx3j60	pgxcs-kftvxrem::pgxcs-kftw09zf		cc9f85c4-5cc0-44e4-81d9-45b96f78aaf0	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhkzj	pgxind-kftx3j7i	pgxcs-kftvxru0::pgxcs-kftw094h		5294476f-a200-453e-9d11-9c50f3c3fa5d	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhl2v	pgxind-kftx3jbj	pgxcs-kftvxsvv		933577d0-75b1-4f9f-baa1-2dd1ab254fd2	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhl2x	pgxind-kftx3i52	pgxcs-kftvxswc		f00e664d-4418-4c3e-b904-abe0d0c91617	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhl3y	pgxind-kftx3jco	pgxcs-kftvxt7e		4595d7e9-85d8-4eab-9b8e-3dd624dd792c	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhl5g	pgxind-kftx3jee	pgxcs-kftvxtq6		f0f4aa30-1bee-42a9-b109-75c60a42da76	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhla3	pgxind-kftx3jj9	pgxcs-kftvxv5j		4083de2f-3ff5-487b-a27b-783d51c4f853	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhlhj	pgxind-kftx3jr7	pgxcs-kftvxxhy		e47265aa-38bc-4122-ad50-44dda65c6bf3	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhlnu	pgxind-kftx3iaa	pgxcs-kftvxzfg		63dbcf72-c115-4367-8230-8188913ecade	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhlp8	pgxind-kftx3jz2	pgxcs-kftvxzwq::pgxcs-kftvz2xr		f4f08354-33f0-4a59-8510-b4406aeab46e	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhlv8	pgxind-kftx3k5q	pgxcs-kftvy1r8		a6096034-3c2c-4c96-88fe-56a22c2d167c	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhm00	pgxind-kftx3ka7	pgxcs-kftvy38k		557f9564-852b-4e7c-a414-bc3fc83758da	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhm29	pgxind-kftx3kcj	pgxcs-kftvy3yw		19715a67-38f2-4183-a857-2290dd06f9a8	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhm4d	pgxind-kftx3kem	pgxcs-kftvy4l6		a6e8c3e6-28a4-4b3b-9785-d6f0773fa1e0	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhm8a	pgxind-kftx3kib	pgxcs-kftvy5up		17cc65cf-816c-4656-b2bf-e9889fe4c5e7	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhmir	pgxind-kftx3l2n	pgxcs-kftvy98l		826d2a46-4a89-4398-8a22-1ba7fefe4a7b	Primary Tumor	NCIT:C7268	Mucinous Minimally Invasive Lung Adenocarcinoma	pgx:icdom-82533	Bronchiolo-alveolar carcinoma, mucinous	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhmj4	pgxind-kftx3l33	pgxcs-kftvy9cg		2c02e281-d84c-4d1b-a89c-c48439becc39	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhmog	pgxind-kftx3l8y	pgxcs-kftvyb2s		c7b943ab-3ca3-43d3-9bfc-4c6785964b28	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhn40	pgxind-kftx3loc	pgxcs-kftvyfwk		af744755-51eb-4daf-9029-5cf88730b1dc	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhnds	pgxind-kftx3j8d	pgxcs-kftvyj0t		c5cf6cde-0db3-40d2-8ac4-2a13484b3442	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhnij	pgxind-kftx3m2p	pgxcs-kftvykij		3ba5f6b9-6458-44e2-a0aa-b5c7e5fcd632	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhnos	pgxind-kftx3m8u	pgxcs-kftvymgx		a82b92b7-6f46-46a1-b815-6188a65ef285	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhnwo	pgxind-kftx3k22	pgxcs-kftvyox8		61646911-1672-45ca-8deb-4192e1ceed49	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhnx1	pgxind-kftx3mgp	pgxcs-kftvyp15		034cf68f-79af-40f3-bb6e-26ae98b3a62f	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhnzj	pgxind-kftx3mj2	pgxcs-kftvyprz		b5c9beed-da9d-4110-9b6d-54a66498d5cc	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvho44	pgxind-kftx3mne	pgxcs-kftvyr6i		745aaf77-a464-4363-b6e4-10d30ff947b8	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvho5a	pgxind-kftx3mof	pgxcs-kftvyrlq		de4bb1d0-8bd9-4614-85ca-c39d8c636bcc	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhoay	pgxind-kftx3mtk	pgxcs-kftvytdn		0e02dc1a-653b-4b16-824a-251a1aa41c2d	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhodd	pgxind-kftx3mvn	pgxcs-kftvyu6p		97df724f-afe1-4db4-9563-853245093fbb	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhoer	pgxind-kftx3mwv	pgxcs-kftvyum1		a2bd3774-b4b4-4419-83a4-d935c285419c	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhokb	pgxind-kftx3n1u	pgxcs-kftvywf6		11e65f8b-4e48-42e7-a87c-bcf2538168c6	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhopd	pgxind-kftx3n6i	pgxcs-kftvyy0b		49cf5040-2d73-4538-8825-7fba37379289	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.2	Middle lobe, lung	middle lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhos3	pgxind-kftx3n8v	pgxcs-kftvyyvw		efd3f14f-f785-4aec-9efd-6dd8e9c41eba	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhovn	pgxind-kftx3ncc	pgxcs-kftvyzya		17d259bd-c709-47d7-8a68-112161537d70	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhoy9	pgxind-kftx3neq	pgxcs-kftvz0si		e47e21b7-550b-4268-8e1a-ab176b0abc1d	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhoyp	pgxind-kftx3nf3	pgxcs-kftvz0xa		34cf39a1-158e-4362-a487-d25c7d98a8cd	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhoys	pgxind-kftx3m4k	pgxcs-kftvz0ya		0a58850b-1093-4c52-9211-b2b4949868c7	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhp3r	pgxind-kftx3n07	pgxcs-kftvz2i4		96a05d4b-3731-4b98-b38f-a6b33cd6ed96	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhp70	pgxind-kftx3nmg	pgxcs-kftvz3jy		d80486cd-f054-4527-a886-cf9446381b9f	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhp8r	pgxind-kftx3no5	pgxcs-kftvz45c		55f79464-e4d9-47be-8ce8-c4959e9eb753	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhpc5	pgxind-kftx3nqm	pgxcs-kftvz57m		22434a49-eb8a-43ac-8c08-ae6dcbe6fbb8	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhpwq	pgxind-kftx3o9z	pgxcs-kftvzbn1		97e9d32a-d9f8-43d3-a459-9cd2bc8cd781	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhq5m	pgxind-kftx3l31	pgxcs-kftvzegr		6176e1f7-8dfd-4de4-8abb-3eff1839de56	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhqcx	pgxind-kftx3jqo	pgxcs-kftvzgs8		d1fb0862-8d9c-4bc4-aac6-81dc4eed66c9	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhqd4	pgxind-kftx3on0	pgxcs-kftvzgu7		e350e922-0a73-4afc-bc24-d40659468fe7	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhqkc	pgxind-kftx3osy	pgxcs-kftvzj58		50f8e9f5-2b07-4343-81d5-133d9d5d1de3	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhqmc	pgxind-kftx3ouf	pgxcs-kftvzjqu		4b700f22-f0d2-49f9-b5c7-b15fdbd6b1f6	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhqt7	pgxind-kftx3ozk	pgxcs-kftvzlxz		8e131477-b3c5-43ea-bb00-c3052e67c74b	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhqyd	pgxind-kftx3p33	pgxcs-kftvznkp		e7f4b521-29a2-4f17-8819-f02507db90f2	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhqyg	pgxind-kftx3p37	pgxcs-kftvznlp		3428ee68-83f2-4f48-8192-45f7e9e79b1d	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhqzc	pgxind-kftx3p3z	pgxcs-kftvznxu		ad27dc24-38a2-4851-8598-ae2bdeb4a9d3	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhr0d	pgxind-kftx3gnr	pgxcs-kftvzo9m		300cb22f-acb4-4acd-8d64-fe8dcdf64801	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhr89	pgxind-kftx3mhw	pgxcs-kftvzqrw		87f48b57-3bd8-4310-924a-7d9d95b8dd11	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhrkt	pgxind-kftx3pld	pgxcs-kftvzupf		dab00804-e92f-43f1-9348-16f3015b5dce	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhrmc	pgxind-kftx3ok9	pgxcs-kftvzv5z		11f47c9a-6435-47fb-ace2-74f29f5f3f01	Primary Tumor	NCIT:C5649	Acinar Lung Adenocarcinoma	pgx:icdom-85503	Acinar cell carcinoma	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhrt5	pgxind-kftx3pb3	pgxcs-kftvzxc0		2b482b5d-5672-4035-b2dd-47311ed936b9	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhs0u	pgxind-kftx3pxo	pgxcs-kftvzzs2		baa282a3-b78b-4be7-9756-4e4c6298f8a3	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhs4y	pgxind-kftx3q0h	pgxcs-kftw014u		171e69fb-ce1c-43e9-9f05-d34ebf4da682	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhsal	pgxind-kftx3q46	pgxcs-kftw02x0		87d21e55-7f4a-4652-b7f7-1e64cb300fae	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhsgs	pgxind-kftx3q8v	pgxcs-kftw04xj		5235cfa0-b767-42cd-aa9b-3bd2f0f4fb64	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhsja	pgxind-kftx3qai	pgxcs-kftw05ry		ceb7629b-71ae-458a-b6a2-5e34cafcc41a	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhsk8	pgxind-kftx3qb1	pgxcs-kftw0629		a6ca2f89-d997-496d-9e2f-996abda1d896	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhsoy	pgxind-kftx3h5d	pgxcs-kftw07ko		48257830-1c09-4bb6-b7a4-3dd3049a42f7	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhsvn	pgxind-kftx3qjv	pgxcs-kftw09qm		fc511a67-5383-4877-aeef-36c0b7934b77	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvht7m	pgxind-kftx3qrx	pgxcs-kftw0dkg		5cdca8c3-1f5d-461c-b09a-6e34a0af1cbb	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvht9a	pgxind-kftx3qta	pgxcs-kftw0e1u		fceb89f9-c4db-42b4-84dd-06a8603c071b	Primary Tumor	NCIT:C5649	Acinar Lung Adenocarcinoma	pgx:icdom-85503	Acinar cell carcinoma	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhtcn	pgxind-kftx3qvy	pgxcs-kftw0f5i		3e08e880-bb50-4460-b1bf-06064f12d0c2	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhtpt	pgxind-kftx3lxh	pgxcs-kftw0jgp		48e8bef9-85ff-4b0f-b249-a1f6c63dd100	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhtq0	pgxind-kftx3r58	pgxcs-kftw0jin::pgxcs-kftw2epg		b560df97-986b-4a88-a0f1-c38a30080edb	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhtt3	pgxind-kftx3r78	pgxcs-kftw0kg1		563c76af-765a-4001-a58c-6f9616b60452	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhtu3	pgxind-kftx3mxj	pgxcs-kftw0ktm		7733adf9-cd8e-4f26-8e90-7018d87da533	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhtwd	pgxind-kftx3fqs	pgxcs-kftw0lhq		15321297-7110-4e79-8d6f-94c95bc83c94	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhucd	pgxind-kftx3ris	pgxcs-kftw0qmq		964f7284-f9b8-4f77-a744-7182685dc6a7	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhudm	pgxind-kftx3rjo	pgxcs-kftw0r2u		bf85a46b-d7c8-4753-a4c0-8f774dba9e06	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.0	Main bronchus	main bronchus						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhujs	pgxind-kftx3kl5	pgxcs-kftw0t0b::pgxcs-kftw4gx3		d8f165af-1df5-4876-abf8-7596e52a3bc3	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhuz3	pgxind-kftx3rrg	pgxcs-kftw0uyy		252c5d60-7033-44c3-8ab5-4604670a80f4	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.0	Main bronchus	main bronchus						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhv06	pgxind-kftx3o6e	pgxcs-kftw0vax		e41efacb-ce84-4ebb-872a-05d866d2bc12	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhv1k	pgxind-kftx3rsz	pgxcs-kftw0vql		b180fdf0-935d-406a-9ec3-0d839d74d322	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhv8i	pgxind-kftx3rx6	pgxcs-kftw0xzh		b37cf4c9-e67c-4653-af68-c4b4c57c8412	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhvit	pgxind-kftx3s2z	pgxcs-kftw11av		2aaab31d-2622-4b76-8fa0-0a433ad7533e	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhvk1	pgxind-kftx3iag	pgxcs-kftw11ns		90e374aa-f02d-40dd-b306-cf392ef1026d	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhvk9	pgxind-kftx3s47	pgxcs-kftw11q7		fb9c6881-c503-45c8-b17a-b47a9e8d9003	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhvu5	pgxind-kftx3san	pgxcs-kftw14w5		1bac4ff6-e35b-40f6-bbe4-705ab672d102	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhvux	pgxind-kftx3sb8	pgxcs-kftw154d		9ab03618-703c-4401-a198-e02510807646	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhvvd	pgxind-kftx3rc4	pgxcs-kftw1598		fedc687f-a217-4e70-a4fd-9c73b3becd75	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhvxn	pgxind-kftx3hsf	pgxcs-kftw15xm		14b6fce1-2aa8-4b9d-be47-ed0444d365c7	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhw4q	pgxind-kftx3r7d	pgxcs-kftw187m		1220e8b3-e16e-454e-bc49-60f49f9fe090	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhw9j	pgxind-kftx3qho	pgxcs-kftw19qa		2885d4b3-34a6-421d-b20c-eedad721d10a	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhwfz	pgxind-kftx3q4c	pgxcs-kftw1bta		2896f7fb-d6cb-4da3-ab40-52d1e739b8d9	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhwi3	pgxind-kftx3ikn	pgxcs-kftw1ciw		c26fde0c-b5d2-41d8-9ad4-f177b18ad52e	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhwow	pgxind-kftx3i8y	pgxcs-kftw1eli		1ec1cfe2-8af6-499d-a6d6-a3404d346028	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhwqs	pgxind-kftx3sva	pgxcs-kftw1f9b::pgxcs-kftw1h9s		179b480b-bbbf-4fa5-9ac5-71e7e0b01f99	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhwuy	pgxind-kftx3fvs	pgxcs-kftw1gl2		ea658763-5482-44b6-a1d1-d9bb66f40092	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhxan	pgxind-kftx3hae	pgxcs-kftw1lng		9babf36a-fe87-4973-a220-97c5c26b76a2	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhxo0	pgxind-kftx3ter	pgxcs-kftw1pvk		5d0e7b83-5577-450a-b1a5-59ca03fc3bc5	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhxr7	pgxind-kftx3pi2	pgxcs-kftw1qwh		58dcad42-2e30-4cb9-ada6-5e72c4bcf406	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhxua	pgxind-kftx3tig	pgxcs-kftw1rxk		4549c88f-18ba-4cf5-b960-a5e1192c27be	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhxzi	pgxind-kftx3tkz	pgxcs-kftw1tjj		3e43db1f-f34c-4cfc-a7a0-f161d85c0ac9	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.2	Middle lobe, lung	middle lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhydn	pgxind-kftx3gfv	pgxcs-kftw1y3o		45de6106-407a-4e9d-a10e-881c01fd965c	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhyfb	pgxind-kftx3gj8	pgxcs-kftw1ylk		a007ecae-0f53-4523-a9b3-8865ed7cf614	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhyi4	pgxind-kftx3ond	pgxcs-kftw1zi5		aae346a0-532d-48a3-89b2-d0a614097fd5	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhyiu	pgxind-kftx3tj0	pgxcs-kftw1zpv		e190a9e4-10ae-4060-a071-4b8b73479023	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhynf	pgxind-kftx3spq	pgxcs-kftw215u		1f5fa8fd-1de8-4456-8935-71b5a8b54bd2	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhypu	pgxind-kftx3r02	pgxcs-kftw2206		4f889554-d97b-4bec-bc9f-19f703c57255	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhyqd	pgxind-kftx3nco	pgxcs-kftw2268		5a1d5fb9-900f-4f73-bead-d67cae987a8a	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhyqi	pgxind-kftx3g1q	pgxcs-kftw227r		a231a29e-bac8-42db-b628-5ec1247cb388	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhyrw	pgxind-kftx3lk7	pgxcs-kftw22mw		5e39b554-238a-4e41-934d-85741069f1c0	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhyt3	pgxind-kftx3shx	pgxcs-kftw2328		c12f1638-214d-40f8-a553-b616a52f6933	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhyya	pgxind-kftx3u13	pgxcs-kftw24pk		de0e8b86-5791-4e7c-b939-30857cd7b0a8	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhyyq	pgxind-kftx3q72	pgxcs-kftw24ud		060717ad-f034-46fa-8e9b-94a9422e4666	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhz01	pgxind-kftx3l39	pgxcs-kftw258o		4e11ad69-d473-4433-822f-276dd3b5ca63	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhz1r	pgxind-kftx3iro	pgxcs-kftw25ti		096d8008-0b37-48c2-a938-a7864cbfb66c	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.8	Overlapping lesion of lung	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhz3k	pgxind-kftx3n22	pgxcs-kftw26cp		60b3aac0-9089-4047-afa5-4577ab50b30d	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhz72	pgxind-kftx3i69	pgxcs-kftw27hy		5e72a9b0-5f80-462e-a586-262f573dc62c	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhz9c	pgxind-kftx3oji	pgxcs-kftw2898		e63d9a32-593f-46e7-9d3b-866435cab585	Primary Tumor	NCIT:C2923	Bronchioloalveolar Carcinoma	pgx:icdom-82503	Bronchiolo-alveolar adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhzhu	pgxind-kftx3tic	pgxcs-kftw2ays		21a9703e-acf2-43a8-a2e2-23158404aed8	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhzk3	pgxind-kftx3uaw	pgxcs-kftw2bpy		660d639d-cc7c-4fe6-897a-6c06cc3e5bec	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhzul	pgxind-kftx3hcy	pgxcs-kftw2f3f		834d2a5b-3a4a-4ca2-aafc-dea8ba20ef23	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhzut	pgxind-kftx3gwt	pgxcs-kftw2f5v		c62220c7-44e3-455f-88ab-82a88c736610	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvhzwe	pgxind-kftx3ufg	pgxcs-kftw2fpo		d683c205-66e8-4be0-a849-14083a585e7d	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi01p	pgxind-kftx3uhh	pgxcs-kftw2hcy		a26f9de7-3ee7-4ed6-928a-ce9dc5734267	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi04d	pgxind-kftx3scn	pgxcs-kftw2i8c		80f196fe-1eaf-40cb-ab58-c84795acc5c7	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi04f	pgxind-kftx3j1a	pgxcs-kftw2i8u		2bedd7e4-dfeb-4252-9c1c-d50eeae4de07	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi061	pgxind-kftx3lw5	pgxcs-kftw2iq8		5a8b5291-c9c2-48a8-9d01-66b150a71eb7	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi09j	pgxind-kftx3s0w	pgxcs-kftw2jv9		21095913-9f26-4968-af07-442e2d73ead5	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi0an	pgxind-kftx3ulf	pgxcs-kftw2k7j		c5363830-3db9-4c0c-aa47-b32fdc888c60	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi0bn	pgxind-kftx3nwy	pgxcs-kftw2klc		8f274178-7a8e-46b6-8d2c-900338bbb946	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi0l4	pgxind-kftx3upk	pgxcs-kftw2nkq		b8f9acbf-0e4b-4967-a11b-7234b6cf83e0	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi0qo	pgxind-kftx3p1q	pgxcs-kftw2pam		54984e66-1d2a-4a62-a5aa-847bc12e02fc	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi13a	pgxind-kftx3uvw	pgxcs-kftw2tdo		56703aef-270a-4537-b9a1-c9ebbe873411	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi157	pgxind-kftx3u1t	pgxcs-kftw2tzl		7be5134a-24c9-43cb-a811-3c8aa89afe53	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi1a0	pgxind-kftx3uyp	pgxcs-kftw2vie		a29977a3-cedd-4861-a566-d4e942002ade	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi1pl	pgxind-kftx3fjh	pgxcs-kftw30ka		16a2d381-75a0-423b-aac2-d5710afb183b	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi1uw	pgxind-kftx3v5y	pgxcs-kftw32al		0748861e-1332-4a53-b714-aaaa467951e6	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi205	pgxind-kftx3uh9	pgxcs-kftw33yf		48f646fe-03c6-4e7b-acf1-9869e379443e	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi213	pgxind-kftx3v89	pgxcs-kftw348l		74bcf2d5-fd42-423e-bd96-b2de1b0cf778	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi26y	pgxind-kftx3mas	pgxcs-kftw365h		3e11762a-faf0-489d-8985-8ede2ccabd76	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi28k	pgxind-kftx3vay	pgxcs-kftw36mg		43a62dbd-5e29-4ba5-a91e-5033f01f118f	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi2ah	pgxind-kftx3vbq	pgxcs-kftw379j		eb9cc301-c323-47e4-97bf-b2605b599d3e	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi2ee	pgxind-kftx3tnm	pgxcs-kftw38hj		185bc9bd-1e20-467c-9c06-908c8aa27e7d	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi2lb	pgxind-kftx3ova	pgxcs-kftw3amu		82d1aff1-8e7c-4703-8dd7-70728bca7784	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi2qi	pgxind-kftx3o17	pgxcs-kftw3cd3		174e4405-4848-4e5e-93cc-0cdf2795c91a	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi2r3	pgxind-kftx3ub4	pgxcs-kftw3cjd		12870223-d36b-4a35-ba3d-70ed75eeab1d	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi2sa	pgxind-kftx3vhe	pgxcs-kftw3cwg		cffeea21-61c8-4f86-b8d3-e67b019768cc	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi2tg	pgxind-kftx3vhw	pgxcs-kftw3d8l		4bdf77d2-33cc-46e0-af34-1e66a90a213a	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi30o	pgxind-kftx3ruv	pgxcs-kftw3flo		0d7f5772-0319-4b56-9970-49fd21082f04	Primary Tumor	NCIT:C5649	Acinar Lung Adenocarcinoma	pgx:icdom-85503	Acinar cell carcinoma	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi397	pgxind-kftx3j9f	pgxcs-kftw3iay		442c64f8-29fb-4026-b505-f5ccd1cb4aec	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi3f0	pgxind-kftx3vnm	pgxcs-kftw3k7z		7cac4663-b026-4cee-84a4-866ee8e1447c	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi3f3	pgxind-kftx3ffz	pgxcs-kftw3k91		95933b01-06ca-4f3e-8995-eb2ab01a2c4c	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi3w1	pgxind-kftx3nts	pgxcs-kftw3po1		a74f6423-b5d3-4ae2-b61f-3ee04b1073bf	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi4a6	pgxind-kftx3kgb	pgxcs-kftw3u91		ed5b47c1-569f-492b-8d6c-155e3ba79acb	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi4ei	pgxind-kftx3htg	pgxcs-kftw3vm0		ea75499c-7bf0-47be-9b09-3c12aaa22f12	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi4he	pgxind-kftx3l0k	pgxcs-kftw3wk0		afec3b25-c3f7-4e48-8fb0-6fb4dd581081	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.2	Middle lobe, lung	middle lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi4js	pgxind-kftx3vse	pgxcs-kftw3x9u		c7c2f2f3-d5f6-4fb8-b02a-79fa39a42756	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi4kr	pgxind-kftx3rwk	pgxcs-kftw3xnb		bce7fd43-3213-4679-8ed2-c8ef632b3c6e	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi4l4	pgxind-kftx3qe7	pgxcs-kftw3xra		26006be0-d6c5-47b7-bb7b-5cb3f78c1ebd	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi4n1	pgxind-kftx3v8x	pgxcs-kftw3ycq		4bbc2e4d-c9c2-4142-924c-c4d939522ddd	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi4rh	pgxind-kftx3w0k	pgxcs-kftw3zs5		3788c2e8-a8d9-41f2-bad4-43e948bd90cd	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi4ss	pgxind-kftx3pni	pgxcs-kftw409h		803e1d61-0ccd-4a97-917d-34b5fdf290f3	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.2	Middle lobe, lung	middle lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi50q	pgxind-kftx3qd0	pgxcs-kftw42wn		609d3070-4b64-42ee-b071-42be33df7600	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi55w	pgxind-kftx3vyr	pgxcs-kftw44l8		c07c8c94-150b-40a2-8830-5be34dd99554	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi59j	pgxind-kftx3u1l	pgxcs-kftw45sf		2f073ffa-787e-4657-b1cd-d2db4865c809	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi5aj	pgxind-kftx3jbz	pgxcs-kftw463h		57b69a21-a1cd-48cd-93f7-aa196441c345	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi5m4	pgxind-kftx3ocn	pgxcs-kftw49wi		5600cb1a-d0f4-468e-b8d2-e431b77496bf	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi5xf	pgxind-kftx3s8m	pgxcs-kftw4dil		b671ceeb-72d0-40e3-8279-954e6ed242dd	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi61n	pgxind-kftx3szd	pgxcs-kftw4evl		c8c5aa67-c6b9-48ba-ace2-b040170d73fc	Primary Tumor	NCIT:C5649	Acinar Lung Adenocarcinoma	pgx:icdom-85503	Acinar cell carcinoma	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi62h	pgxind-kftx3kdl	pgxcs-kftw4f4e		88c65791-1a9c-4121-955a-9bd5ed1b0bba	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi64r	pgxind-kftx3u7w	pgxcs-kftw4fvn		eb822f95-8b15-4c86-b5e5-b0afe9c32e0c	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi64w	pgxind-kftx3wa9	pgxcs-kftw4fx4		9a7a1b22-9df6-438f-ad00-54755c7dbc7c	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi6dc	pgxind-kftx3jyw	pgxcs-kftw4iny		ea556296-ec05-4e4f-b95e-6bf02abb4463	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi6ed	pgxind-kftx3spy	pgxcs-kftw4iz7		962f85ff-1f27-49e4-8c3d-798facea122f	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.0	Main bronchus	main bronchus						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi6i2	pgxind-kftx3mdr	pgxcs-kftw4k6k		7f56df3f-b649-43d1-ab46-ad460233e46b	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi6i9	pgxind-kftx3vql	pgxcs-kftw4k8i		c5032c5f-4386-4aae-b986-480e4c7855db	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi6o6	pgxind-kftx3nx7	pgxcs-kftw4m7j		a3bf3f65-7b44-4993-a126-c76870dbbbac	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi6u0	pgxind-kftx3ro2	pgxcs-kftw4o2e::pgxcs-kftw50gp		7f411683-9d4e-4470-9987-eeccbdf090bb	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi6va	pgxind-kftx3wdr	pgxcs-kftw4oj5		32165b3d-08b3-4601-85e2-684be9dd8264	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi6ys	pgxind-kftx3t4j	pgxcs-kftw4pow		431c3f05-aa24-4d13-8dfe-96145289ae02	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi76i	pgxind-kftx3w9j	pgxcs-kftw4s8k		8a3a376a-a4db-4d4f-85ce-a894a2aa60bb	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi78f	pgxind-kftx3wfx	pgxcs-kftw4st2		7b879b39-8c84-40d8-a7b7-105512030f2a	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi7ce	pgxind-kftx3kc6	pgxcs-kftw4u37		ec73cdb0-efa2-4cc2-9a75-a6fc45dad0ea	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.2	Middle lobe, lung	middle lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi7fu	pgxind-kftx3jjb	pgxcs-kftw4v86		c8aa8a2e-e681-4a82-9320-f35f67650581	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi7gi	pgxind-kftx3r1i	pgxcs-kftw4vfk		6c2f3100-7ed8-41dd-9f8f-98b8eb245c12	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi7jl	pgxind-kftx3fan	pgxcs-kftw4wfx		8781a00c-0e9c-46de-89be-dcd0a2504918	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi7qp	pgxind-kftx3tny	pgxcs-kftw4yrk		3ad22921-3e1a-488e-83df-5ae8d24dbd06	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi7sy	pgxind-kftx3r6d	pgxcs-kftw4zg8		85e8a3bf-0536-4556-a40f-8a523c04b337	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi7u9	pgxind-kftx3pl4	pgxcs-kftw4zwz		2421f79c-fb83-46f6-9ae2-dd275575f568	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi7vz	pgxind-kftx3wgj	pgxcs-kftw50f9		245ba0b0-c164-4d2e-8539-d23afb47d371	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi7y4	pgxind-kftx3v5q	pgxcs-kftw514o		43ddcc1b-208a-4857-ad5c-4db159871bc8	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi7zk	pgxind-kftx3nli	pgxcs-kftw51kk		a236f15a-76cc-4a2d-9087-e824ad581453	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi8ej	pgxind-kftx3ml5	pgxcs-kftw56dz		23157ce2-7257-4118-9a6e-4cdfbc6c4bf7	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi8ko	pgxind-kftx3gtl	pgxcs-kftw58bk		0bb7c904-7964-424f-8b26-4e30a30f5641	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi8o9	pgxind-kftx3iz0	pgxcs-kftw59h8		7ecb9621-7a1f-4876-9dfb-9b77cc4cb7b4	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi8od	pgxind-kftx3qlz	pgxcs-kftw59i7		9dc330bf-acbd-4419-b533-35cf59acec71	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi8oe	pgxind-kftx3fkh	pgxcs-kftw59j6		6b0b11c9-2adc-4b55-b7bb-cf67b11cab86	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.2	Middle lobe, lung	middle lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi8ru	pgxind-kftx3gih	pgxcs-kftw5amh		122d2045-4c09-47da-90e8-6ee5d081ea12	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi8t7	pgxind-kftx3n4o	pgxcs-kftw5b4i		22128163-5e4d-449d-bba8-f5d426f24d24	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi959	pgxind-kftx3fkn	pgxcs-kftw5f14		09656581-db34-4e6e-afe0-80666eb5fba6	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi9j7	pgxind-kftx3r1a	pgxcs-kftw5ggn		a2a8125a-aadb-4e8f-9e80-841b65c647ee	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi9jm	pgxind-kftx3tli	pgxcs-kftw5gky		8178f402-db5c-4343-a6f6-4d4f9d3bf4ac	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi9lo	pgxind-kftx3pvf	pgxcs-kftw5h94		bd57c86d-bb0d-40a3-9292-97d6b33db1ea	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi9m2	pgxind-kftx3plb	pgxcs-kftw5hdh		5de486c6-1569-4f07-97ce-dbbc7889b402	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.8	Overlapping lesion of lung	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi9mz	pgxind-kftx3ny2	pgxcs-kftw5hnn		f61bcfbe-5dc5-4346-b44f-3b90cebd6653	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi9nt	pgxind-kftx3wmp	pgxcs-kftw5hwr		0c12ba81-c5dd-4119-a91b-71a3bddb3a74	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi9pd	pgxind-kftx3v5a	pgxcs-kftw5idc		c19c0f70-6be3-4370-b643-aaad381bd186	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi9pq	pgxind-kftx3ubm	pgxcs-kftw5iju		a75dde6a-c75d-42c3-a456-dff0f8d3c960	Primary Tumor	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi9q5	pgxind-kftx3wmr	pgxcs-kftw5ioa		bac0b02d-ac3b-4784-b8bf-180eadd548a3	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.3	Lower lobe, lung	lower lobe of lung						EFO:0030049	alive (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030049	alive (follow-up status)	DUO:0000004	no restriction
pgxbs-kftvi9rv	pgxind-kftx3k1o	pgxcs-kftw5j7r		98687adb-f8e9-4e6e-bc1b-396a3ddfac96	Primary Tumor	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.1	Upper lobe, lung	upper lobe of lung						EFO:0030041	dead (follow-up status)				None	None	XXX	0.0	0.0												EFO:0030041	dead (follow-up status)	DUO:0000004	no restriction
pgxbs-khv36oi4	pgxind-khv36oij	pgxcs-khv36oim		PGX_AM_BS_brain24	lung carcinoma [brain metastasis]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				None	None	XXX	0.0	0.0												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-khv36okt	pgxind-khv36ol9	pgxcs-khv36olc		PGX_AM_BS_brain26	lung carcinoma [brain metastasis]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				None	None	XXX	0.0	0.0												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-khv36ome	pgxind-khv36omu	pgxcs-khv36omx		PGX_AM_BS_brain27	lung carcinoma [brain metastasis]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				None	None	XXX	0.0	0.0												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-khv36onr	pgxind-khv36oo7	pgxcs-khv36ooa		PGX_AM_BS_brain28	lung carcinoma [brain metastasis]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				None	None	XXX	0.0	0.0												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidvf	pgxind-kftx41fv	pgxcs-kftw6szd		PGX_AM_BS_GSM402759	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402759	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidvi	pgxind-kftx41fz	pgxcs-kftw6t0c		PGX_AM_BS_GSM402761	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402761	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidvl	pgxind-kftx41g3	pgxcs-kftw6t1b		PGX_AM_BS_GSM402763	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402763	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidvq	pgxind-kftx41g9	pgxcs-kftw6t2r		PGX_AM_BS_GSM402766	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402766	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidw2	pgxind-kftx41gn	pgxcs-kftw6t65		PGX_AM_BS_GSM402773	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402773	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidw4	pgxind-kftx41gp	pgxcs-kftw6t6n		PGX_AM_BS_GSM402774	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402774	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidw9	pgxind-kftx41gv	pgxcs-kftw6t83		PGX_AM_BS_GSM402777	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402777	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidwe	pgxind-kftx41h1	pgxcs-kftw6t9k		PGX_AM_BS_GSM402780	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402780	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidwj	pgxind-kftx41h7	pgxcs-kftw6tb0		PGX_AM_BS_GSM402783	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402783	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidwk	pgxind-kftx41h9	pgxcs-kftw6tbi		PGX_AM_BS_GSM402784	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402784	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidwr	pgxind-kftx41hh	pgxcs-kftw6tdp		PGX_AM_BS_GSM402788	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402788	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidx4	pgxind-kftx41hy	pgxcs-kftw6thl		PGX_AM_BS_GSM402796	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402796	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvidx9	pgxind-kftx41i4	pgxcs-kftw6tkm		PGX_AM_BS_GSM402802	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM402802	geo:GSE16092	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieb0	pgxind-kftx41z3	pgxcs-kftw6xwf		PGX_AM_BS_GSM434256	non-small cell Lung carcinoma [cell line NCI-H2887]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434256	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieb2	pgxind-kftx41z5	pgxcs-kftw6xug		PGX_AM_BS_GSM434252	lung adenocarcinoma [cell line NCI-H1819]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434252	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieb5	pgxind-kftx41z9	pgxcs-kftw6xvf		PGX_AM_BS_GSM434254	lung adenocarcinoma [cell line NCI-H2347]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434254	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieba	pgxind-kftx41zf	pgxcs-kftw6xxe		PGX_AM_BS_GSM434258	Lung adenocarcinoma [cell line HCC1171]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434258	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviebh	pgxind-kftx41zn	pgxcs-kftw6xzm		PGX_AM_BS_GSM434262	Lung adenocarcinoma [cell line HCC461]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434262	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviebk	pgxind-kftx41zr	pgxcs-kftw6y0l		PGX_AM_BS_GSM434264	Lung adenocarcinoma [cell line HCC78]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434264	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviebm	pgxind-kftx41zt	pgxcs-kftw6y13		PGX_AM_BS_GSM434265	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434265	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviebr	pgxind-kftx41zz	pgxcs-kftw6y2j		PGX_AM_BS_GSM434268	lung adenocarcinoma [cell line NCI-H1648]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434268	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviec2	pgxind-kftx420d	pgxcs-kftw6y5z		PGX_AM_BS_GSM434275	lung adenocarcinoma [cell line HOP-62]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434275	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviec4	pgxind-kftx420f	pgxcs-kftw6y6i		PGX_AM_BS_GSM434276	Lung adenocarcinoma [cell line Calu-3]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434276	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviec6	pgxind-kftx420h	pgxcs-kftw6y70		PGX_AM_BS_GSM434277	Lung adenocarcinoma [cell line NCI-H1395]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434277	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviec9	pgxind-kftx420l	pgxcs-kftw6y80		PGX_AM_BS_GSM434279	lung adenocarcinoma [cell line NCI-H1755]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434279	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieca	pgxind-kftx420n	pgxcs-kftw6y8i		PGX_AM_BS_GSM434280	Bronchioalveolar carcinoma [cell line NCI-H1781]	NCIT:C2923	Bronchioloalveolar carcinoma	pgx:icdom-82513	Alveolar adenocarcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434280	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviecc	pgxind-kftx420p	pgxcs-kftw6y90		PGX_AM_BS_GSM434281	Squamous cell lung carcinoma [cell line NCI-H520]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434281	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviecg	pgxind-kftx420u	pgxcs-kftw6y9z		PGX_AM_BS_GSM434283	adenosquamous lung carcinoma [cell line HCC2279]	NCIT:C9133	Lung Adenosquamous Carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434283	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviech	pgxind-kftx420w	pgxcs-kftw6yah		PGX_AM_BS_GSM434284	Lung adenocarcinoma [cell line HCC2935]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434284	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviecj	pgxind-kftx420y	pgxcs-kftw6yaz		PGX_AM_BS_GSM434285	Lung adenocarcinoma [cell line HCC364]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434285	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviecm	pgxind-kftx4211	pgxcs-kftw6yby		PGX_AM_BS_GSM434287	large cell lung carcinoma [cell line LCLC-103-H]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434287	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieco	pgxind-kftx4213	pgxcs-kftw6ycg		PGX_AM_BS_GSM434288	Large cell lung carcinoma [cell line LCLC-97TMI]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434288	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviect	pgxind-kftx4219	pgxcs-kftw6ydy		PGX_AM_BS_GSM434291	lung adenocarcinoma [cell line SK-LU-1]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434291	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviecw	pgxind-kftx421d	pgxcs-kftw6yey		PGX_AM_BS_GSM434293	Lung adenocarcinoma [cell line NCI-H1975]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434293	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviedl	pgxind-kftx4228	pgxcs-kftw6ymb		PGX_AM_BS_GSM434308	papillary lung adenocarcinoma [cell line NCI-H441]	NCIT:C5650	Papillary lung adenocarcinoma	pgx:icdom-82603	Papillary adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434308	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviedn	pgxind-kftx422a	pgxcs-kftw6ymt		PGX_AM_BS_GSM434309	lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434309	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviedz	pgxind-kftx422o	pgxcs-kftw6yt0		PGX_AM_BS_GSM434316	lung adenocarcinoma [cell line NCI-H2009]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434316	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviee5	pgxind-kftx422x	pgxcs-kftw6yv0		PGX_AM_BS_GSM434320	Lung adenocarcinoma [cell line HCC2450]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434320	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviee8	pgxind-kftx4231	pgxcs-kftw6yvz		PGX_AM_BS_GSM434322	squamous cell Lung carcinoma [cell line HCC95]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434322	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieea	pgxind-kftx4233	pgxcs-kftw6ywg		PGX_AM_BS_GSM434323	lung adenocarcinoma [cell line A-427]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434323	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieec	pgxind-kftx4235	pgxcs-kftw6ywy		PGX_AM_BS_GSM434324	Squamous cell lung carcinoma [cell line Calu-1]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434324	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieef	pgxind-kftx4239	pgxcs-kftw6yxx		PGX_AM_BS_GSM434326	lung adenocarcinoma [cell line NCI-H1355]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434326	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieeh	pgxind-kftx423b	pgxcs-kftw6yyf		PGX_AM_BS_GSM434327	Lung adenocarcinoma [cell line NCI-H1563]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434327	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieej	pgxind-kftx423d	pgxcs-kftw6yyx		PGX_AM_BS_GSM434328	Lung adenocarcinoma [cell line NCI-H1734]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434328	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieem	pgxind-kftx423h	pgxcs-kftw6yzv		PGX_AM_BS_GSM434330	lung adenocarcinoma [cell line NCI-H1838]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434330	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieep	pgxind-kftx423l	pgxcs-kftw6z0u		PGX_AM_BS_GSM434332	Lung adenocarcinoma [cell line NCI-H2030]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434332	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieet	pgxind-kftx423p	pgxcs-kftw6z1u		PGX_AM_BS_GSM434334	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434334	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieeu	pgxind-kftx423r	pgxcs-kftw6z2b		PGX_AM_BS_GSM434335	lung adenocarcinoma [cell line NCI-H23]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM434335	geo:GSE17247	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieew	pgxind-kftx423t	pgxcs-kftw6z2s		PGX_AM_BS_GSM434786	squamous cell lung carcinoma [cell line NCI-H1703]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434786	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieey	pgxind-kftx423v	pgxcs-kftw6z3a		PGX_AM_BS_GSM434787	non-small cell  lung carcinoma [cell line NCI-H1869]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434787	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvief0	pgxind-kftx423x	pgxcs-kftw6z3r		PGX_AM_BS_GSM434788	squamous cell lung carcinoma [cell line NCI-H2066]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434788	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvief1	pgxind-kftx423z	pgxcs-kftw6z49		PGX_AM_BS_GSM434789	squamous cell lung carcinoma [cell line NCI-H2170]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434789	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvief3	pgxind-kftx4241	pgxcs-kftw6z4q		PGX_AM_BS_GSM434790	squamous cell lung carcinoma [cell line NCI-H2286]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434790	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvief5	pgxind-kftx4243	pgxcs-kftw6z58		PGX_AM_BS_GSM434791	Bronchio-alveolar carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434791	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviefe	pgxind-kftx424d	pgxcs-kftw6z7n		PGX_AM_BS_GSM434796	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434796	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviefu	pgxind-kftx424y	pgxcs-kftw6zch		PGX_AM_BS_GSM434806	Large cell carcinoma	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434806	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieg3	pgxind-kftx4258	pgxcs-kftw6zex		PGX_AM_BS_GSM434811	Large cell carcinoma	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM434811	geo:GSE17429	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviek6	pgxind-kftx42ab	pgxcs-kftw70o1		PGX_AM_BS_GSM169437	Small cell lung carcinoma [cell line NCI-H510]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM169437	geo:GSE7068	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviekb	pgxind-kftx42ah	pgxcs-kftw70pj		PGX_AM_BS_GSM169440	small cell lung carcinoma [cell line NCI-H211]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM169440	geo:GSE7068	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviekd	pgxind-kftx42aj	pgxcs-kftw70q1		PGX_AM_BS_GSM169441	small-cell lung carcinoma [cell line NCI-H345]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM169441	geo:GSE7068	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieke	pgxind-kftx42al	pgxcs-kftw70qi		PGX_AM_BS_GSM169442	small-cell lung carcinoma [cell line H524]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM169442	geo:GSE7068	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvieki	pgxind-kftx42ap	pgxcs-kftw70rz		PGX_AM_BS_GSM169445	Small cell lung carcinoma [cell line DMS 79]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM169445	geo:GSE7068	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviekl	pgxind-kftx42at	pgxcs-kftw70sz		PGX_AM_BS_GSM169447	Small cell lung carcinoma [cell line SHP-77]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM169447	geo:GSE7068	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviekq	pgxind-kftx42az	pgxcs-kftw70uf		PGX_AM_BS_GSM169450	small cell Lung carcinoma [cell line NCI-H82]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM169450	geo:GSE7068	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviekr	pgxind-kftx42b1	pgxcs-kftw70ux		PGX_AM_BS_GSM169451	small cell Lung carcinoma [cell line NCI-H196]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM169451	geo:GSE7068	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviekv	pgxind-kftx42b5	pgxcs-kftw70vw		PGX_AM_BS_GSM169453	small cell Lung carcinoma [cell line H69AR]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM169453	geo:GSE7068	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviexy	pgxind-kftx42ra	pgxcs-kftw74z1		PGX_AM_BS_GSM242139	Lung carcinoma [cell line]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				King of Prussia	United States of America	USA	40.09	-75.4					geo:GSM242139	geo:GSE9585	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviez2	pgxind-kftx42sn	pgxcs-kftw75as		PGX_AM_BS_GSM242163	Lung carcinoma [cell line]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				King of Prussia	United States of America	USA	40.09	-75.4					geo:GSM242163	geo:GSE9585	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvifst	pgxind-kftx43t2	pgxcs-kftw7ec5		PGX_AM_BS_GSM449605	Lung squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM449605	geo:GSE17958	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvifsw	pgxind-kftx43t6	pgxcs-kftw7ed5		PGX_AM_BS_GSM449607	Lung squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM449607	geo:GSE17958	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvig6k	pgxind-kftx449u	pgxcs-kftw7ik6		PGX_AM_BS_GSM455987	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM455987	geo:GSE18252	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvig72	pgxind-kftx44ah	pgxcs-kftw7ipn		PGX_AM_BS_GSM455998	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM455998	geo:GSE18252	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvig77	pgxind-kftx44an	pgxcs-kftw7ir4		PGX_AM_BS_GSM456001	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM456001	geo:GSE18252	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvig7m	pgxind-kftx44b5	pgxcs-kftw7ivm		PGX_AM_BS_GSM456010	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM456010	geo:GSE18252	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvig7r	pgxind-kftx44bb	pgxcs-kftw7iwk		PGX_AM_BS_GSM456012	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM456012	geo:GSE18252	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvigc7	pgxind-kftx44gu	pgxcs-kftw7kap		PGX_AM_BS_GSM456110	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM456110	geo:GSE18252	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvigc8	pgxind-kftx44gw	pgxcs-kftw7kb6		PGX_AM_BS_GSM456111	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM456111	geo:GSE18252	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvigca	pgxind-kftx44gy	pgxcs-kftw7kbp		PGX_AM_BS_GSM456112	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM456112	geo:GSE18252	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvigcb	pgxind-kftx44h0	pgxcs-kftw7kc8		PGX_AM_BS_GSM456113	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM456113	geo:GSE18252	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvigd2	pgxind-kftx44hx	pgxcs-kftw7kk2		PGX_AM_BS_GSM466320	Lung adenocarcinoma [cell line HCC827 GR1]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM466320	geo:GSE18797	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvigd9	pgxind-kftx44i5	pgxcs-kftw7km1		PGX_AM_BS_GSM466324	Lung adenocarcinoma [cell line HCC827 GR7]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM466324	geo:GSE18797	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvigdd	pgxind-kftx44i9	pgxcs-kftw7kn0		PGX_AM_BS_GSM466326	lung adenocarcinoma [cell line HCC827 PFR1]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM466326	geo:GSE18797	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvigdg	pgxind-kftx44id	pgxcs-kftw7knz		PGX_AM_BS_GSM466328	lung adenocarcinoma [cell line HCC827 PFR4]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM466328	geo:GSE18797	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvigdi	pgxind-kftx44if	pgxcs-kftw7koh		PGX_AM_BS_GSM466329	lung adenocarcinoma [cell line HCC827 PFR5]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM466329	geo:GSE18797	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvihzq	pgxind-kftx46i4	pgxcs-kftw82lk		PGX_AM_BS_GSM307984	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM307984	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvihzu	pgxind-kftx46i8	pgxcs-kftw82mk		PGX_AM_BS_GSM308016	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308016	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvihzv	pgxind-kftx46ia	pgxcs-kftw82n2		PGX_AM_BS_GSM308021	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308021	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvihzx	pgxind-kftx46ic	pgxcs-kftw82nj		PGX_AM_BS_GSM308022	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308022	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvihzy	pgxind-kftx46ie	pgxcs-kftw82o1		PGX_AM_BS_GSM308023	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308023	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii00	pgxind-kftx46ig	pgxcs-kftw82oj		PGX_AM_BS_GSM308024	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308024	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii05	pgxind-kftx46im	pgxcs-kftw82pz		PGX_AM_BS_GSM308029	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308029	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii08	pgxind-kftx46iq	pgxcs-kftw82qy		PGX_AM_BS_GSM308236	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308236	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii0a	pgxind-kftx46is	pgxcs-kftw82rg		PGX_AM_BS_GSM308238	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308238	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii0c	pgxind-kftx46iu	pgxcs-kftw82ry		PGX_AM_BS_GSM308240	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308240	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii0f	pgxind-kftx46iy	pgxcs-kftw82sw		PGX_AM_BS_GSM308248	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308248	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii0n	pgxind-kftx46j9	pgxcs-kftw82vc		PGX_AM_BS_GSM308471	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308471	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii0s	pgxind-kftx46jf	pgxcs-kftw82wt		PGX_AM_BS_GSM308475	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308475	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii0u	pgxind-kftx46jh	pgxcs-kftw82xb		PGX_AM_BS_GSM308476	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308476	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii0w	pgxind-kftx46jj	pgxcs-kftw82xs		PGX_AM_BS_GSM308477	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308477	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii0z	pgxind-kftx46jn	pgxcs-kftw82yr		PGX_AM_BS_GSM308479	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308479	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii12	pgxind-kftx46jr	pgxcs-kftw82zr		PGX_AM_BS_GSM308484	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308484	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvii16	pgxind-kftx46jv	pgxcs-kftw830q		PGX_AM_BS_GSM308489	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Groningen	Netherlands	NLD	53.22	6.57					geo:GSM308489	geo:GSE12280	geo:GPL7096					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviitt	pgxind-kftx47j4	pgxcs-kftw8bv1		PGX_AM_BS_GSM353230	lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New Haven	United States of America	USA	41.31	-72.93					geo:GSM353230	geo:GSE14079	geo:GPL1998					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviity	pgxind-kftx47ja	pgxcs-kftw8bwi		PGX_AM_BS_GSM353233	Lung adenocarcinoma [cell line Calu-3]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New Haven	United States of America	USA	41.31	-72.93					geo:GSM353233	geo:GSE14079	geo:GPL1998					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviiu0	pgxind-kftx47jc	pgxcs-kftw8bx0		PGX_AM_BS_GSM353234	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New Haven	United States of America	USA	41.31	-72.93					geo:GSM353234	geo:GSE14079	geo:GPL1998					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvijov	pgxind-kftx48li	pgxcs-kftw8lg5		PGX_AM_BS_GSM62324	Lung adenocarcinoma [cell line NCI-H1395]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM62324	geo:GSE2922	geo:GPL2043					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvijoy	pgxind-kftx48lm	pgxcs-kftw8lh4		PGX_AM_BS_GSM62326	lung adenocarcinoma [cell line NCI-H1648]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM62326	geo:GSE2922	geo:GPL2043					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvijp4	pgxind-kftx48lu	pgxcs-kftw8lj4		PGX_AM_BS_GSM62330	lung adenocarcinoma [cell line NCI-H2122]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM62330	geo:GSE2922	geo:GPL2043					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvijp6	pgxind-kftx48lw	pgxcs-kftw8ljl		PGX_AM_BS_GSM62332	lung adenocarcinoma [cell line NCI-H2347]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM62332	geo:GSE2922	geo:GPL2043					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvijp8	pgxind-kftx48ly	pgxcs-kftw8lk3		PGX_AM_BS_GSM62333	Lung adenocarcinoma [cell line HCC78]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM62333	geo:GSE2922	geo:GPL2043					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvijpm	pgxind-kftx48mg	pgxcs-kftw8loz		PGX_AM_BS_GSM62969	squamous cell Lung carcinoma [cell line HCC95]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM62969	geo:GSE2922	geo:GPL2043					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvijpo	pgxind-kftx48mi	pgxcs-kftw8lph		PGX_AM_BS_GSM62970	Lung adenocarcinoma [cell line HCC2450]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM62970	geo:GSE2922	geo:GPL2043					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvijpq	pgxind-kftx48mk	pgxcs-kftw8lpy		PGX_AM_BS_GSM62971	squamous cell lung carcinoma [cell line SK-MES-1]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM62971	geo:GSE2922	geo:GPL2043					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvijpv	pgxind-kftx48mq	pgxcs-kftw8lrf		PGX_AM_BS_GSM63350	Lung adenocarcinoma [cell line HCC827]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM63350	geo:GSE2922	geo:GPL2616					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvijq0	pgxind-kftx48mw	pgxcs-kftw8lsv		PGX_AM_BS_GSM63353	Squamous cell lung carcinoma [cell line NCI-H520]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM63353	geo:GSE2922	geo:GPL2043					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvipx6	pgxind-kftx4fx3	pgxcs-kftwafem		PGX_AM_BS_GSM50209	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50209	geo:GSE2520	geo:GPL2014					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvipxa	pgxind-kftx4fx8	pgxcs-kftwaffm		PGX_AM_BS_GSM50211	lung adenocarcinoma [cell line HOP-62]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50211	geo:GSE2520	geo:GPL2014					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvipxi	pgxind-kftx4fxi	pgxcs-kftwafi2		PGX_AM_BS_GSM50216	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50216	geo:GSE2520	geo:GPL2014					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvipxk	pgxind-kftx4fxk	pgxcs-kftwafil		PGX_AM_BS_GSM50217	lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50217	geo:GSE2520	geo:GPL2014					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviq01	pgxind-kftx4g0m	pgxcs-kftwagbn		PGX_AM_BS_GSM50272	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50272	geo:GSE2520	geo:GPL2015					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviq03	pgxind-kftx4g0n	pgxcs-kftwagc5		PGX_AM_BS_GSM50273	non-small cell Lung carcinoma [cell line EKVX]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50273	geo:GSE2520	geo:GPL2015					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviq05	pgxind-kftx4g0p	pgxcs-kftwagcn		PGX_AM_BS_GSM50274	lung adenocarcinoma [cell line HOP-62]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50274	geo:GSE2520	geo:GPL2015					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviq06	pgxind-kftx4g0r	pgxcs-kftwagd5		PGX_AM_BS_GSM50275	non-small cell Lung carcinoma [cell line HOP-92]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50275	geo:GSE2520	geo:GPL2015					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviq0a	pgxind-kftx4g0v	pgxcs-kftwage4		PGX_AM_BS_GSM50277	lung adenocarcinoma [cell line NCI-H23]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50277	geo:GSE2520	geo:GPL2015					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviq0d	pgxind-kftx4g0z	pgxcs-kftwagf4		PGX_AM_BS_GSM50279	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50279	geo:GSE2520	geo:GPL2015					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviq0f	pgxind-kftx4g11	pgxcs-kftwagfm		PGX_AM_BS_GSM50280	lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM50280	geo:GSE2520	geo:GPL2015					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvirpg	pgxind-kftx4i47	pgxcs-kftwaz90		PGX_AM_BS_GSM536267	Bronchial carcinoid	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM536267	geo:GSE21468	geo:GPL4093					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvirq7	pgxind-kftx4i54	pgxcs-kftwazif		PGX_AM_BS_GSM536283	small cell lung cancer	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM536283	geo:GSE21468	geo:GPL4093					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvirqr	pgxind-kftx4i5s	pgxcs-kftwazo7		PGX_AM_BS_GSM536295	small cell lung cancer	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM536295	geo:GSE21468	geo:GPL4093					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit6x	pgxind-kftx4jyn	pgxcs-kftwbfqh		PGX_AM_BS_GSM511564	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511564	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit70	pgxind-kftx4jyr	pgxcs-kftwbfrg		PGX_AM_BS_GSM511566	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511566	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit72	pgxind-kftx4jyt	pgxcs-kftwbfrx		PGX_AM_BS_GSM511567	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511567	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit75	pgxind-kftx4jyx	pgxcs-kftwbfsz		PGX_AM_BS_GSM511569	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511569	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit77	pgxind-kftx4jyz	pgxcs-kftwbfth		PGX_AM_BS_GSM511570	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511570	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit78	pgxind-kftx4jz2	pgxcs-kftwbfty		PGX_AM_BS_GSM511571	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511571	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7c	pgxind-kftx4jz6	pgxcs-kftwbfux		PGX_AM_BS_GSM511573	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511573	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7f	pgxind-kftx4jza	pgxcs-kftwbfvx		PGX_AM_BS_GSM511575	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511575	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7h	pgxind-kftx4jzc	pgxcs-kftwbfwf		PGX_AM_BS_GSM511576	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511576	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7i	pgxind-kftx4jze	pgxcs-kftwbfww		PGX_AM_BS_GSM511577	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511577	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7l	pgxind-kftx4jzi	pgxcs-kftwbfxv		PGX_AM_BS_GSM511579	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511579	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7n	pgxind-kftx4jzk	pgxcs-kftwbfyd		PGX_AM_BS_GSM511580	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511580	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7p	pgxind-kftx4jzm	pgxcs-kftwbfyv		PGX_AM_BS_GSM511581	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511581	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7s	pgxind-kftx4jzq	pgxcs-kftwbfzv		PGX_AM_BS_GSM511583	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511583	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit7t	pgxind-kftx4jzs	pgxcs-kftwbg0c		PGX_AM_BS_GSM511584	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511584	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit82	pgxind-kftx4k02	pgxcs-kftwbg2s		PGX_AM_BS_GSM511589	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511589	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit83	pgxind-kftx4k04	pgxcs-kftwbfsh		PGX_AM_BS_GSM511568	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511568	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit8b	pgxind-kftx4k0e	pgxcs-kftwbg5o		PGX_AM_BS_GSM511595	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511595	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit8d	pgxind-kftx4k0g	pgxcs-kftwbg66		PGX_AM_BS_GSM511596	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511596	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit8f	pgxind-kftx4k0i	pgxcs-kftwbg6q		PGX_AM_BS_GSM511597	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511597	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit8g	pgxind-kftx4k0k	pgxcs-kftwbg79		PGX_AM_BS_GSM511598	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511598	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit8i	pgxind-kftx4k0m	pgxcs-kftwbg7r		PGX_AM_BS_GSM511599	non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511599	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit8t	pgxind-kftx4k10	pgxcs-kftwbgb5		PGX_AM_BS_GSM511606	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511606	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit8y	pgxind-kftx4k16	pgxcs-kftwbgcn		PGX_AM_BS_GSM511609	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511609	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit90	pgxind-kftx4k18	pgxcs-kftwbgd6		PGX_AM_BS_GSM511610	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511610	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit93	pgxind-kftx4k1d	pgxcs-kftwbge5		PGX_AM_BS_GSM511612	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511612	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvit98	pgxind-kftx4k1j	pgxcs-kftwbghc		PGX_AM_BS_GSM511615	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM511615	geo:GSE20393	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitfw	pgxind-kftx4k9q	pgxcs-kftwbihz		PGX_AM_BS_GSM513936	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513936	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitg2	pgxind-kftx4k9y	pgxcs-kftwbijy		PGX_AM_BS_GSM513940	Lung adenocarcinoma [cell line NCI-H1563]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513940	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitg7	pgxind-kftx4ka4	pgxcs-kftwbilf		PGX_AM_BS_GSM513943	Lung adenocarcinoma [cell line NCI-H1693]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513943	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitg9	pgxind-kftx4ka6	pgxcs-kftwbilx		PGX_AM_BS_GSM513944	Lung adenocarcinoma [cell line NCI-H1734]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513944	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitge	pgxind-kftx4kac	pgxcs-kftwbine		PGX_AM_BS_GSM513947	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513947	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitgg	pgxind-kftx4kae	pgxcs-kftwbinv		PGX_AM_BS_GSM513948	Lung adenocarcinoma [cell line Calu-3]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513948	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitgh	pgxind-kftx4kag	pgxcs-kftwbiof		PGX_AM_BS_GSM513949	lung adenocarcinoma [cell line NCI-H1838]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513949	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitgl	pgxind-kftx4kak	pgxcs-kftwbipf		PGX_AM_BS_GSM513951	Lung adenocarcinoma [cell line NCI-H1975]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513951	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitgm	pgxind-kftx4kam	pgxcs-kftwbipw		PGX_AM_BS_GSM513952	Lung adenocarcinoma [cell line NCI-H1993]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513952	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitgo	pgxind-kftx4kao	pgxcs-kftwbiqd		PGX_AM_BS_GSM513953	non-small cell Lung carcinoma [cell line NCI-H2023]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513953	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitgq	pgxind-kftx4kaq	pgxcs-kftwbiqw		PGX_AM_BS_GSM513954	Lung adenocarcinoma [cell line NCI-H2073]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513954	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitgw	pgxind-kftx4kay	pgxcs-kftwbisw		PGX_AM_BS_GSM513958	Large cell lung carcinoma [cell line NCI-H2126]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513958	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitgy	pgxind-kftx4kb0	pgxcs-kftwbitd		PGX_AM_BS_GSM513959	lung adenocarcinoma [cell line NCI-H2228]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513959	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvith1	pgxind-kftx4kb4	pgxcs-kftwbiuc		PGX_AM_BS_GSM513961	lung adenocarcinoma [cell line NCI-H23]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513961	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvith3	pgxind-kftx4kb6	pgxcs-kftwbiwy		PGX_AM_BS_GSM513962	non-small cell Lung carcinoma [cell line NCI-H2342]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513962	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvith7	pgxind-kftx4kbc	pgxcs-kftwbiyh		PGX_AM_BS_GSM513965	lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513965	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvith9	pgxind-kftx4kbe	pgxcs-kftwbiyy		PGX_AM_BS_GSM513966	lung adenocarcinoma [cell line NCI-H838]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513966	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvithb	pgxind-kftx4kbg	pgxcs-kftwbizg		PGX_AM_BS_GSM513967	lung adenocarcinoma [cell line NCI-H920]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513967	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvithe	pgxind-kftx4kbk	pgxcs-kftwbj0f		PGX_AM_BS_GSM513969	Lung adenocarcinoma [cell line HCC827]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513969	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvithh	pgxind-kftx4kbo	pgxcs-kftwbj1d		PGX_AM_BS_GSM513971	squamous cell lung carcinoma [cell line SK-MES-1]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513971	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvithj	pgxind-kftx4kbq	pgxcs-kftwbj1v		PGX_AM_BS_GSM513972	Lung adenocarcinoma [cell line LXF 289]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513972	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitho	pgxind-kftx4kbx	pgxcs-kftwbj3d		PGX_AM_BS_GSM513975	lung adenocarcinoma [cell line NCI-H1651]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513975	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvithr	pgxind-kftx4kc1	pgxcs-kftwbj4c		PGX_AM_BS_GSM513977	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513977	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviti1	pgxind-kftx4kcc	pgxcs-kftwbj77		PGX_AM_BS_GSM513983	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513983	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviti3	pgxind-kftx4kce	pgxcs-kftwbj7o		PGX_AM_BS_GSM513984	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513984	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviti5	pgxind-kftx4kcg	pgxcs-kftwbj86		PGX_AM_BS_GSM513985	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513985	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitia	pgxind-kftx4kcm	pgxcs-kftwbj9m		PGX_AM_BS_GSM513988	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513988	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitib	pgxind-kftx4kco	pgxcs-kftwbja3		PGX_AM_BS_GSM513989	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513989	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitin	pgxind-kftx4kd3	pgxcs-kftwbjdg		PGX_AM_BS_GSM513996	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM513996	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitiv	pgxind-kftx4kdd	pgxcs-kftwbjfu		PGX_AM_BS_GSM514001	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514001	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitj4	pgxind-kftx4kdp	pgxcs-kftwbjiq		PGX_AM_BS_GSM514007	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514007	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitju	pgxind-kftx4kel	pgxcs-kftwbjqc		PGX_AM_BS_GSM514023	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514023	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitjw	pgxind-kftx4ken	pgxcs-kftwbjqu		PGX_AM_BS_GSM514024	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514024	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitkd	pgxind-kftx4kf8	pgxcs-kftwbjvq		PGX_AM_BS_GSM514034	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514034	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitkz	pgxind-kftx4kfy	pgxcs-kftwbk24		PGX_AM_BS_GSM514047	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514047	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitl4	pgxind-kftx4kg4	pgxcs-kftwbk5s		PGX_AM_BS_GSM514050	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514050	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitlc	pgxind-kftx4kge	pgxcs-kftwbk88		PGX_AM_BS_GSM514055	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514055	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitnw	pgxind-kftx4kjk	pgxcs-kftwbkz7		PGX_AM_BS_GSM514111	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514111	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitoy	pgxind-kftx4kkx	pgxcs-kftwblc7		PGX_AM_BS_GSM514134	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514134	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitp0	pgxind-kftx4kkz	pgxcs-kftwblcp		PGX_AM_BS_GSM514135	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514135	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitp3	pgxind-kftx4kl3	pgxcs-kftwbldo		PGX_AM_BS_GSM514137	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514137	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitpc	pgxind-kftx4kld	pgxcs-kftwblg4		PGX_AM_BS_GSM514142	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514142	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitpr	pgxind-kftx4klw	pgxcs-kftwblke		PGX_AM_BS_GSM514151	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514151	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitpx	pgxind-kftx4km4	pgxcs-kftwblmb		PGX_AM_BS_GSM514155	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514155	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitq2	pgxind-kftx4kma	pgxcs-kftwblnr		PGX_AM_BS_GSM514158	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514158	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitq6	pgxind-kftx4kme	pgxcs-kftwblop		PGX_AM_BS_GSM514160	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514160	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitq9	pgxind-kftx4kmi	pgxcs-kftwblpo		PGX_AM_BS_GSM514162	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514162	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitqh	pgxind-kftx4kmt	pgxcs-kftwbls3		PGX_AM_BS_GSM514167	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514167	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitr0	pgxind-kftx4knf	pgxcs-kftwblxf		PGX_AM_BS_GSM514178	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514178	geo:GSE20481	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitxi	pgxind-kftx4kvb	pgxcs-kftwbnwt		PGX_AM_BS_GSM514317	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514317	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitxn	pgxind-kftx4kvh	pgxcs-kftwbny9		PGX_AM_BS_GSM514320	lung adenocarcinoma [cell line CLS-54]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514320	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitxq	pgxind-kftx4kvl	pgxcs-kftwbnz8		PGX_AM_BS_GSM514322	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514322	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitxu	pgxind-kftx4kvp	pgxcs-kftwbo07		PGX_AM_BS_GSM514324	Lung adenocarcinoma [cell line LXF 289]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514324	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitxv	pgxind-kftx4kvr	pgxcs-kftwbo0p		PGX_AM_BS_GSM514325	Lung adenocarcinoma [cell line NCI-H1437]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514325	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitxx	pgxind-kftx4kvt	pgxcs-kftwbo16		PGX_AM_BS_GSM514326	Lung adenocarcinoma [cell line NCI-H1563]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514326	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvity0	pgxind-kftx4kvx	pgxcs-kftwbo25		PGX_AM_BS_GSM514328	Lung adenocarcinoma [cell line NCI-H1623]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514328	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvity5	pgxind-kftx4kw4	pgxcs-kftwbo3m		PGX_AM_BS_GSM514331	Lung adenocarcinoma [cell line NCI-H1734]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514331	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitya	pgxind-kftx4kwa	pgxcs-kftwbo53		PGX_AM_BS_GSM514334	lung adenocarcinoma [cell line NCI-H1838]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514334	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvityd	pgxind-kftx4kwe	pgxcs-kftwbo62		PGX_AM_BS_GSM514336	Lung adenocarcinoma [cell line NCI-H1975]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514336	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvityh	pgxind-kftx4kwi	pgxcs-kftwbo71		PGX_AM_BS_GSM514338	non-small cell Lung carcinoma [cell line NCI-H2023]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514338	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvityi	pgxind-kftx4kwk	pgxcs-kftwbo7i		PGX_AM_BS_GSM514339	Lung adenocarcinoma [cell line NCI-H2073]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514339	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvityk	pgxind-kftx4kwm	pgxcs-kftwbo80		PGX_AM_BS_GSM514340	Non-small cell lung carcinoma [cell line NCI-H2085]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514340	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvityn	pgxind-kftx4kwq	pgxcs-kftwbo8z		PGX_AM_BS_GSM514342	lung adenocarcinoma [cell line NCI-H2122]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514342	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvityp	pgxind-kftx4kws	pgxcs-kftwbo9h		PGX_AM_BS_GSM514343	Large cell lung carcinoma [cell line NCI-H2126]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514343	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvityr	pgxind-kftx4kwu	pgxcs-kftwbo9y		PGX_AM_BS_GSM514344	lung adenocarcinoma [cell line NCI-H2228]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514344	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitys	pgxind-kftx4kww	pgxcs-kftwboag		PGX_AM_BS_GSM514345	lung adenocarcinoma [cell line NCI-H2291]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514345	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvityu	pgxind-kftx4kwy	pgxcs-kftwboax		PGX_AM_BS_GSM514346	lung adenocarcinoma [cell line NCI-H23]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514346	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvityw	pgxind-kftx4kx0	pgxcs-kftwbobf		PGX_AM_BS_GSM514347	non-small cell Lung carcinoma [cell line NCI-H2342]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514347	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvityy	pgxind-kftx4kx2	pgxcs-kftwbobw		PGX_AM_BS_GSM514348	lung adenocarcinoma [cell line NCI-H2347]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514348	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvityz	pgxind-kftx4kx4	pgxcs-kftwboce		PGX_AM_BS_GSM514349	lung adenocarcinoma [cell line NCI-H2405]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514349	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitz1	pgxind-kftx4kx6	pgxcs-kftwbocv		PGX_AM_BS_GSM514350	lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514350	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitz5	pgxind-kftx4kxa	pgxcs-kftwbodu		PGX_AM_BS_GSM514352	lung adenocarcinoma [cell line NCI-H838]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514352	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitzq	pgxind-kftx4ky1	pgxcs-kftwbok5		PGX_AM_BS_GSM514365	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514365	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvitzv	pgxind-kftx4ky7	pgxcs-kftwboll		PGX_AM_BS_GSM514368	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514368	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu0f	pgxind-kftx4kyv	pgxcs-kftwborf		PGX_AM_BS_GSM514380	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514380	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu1o	pgxind-kftx4l0g	pgxcs-kftwbp71		PGX_AM_BS_GSM514408	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514408	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu2e	pgxind-kftx4l1c	pgxcs-kftwbpeq		PGX_AM_BS_GSM514424	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514424	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu2n	pgxind-kftx4l1m	pgxcs-kftwbph5		PGX_AM_BS_GSM514429	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514429	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu2t	pgxind-kftx4l1u	pgxcs-kftwbpj3		PGX_AM_BS_GSM514433	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514433	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu31	pgxind-kftx4l24	pgxcs-kftwbpli		PGX_AM_BS_GSM514438	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514438	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu3o	pgxind-kftx4l2v	pgxcs-kftwbps9		PGX_AM_BS_GSM514452	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514452	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu48	pgxind-kftx4l3h	pgxcs-kftwbpy1		PGX_AM_BS_GSM514464	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514464	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu4a	pgxind-kftx4l3j	pgxcs-kftwbpyj		PGX_AM_BS_GSM514465	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514465	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu4i	pgxind-kftx4l3r	pgxcs-kftwbq0x		PGX_AM_BS_GSM514470	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514470	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu4l	pgxind-kftx4l3v	pgxcs-kftwbq1v		PGX_AM_BS_GSM514472	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514472	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu4t	pgxind-kftx4l44	pgxcs-kftwbq6d		PGX_AM_BS_GSM514477	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514477	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu4y	pgxind-kftx4l49	pgxcs-kftwbq7t		PGX_AM_BS_GSM514480	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514480	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu58	pgxind-kftx4l4l	pgxcs-kftwbqar		PGX_AM_BS_GSM514486	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514486	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu5q	pgxind-kftx4l56	pgxcs-kftwbqg4		PGX_AM_BS_GSM514497	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514497	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu5v	pgxind-kftx4l5b	pgxcs-kftwbqhk		PGX_AM_BS_GSM514500	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514500	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu68	pgxind-kftx4l5r	pgxcs-kftwbqlg		PGX_AM_BS_GSM514508	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514508	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu6a	pgxind-kftx4l5t	pgxcs-kftwbqlx		PGX_AM_BS_GSM514509	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514509	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu6i	pgxind-kftx4l63	pgxcs-kftwbqod		PGX_AM_BS_GSM514514	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514514	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu6l	pgxind-kftx4l67	pgxcs-kftwbqpc		PGX_AM_BS_GSM514516	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514516	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu6n	pgxind-kftx4l69	pgxcs-kftwbqpt		PGX_AM_BS_GSM514517	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514517	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu6q	pgxind-kftx4l6d	pgxcs-kftwbqqs		PGX_AM_BS_GSM514519	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514519	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu6s	pgxind-kftx4l6f	pgxcs-kftwbqra		PGX_AM_BS_GSM514520	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514520	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu6x	pgxind-kftx4l6l	pgxcs-kftwbqss		PGX_AM_BS_GSM514523	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514523	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu70	pgxind-kftx4l6p	pgxcs-kftwbqtr		PGX_AM_BS_GSM514525	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514525	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu76	pgxind-kftx4l6x	pgxcs-kftwbqvo		PGX_AM_BS_GSM514529	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514529	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu7a	pgxind-kftx4l71	pgxcs-kftwbqwn		PGX_AM_BS_GSM514531	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514531	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu7j	pgxind-kftx4l7c	pgxcs-kftwbqzj		PGX_AM_BS_GSM514537	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514537	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu7o	pgxind-kftx4l7i	pgxcs-kftwbr0z		PGX_AM_BS_GSM514540	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514540	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu8j	pgxind-kftx4l8k	pgxcs-kftwbra5		PGX_AM_BS_GSM514559	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514559	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu8l	pgxind-kftx4l8m	pgxcs-kftwbran		PGX_AM_BS_GSM514560	lung adenocarcinoma [cell line SK-LU-1]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514560	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviu8n	pgxind-kftx4l8o	pgxcs-kftwbrb5		PGX_AM_BS_GSM514561	squamous cell lung carcinoma [cell line SK-MES-1]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				abbott park	United States of America	USA	42.3	-87.9					geo:GSM514561	geo:GSE20481	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviuit	pgxind-kftx4ll2	pgxcs-kftwbufj		PGX_AM_BS_GSM517034	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM517034	geo:GSE20574	geo:GPL9128					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftviuiw	pgxind-kftx4ll6	pgxcs-kftwbug1		PGX_AM_BS_GSM517071	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM517071	geo:GSE20584	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvix9h	pgxind-kftx4oyv	pgxcs-kftwcoy5		PGX_AM_BS_GSM638959	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM638959	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvix9y	pgxind-kftx4ozf	pgxcs-kftwcp13		PGX_AM_BS_GSM638965	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM638965	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixai	pgxind-kftx4p04	pgxcs-kftwcp6z		PGX_AM_BS_GSM638978	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM638978	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixc6	pgxind-kftx4p25	pgxcs-kftwcpom		PGX_AM_BS_GSM639015	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639015	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixcq	pgxind-kftx4p2t	pgxcs-kftwcpui		PGX_AM_BS_GSM639027	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639027	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixda	pgxind-kftx4p3i	pgxcs-kftwcq2n		PGX_AM_BS_GSM639039	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639039	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixde	pgxind-kftx4p3o	pgxcs-kftwcq44		PGX_AM_BS_GSM639042	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639042	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixe5	pgxind-kftx4p4l	pgxcs-kftwcqc2		PGX_AM_BS_GSM639058	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639058	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixet	pgxind-kftx4p5f	pgxcs-kftwcqjk		PGX_AM_BS_GSM639073	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639073	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixf0	pgxind-kftx4p5n	pgxcs-kftwcqa3		PGX_AM_BS_GSM639054	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639054	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixf1	pgxind-kftx4p5p	pgxcs-kftwcqm1		PGX_AM_BS_GSM639078	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639078	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixfv	pgxind-kftx4p6q	pgxcs-kftwcqv5		PGX_AM_BS_GSM639096	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639096	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixgc	pgxind-kftx4p7a	pgxcs-kftwcr08		PGX_AM_BS_GSM639106	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639106	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixgz	pgxind-kftx4p83	pgxcs-kftwcr99		PGX_AM_BS_GSM639120	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639120	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixh4	pgxind-kftx4p89	pgxcs-kftwcrar		PGX_AM_BS_GSM639123	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639123	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixh5	pgxind-kftx4p8b	pgxcs-kftwcrb8		PGX_AM_BS_GSM639124	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639124	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixhr	pgxind-kftx4p91	pgxcs-kftwcrho		PGX_AM_BS_GSM639137	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639137	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixhu	pgxind-kftx4p96	pgxcs-kftwcrio		PGX_AM_BS_GSM639139	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639139	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixi2	pgxind-kftx4p9f	pgxcs-kftwcrl5		PGX_AM_BS_GSM639145	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639145	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixif	pgxind-kftx4p9v	pgxcs-kftwcrep		PGX_AM_BS_GSM639131	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639131	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixix	pgxind-kftx4pah	pgxcs-kftwcrui		PGX_AM_BS_GSM639165	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639165	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixj6	pgxind-kftx4par	pgxcs-kftwcrx1		PGX_AM_BS_GSM639170	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639170	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvixjt	pgxind-kftx4pbj	pgxcs-kftwcs41		PGX_AM_BS_GSM639184	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM639184	geo:GSE25016	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvizra	pgxind-kftx4roq	pgxcs-kftwddh4		PGX_AM_BS_GSM385518	lung adenocarcinoma [cell line NCI-H2009]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM385518	geo:GSE15126	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvizrb	pgxind-kftx4ros	pgxcs-kftwddhl		PGX_AM_BS_GSM385519	lung adenocarcinoma [cell line NCI-H23]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM385519	geo:GSE15126	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvizre	pgxind-kftx4row	pgxcs-kftwddil		PGX_AM_BS_GSM385521	papillary lung adenocarcinoma [cell line NCI-H441]	NCIT:C5650	Papillary lung adenocarcinoma	pgx:icdom-82603	Papillary adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM385521	geo:GSE15126	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvizrg	pgxind-kftx4roy	pgxcs-kftwddj3		PGX_AM_BS_GSM385522	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM385522	geo:GSE15126	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvizrl	pgxind-kftx4rp4	pgxcs-kftwddkk		PGX_AM_BS_GSM385525	lung adenocarcinoma [cell line SK-LU-1]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM385525	geo:GSE15126	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvizrq	pgxind-kftx4rpa	pgxcs-kftwddm2		PGX_AM_BS_GSM385529	lung adenocarcinoma [cell line NCI-H2009]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM385529	geo:GSE15126	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvizrs	pgxind-kftx4rpc	pgxcs-kftwddmj		PGX_AM_BS_GSM385530	lung adenocarcinoma [cell line NCI-H23]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM385530	geo:GSE15126	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvizrx	pgxind-kftx4rpi	pgxcs-kftwddo1		PGX_AM_BS_GSM385533	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM385533	geo:GSE15126	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvizs1	pgxind-kftx4rpo	pgxcs-kftwddpi		PGX_AM_BS_GSM385536	lung adenocarcinoma [cell line SK-LU-1]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM385536	geo:GSE15126	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3ih	pgxind-kftx4wb0	pgxcs-kftwejee		PGX_AM_BS_GSM827196	small cell Lung carcinoma [cell line KHM-3S]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827196	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3io	pgxind-kftx4wb8	pgxcs-kftwejge		PGX_AM_BS_GSM827200	squamous cell lung carcinoma [cell line VMRC-LCP]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827200	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3ip	pgxind-kftx4wba	pgxcs-kftwejgv		PGX_AM_BS_GSM827201	squamous cell lung carcinoma [cell line LC-1sq]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827201	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3jg	pgxind-kftx4wc7	pgxcs-kftwejqv		PGX_AM_BS_GSM827217	small cell Lung carcinoma [cell line MS-1]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827217	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3mh	pgxind-kftx4wr2	pgxcs-kftwekn7		PGX_AM_BS_GSM827284	lung adenocarcinoma [cell line A-427]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827284	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3o2	pgxind-kftx4wsz	pgxcs-kftwel64		PGX_AM_BS_GSM827318	squamous cell lung carcinoma [cell line SK-MES-1]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827318	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3py	pgxind-kftx4wvb	pgxcs-kftwelq0		PGX_AM_BS_GSM827359	Bronchioalveolar carcinoma [cell line NCI-H1781]	NCIT:C2923	Bronchioloalveolar carcinoma	pgx:icdom-82513	Alveolar adenocarcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827359	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3qj	pgxind-kftx4ww2	pgxcs-kftwelwd		PGX_AM_BS_GSM827372	squamous cell lung carcinoma [HCC44]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827372	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3ql	pgxind-kftx4ww4	pgxcs-kftwelwv		PGX_AM_BS_GSM827373	Lung adenocarcinoma [cell line HCC78]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827373	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3qq	pgxind-kftx4wwa	pgxcs-kftwelyb		PGX_AM_BS_GSM827376	squamous cell lung carcinoma [cell line LK-2]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827376	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3qw	pgxind-kftx4wwi	pgxcs-kftwem2c		PGX_AM_BS_GSM827380	small cell Lung carcinoma [cell line STC1]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827380	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3r0	pgxind-kftx4wwm	pgxcs-kftwem3c		PGX_AM_BS_GSM827382	Lung giant cell carcinoma [cell line Lu-65]	NCIT:C4452	Lung giant cell carcinoma	pgx:icdom-80313	Giant cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827382	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3r1	pgxind-kftx4wwo	pgxcs-kftwelqi		PGX_AM_BS_GSM827360	Lung carcinoma [cell line UMC-11]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827360	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3s7	pgxind-kftx4wy2	pgxcs-kftwemg3		PGX_AM_BS_GSM827408	non-small cell Lung carcinoma [cell line NCI-H2342]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827408	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3sf	pgxind-kftx4wyc	pgxcs-kftwemij		PGX_AM_BS_GSM827413	lung adenocarcinoma [cell line SK-LU-1]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827413	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3t4	pgxind-kftx4wz7	pgxcs-kftwempv		PGX_AM_BS_GSM827428	small cell Lung carcinoma [cell line COR-L279]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827428	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3u6	pgxind-kftx4x0i	pgxcs-kftwen15		PGX_AM_BS_GSM827451	squamous cell lung carcinoma [cell line LUDLU-1]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827451	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3us	pgxind-kftx4x19	pgxcs-kftwen7j		PGX_AM_BS_GSM827464	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827464	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3uu	pgxind-kftx4x1b	pgxcs-kftwen81		PGX_AM_BS_GSM827465	Bronchogenic carcinoma [cell line ChaGo-K-1]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827465	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3v0	pgxind-kftx4x1j	pgxcs-kftwenc9		PGX_AM_BS_GSM827469	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827469	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3vf	pgxind-kftx4x22	pgxcs-kftwengp		PGX_AM_BS_GSM827478	lung adenocarcinoma [cell line NCI-H23]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827478	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3vh	pgxind-kftx4x24	pgxcs-kftwenh7		PGX_AM_BS_GSM827479	lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827479	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3vk	pgxind-kftx4x27	pgxcs-kftweni6		PGX_AM_BS_GSM827481	lung adenocarcinoma [cell line NCI-H650]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827481	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3vm	pgxind-kftx4x29	pgxcs-kftwenin		PGX_AM_BS_GSM827482	lung adenocarcinoma [cell line NCI-H838]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827482	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3vp	pgxind-kftx4x2e	pgxcs-kftwenjn		PGX_AM_BS_GSM827484	large cell lung carcinoma [cell line NCI-H1581]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827484	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3w2	pgxind-kftx4x2u	pgxcs-kftwennk		PGX_AM_BS_GSM827492	lung adenocarcinoma [cell line 201T]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827492	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3ws	pgxind-kftx4x3o	pgxcs-kftwenuw		PGX_AM_BS_GSM827507	Lung adenocarcinoma [cell line NCI-H1734]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827507	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3wt	pgxind-kftx4x3q	pgxcs-kftwenk4		PGX_AM_BS_GSM827485	squamous cell lung carcinoma [cell line NCI-H1703]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827485	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3wx	pgxind-kftx4x3u	pgxcs-kftwenwd		PGX_AM_BS_GSM827510	non-small cell Lung carcinoma [cell line NCI-H2135]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827510	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3wz	pgxind-kftx4x3w	pgxcs-kftwenwv		PGX_AM_BS_GSM827511	squamous cell lung carcinoma [cell line NCI-H2170]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827511	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3xm	pgxind-kftx4x4p	pgxcs-kftweo3q		PGX_AM_BS_GSM827525	small cell Lung carcinoma [cell line NCI-H2171]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827525	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3xo	pgxind-kftx4x4r	pgxcs-kftweo48		PGX_AM_BS_GSM827526	lung adenocarcinoma [cell line NCI-H2122]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827526	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3xp	pgxind-kftx4x4t	pgxcs-kftweo4q		PGX_AM_BS_GSM827527	small cell Lung carcinoma [cell line NCI-H2081]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827527	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3xr	pgxind-kftx4x4v	pgxcs-kftweo57		PGX_AM_BS_GSM827528	lung adenocarcinoma [cell line NCI-H2009]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827528	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3y5	pgxind-kftx4x5b	pgxcs-kftweo97		PGX_AM_BS_GSM827536	Lung adenocarcinoma [cell line NCI-H1563]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827536	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3yr	pgxind-kftx4x61	pgxcs-kftweofn		PGX_AM_BS_GSM827549	Lung adenocarcinoma [cell line Calu-3]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827549	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3z6	pgxind-kftx4x6k	pgxcs-kftweomc		PGX_AM_BS_GSM827558	lung adenocarcinoma [cell line NCI-H1755]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827558	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj3za	pgxind-kftx4x6o	pgxcs-kftweonb		PGX_AM_BS_GSM827560	Lung adenocarcinoma [cell line NCI-H1693]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827560	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj405	pgxind-kftx4x7s	pgxcs-kftweowp		PGX_AM_BS_GSM827579	Bronchioalveolar carcinoma [cell line NCI-H1666]	NCIT:C2923	Bronchioloalveolar carcinoma	pgx:icdom-82513	Alveolar adenocarcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827579	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj40i	pgxind-kftx4x88	pgxcs-kftwep0n		PGX_AM_BS_GSM827587	Adenosquamous lung carcinoma [cell line NCI-H647]	NCIT:C9133	Lung Adenosquamous Carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827587	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj40q	pgxind-kftx4x8i	pgxcs-kftwep33		PGX_AM_BS_GSM827592	Lung adenocarcinoma [cell line VMRC-LCD]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Charlestown	United States of America	USA	42.38	-71.06					geo:GSM827592	geo:GSE20306	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj57c	pgxind-kftx4yol	pgxcs-kftwf23u		PGX_AM_BS_GSM707437	lung adenocarcinoma [long-term survivor]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707437	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj582	pgxind-kftx4yph	pgxcs-kftwf2dq		PGX_AM_BS_GSM707453	lung adenocarcinoma [short-term survivor]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707453	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj584	pgxind-kftx4ypj	pgxcs-kftwf2e8		PGX_AM_BS_GSM707454	Lung carcinoma [large-cell carcinoma, short-term survivor]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707454	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj586	pgxind-kftx4ypl	pgxcs-kftwf2eq		PGX_AM_BS_GSM707455	squamous cell lung carcinoma [long-term survivor]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707455	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj587	pgxind-kftx4ypn	pgxcs-kftwf2f8		PGX_AM_BS_GSM707456	Lung carcinoma [large-cell carcinoma, short-term survivor]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707456	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj589	pgxind-kftx4ypp	pgxcs-kftwf22d		PGX_AM_BS_GSM707434	Lung carcinoma [large-cell carcinoma, short-term survivor]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707434	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj58o	pgxind-kftx4yq8	pgxcs-kftwf2k5		PGX_AM_BS_GSM707466	Lung carcinoma [large-cell carcinoma, short-term survivor]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707466	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj58q	pgxind-kftx4yqa	pgxcs-kftwf2km		PGX_AM_BS_GSM707467	lung adenocarcinoma [short-term survivor]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707467	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj58r	pgxind-kftx4yqc	pgxcs-kftwf2l3		PGX_AM_BS_GSM707468	squamous cell lung carcinoma [short-term survivor]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707468	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj59f	pgxind-kftx4yr4	pgxcs-kftwf2rx		PGX_AM_BS_GSM707486	lung adenocarcinoma [short-term survivor]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707486	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj59k	pgxind-kftx4yra	pgxcs-kftwf2td		PGX_AM_BS_GSM707492	squamous cell lung carcinoma [long-term survivor]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707492	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj59n	pgxind-kftx4yre	pgxcs-kftwf2ud		PGX_AM_BS_GSM707495	Lung carcinoma [large-cell carcinoma, short-term survivor]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707495	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj59t	pgxind-kftx4yrm	pgxcs-kftwf2wa		PGX_AM_BS_GSM707501	lung adenocarcinoma [long-term survivor]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707501	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5ac	pgxind-kftx4ys8	pgxcs-kftwf31n		PGX_AM_BS_GSM707513	lung adenocarcinoma [long-term survivor]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707513	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5af	pgxind-kftx4ysc	pgxcs-kftwf32m		PGX_AM_BS_GSM707515	Lung carcinoma [large-cell carcinoma, long-term survivor]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707515	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5aw	pgxind-kftx4ysx	pgxcs-kftwf37h		PGX_AM_BS_GSM707525	squamous cell lung carcinoma [short-term survivor]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707525	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5b0	pgxind-kftx4yt3	pgxcs-kftwf38y		PGX_AM_BS_GSM707529	lung adenocarcinoma [long-term survivor]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707529	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5b9	pgxind-kftx4yte	pgxcs-kftwf3bf		PGX_AM_BS_GSM707535	Lung carcinoma [large-cell carcinoma, long-term survivor]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707535	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5bo	pgxind-kftx4ytv	pgxcs-kftwf3i0		PGX_AM_BS_GSM707548	lung adenocarcinoma [short-term survivor]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM707548	geo:GSE28572	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5ow	pgxind-kftx4za9	pgxcs-kftwf7kl		PGX_AM_BS_GSM749528	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM749528	geo:GSE30255	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5ox	pgxind-kftx4zab	pgxcs-kftwf7l3		PGX_AM_BS_GSM749529	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM749529	geo:GSE30255	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5oz	pgxind-kftx4zad	pgxcs-kftwf7ll		PGX_AM_BS_GSM749530	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM749530	geo:GSE30255	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5p0	pgxind-kftx4zaf	pgxcs-kftwf7m3		PGX_AM_BS_GSM749531	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM749531	geo:GSE30255	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj5p2	pgxind-kftx4zah	pgxcs-kftwf7ml		PGX_AM_BS_GSM749532	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM749532	geo:GSE30255	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6cn	pgxind-kftx503g	pgxcs-kftwfeyt		PGX_AM_BS_GSM824991	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM824991	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6ct	pgxind-kftx503o	pgxcs-kftwff0t		PGX_AM_BS_GSM824995	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM824995	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6cw	pgxind-kftx503s	pgxcs-kftwff1t		PGX_AM_BS_GSM824997	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM824997	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6d0	pgxind-kftx503w	pgxcs-kftwff2u		PGX_AM_BS_GSM824999	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM824999	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6dk	pgxind-kftx504l	pgxcs-kftwff8v		PGX_AM_BS_GSM825015	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM825015	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6dp	pgxind-kftx504r	pgxcs-kftwffac		PGX_AM_BS_GSM825025	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM825025	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6fo	pgxind-kftx5075	pgxcs-kftwffxg		PGX_AM_BS_GSM825081	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM825081	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6oy	pgxind-kftx50ik	pgxcs-kftwfiqv		PGX_AM_BS_GSM837651	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837651	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6pk	pgxind-kftx50ja	pgxcs-kftwfix5		PGX_AM_BS_GSM837665	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837665	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6py	pgxind-kftx50jt	pgxcs-kftwfj1j		PGX_AM_BS_GSM837674	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837674	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6qg	pgxind-kftx50kf	pgxcs-kftwfj6w		PGX_AM_BS_GSM837685	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837685	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6qi	pgxind-kftx50kh	pgxcs-kftwfj7e		PGX_AM_BS_GSM837686	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837686	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6qs	pgxind-kftx50kt	pgxcs-kftwfjaa		PGX_AM_BS_GSM837692	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837692	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6ra	pgxind-kftx50lg	pgxcs-kftwfjhf		PGX_AM_BS_GSM837703	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837703	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6rf	pgxind-kftx50lm	pgxcs-kftwfjiw		PGX_AM_BS_GSM837706	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837706	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6rg	pgxind-kftx50lo	pgxcs-kftwfjje		PGX_AM_BS_GSM837707	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837707	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6rv	pgxind-kftx50m6	pgxcs-kftwfjnr		PGX_AM_BS_GSM837716	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837716	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6s3	pgxind-kftx50mg	pgxcs-kftwfjq7		PGX_AM_BS_GSM837721	lung adenocarcinoma [East Asian]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837721	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6tk	pgxind-kftx50o9	pgxcs-kftwfk5p		PGX_AM_BS_GSM837802	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837802	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6u2	pgxind-kftx50ow	pgxcs-kftwfkb3		PGX_AM_BS_GSM837813	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837813	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6u8	pgxind-kftx50p4	pgxcs-kftwfkd1		PGX_AM_BS_GSM837817	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837817	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6uf	pgxind-kftx50pc	pgxcs-kftwfkez		PGX_AM_BS_GSM837821	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837821	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6uy	pgxind-kftx50q0	pgxcs-kftwfkks		PGX_AM_BS_GSM837833	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837833	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6vf	pgxind-kftx50qk	pgxcs-kftwfkr8		PGX_AM_BS_GSM837843	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837843	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6w3	pgxind-kftx50rf	pgxcs-kftwfkyk		PGX_AM_BS_GSM837858	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837858	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6xi	pgxind-kftx50t5	pgxcs-kftwfld5		PGX_AM_BS_GSM837888	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837888	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj6xl	pgxind-kftx50t9	pgxcs-kftwfle4		PGX_AM_BS_GSM837890	lung adenocarcinoma [Western European]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Evry	France	FRA	48.63	2.45					geo:GSM837890	geo:GSE33848	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7ef	pgxind-kftx51dj	pgxcs-kftwfqkb		PGX_AM_BS_GSM889588	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889588	geo:GSE36363	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7ej	pgxind-kftx51dn	pgxcs-kftwfqla		PGX_AM_BS_GSM889590	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889590	geo:GSE36363	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7gf	pgxind-kftx51fx	pgxcs-kftwfr73		PGX_AM_BS_GSM889655	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889655	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7gi	pgxind-kftx51g1	pgxcs-kftwfr82		PGX_AM_BS_GSM889657	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889657	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7gn	pgxind-kftx51g7	pgxcs-kftwfr9i		PGX_AM_BS_GSM889660	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889660	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7h0	pgxind-kftx51go	pgxcs-kftwfrdc		PGX_AM_BS_GSM889668	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889668	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7hf	pgxind-kftx51h6	pgxcs-kftwfrhp		PGX_AM_BS_GSM889677	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889677	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7hn	pgxind-kftx51hg	pgxcs-kftwfrk4		PGX_AM_BS_GSM889682	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889682	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7hr	pgxind-kftx51hl	pgxcs-kftwfrl3		PGX_AM_BS_GSM889684	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889684	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7hu	pgxind-kftx51hp	pgxcs-kftwfrm3		PGX_AM_BS_GSM889686	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889686	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7hz	pgxind-kftx51hv	pgxcs-kftwfrnk		PGX_AM_BS_GSM889689	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889689	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7i6	pgxind-kftx51i3	pgxcs-kftwfrpi		PGX_AM_BS_GSM889693	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889693	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7i7	pgxind-kftx51i5	pgxcs-kftwfrq0		PGX_AM_BS_GSM889694	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889694	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7i9	pgxind-kftx51i7	pgxcs-kftwfrqh		PGX_AM_BS_GSM889695	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889695	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7iq	pgxind-kftx51ir	pgxcs-kftwfrve		PGX_AM_BS_GSM889706	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889706	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj7it	pgxind-kftx51iv	pgxcs-kftwfrvv		PGX_AM_BS_GSM889708	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889708	geo:GSE36363	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj86v	pgxind-kftx52cg	pgxcs-kftwfzc0		PGX_AM_BS_GSM979198	Non-Small Cell Lung carcinoma [KRASneg]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979198	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj870	pgxind-kftx52cm	pgxcs-kftwfzdi		PGX_AM_BS_GSM979201	Non-Small Cell Lung carcinoma [KRASneg]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979201	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj879	pgxind-kftx52cw	pgxcs-kftwfzfy		PGX_AM_BS_GSM979206	Non-Small Cell Lung carcinoma [KRASneg]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979206	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj87a	pgxind-kftx52cy	pgxcs-kftwfzim		PGX_AM_BS_GSM979207	Non-Small Cell Lung carcinoma [KRASneg]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979207	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj87d	pgxind-kftx52d2	pgxcs-kftwfzjn		PGX_AM_BS_GSM979209	Non-Small Cell Lung carcinoma [KRASneg]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979209	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj87h	pgxind-kftx52d6	pgxcs-kftwfzko		PGX_AM_BS_GSM979211	Non-Small Cell Lung carcinoma [KRASneg]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979211	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj88j	pgxind-kftx52ei	pgxcs-kftwfzw5		PGX_AM_BS_GSM979234	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979234	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj88t	pgxind-kftx52eu	pgxcs-kftwfzz2		PGX_AM_BS_GSM979240	Non-Small Cell Lung carcinoma [KRASpos]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979240	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj899	pgxind-kftx52fe	pgxcs-kftwg042		PGX_AM_BS_GSM979250	Non-Small Cell Lung carcinoma [KRASneg]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979250	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj89o	pgxind-kftx52fw	pgxcs-kftwg08h		PGX_AM_BS_GSM979259	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979259	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj89q	pgxind-kftx52fy	pgxcs-kftwg08z		PGX_AM_BS_GSM979260	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979260	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8ac	pgxind-kftx52gn	pgxcs-kftwg0ff		PGX_AM_BS_GSM979273	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979273	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8ae	pgxind-kftx52gp	pgxcs-kftwg0fx		PGX_AM_BS_GSM979274	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979274	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8am	pgxind-kftx52gz	pgxcs-kftwg0ie		PGX_AM_BS_GSM979279	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979279	geo:GSE39793	geo:GPL2005					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8b5	pgxind-kftx52hl	pgxcs-kftwg0nt		PGX_AM_BS_GSM979290	Non-Small Cell Lung carcinoma [KRASneg]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979290	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8ba	pgxind-kftx52hr	pgxcs-kftwg0rm		PGX_AM_BS_GSM979293	Non-Small Cell Lung carcinoma [KRASneg]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979293	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8ci	pgxind-kftx52ja	pgxcs-kftwg152		PGX_AM_BS_GSM979320	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979320	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8cs	pgxind-kftx52jm	pgxcs-kftwg181		PGX_AM_BS_GSM979326	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979326	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8cu	pgxind-kftx52jo	pgxcs-kftwg18j		PGX_AM_BS_GSM979327	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979327	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8dd	pgxind-kftx52kc	pgxcs-kftwg1eh		PGX_AM_BS_GSM979339	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979339	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8dz	pgxind-kftx52l3	pgxcs-kftwg1kx		PGX_AM_BS_GSM979352	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979352	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8ee	pgxind-kftx52ll	pgxcs-kftwg1px		PGX_AM_BS_GSM979362	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979362	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8eh	pgxind-kftx52lp	pgxcs-kftwg1qy		PGX_AM_BS_GSM979364	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979364	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8ej	pgxind-kftx52lr	pgxcs-kftwg1rg		PGX_AM_BS_GSM979365	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				South San Francisco	United States of America	USA	37.65	-122.41					geo:GSM979365	geo:GSE39793	geo:GPL2004					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8fa	pgxind-kftx52mo	pgxcs-kftwg234		PGX_AM_BS_GSM986174	small cell Lung carcinoma [cell line NCI-H1688]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM986174	geo:GSE40142	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8fd	pgxind-kftx52ms	pgxcs-kftwg21j		PGX_AM_BS_GSM986171	small cell lung carcinoma [cell line NCI-H211]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM986171	geo:GSE40142	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8ff	pgxind-kftx52mu	pgxcs-kftwg222		PGX_AM_BS_GSM986172	small cell Lung carcinoma [cell line NCI-H146]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM986172	geo:GSE40142	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8fu	pgxind-kftx52nc	pgxcs-kftwg274		PGX_AM_BS_GSM986182	small cell Lung carcinoma [cell line GLC-2]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM986182	geo:GSE40142	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8fw	pgxind-kftx52ne	pgxcs-kftwg27m		PGX_AM_BS_GSM986183	small cell Lung carcinoma [cell line GLC-8]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM986183	geo:GSE40142	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8g1	pgxind-kftx52nk	pgxcs-kftwg294		PGX_AM_BS_GSM986186	small cell Lung carcinoma [cell line GLC-36]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM986186	geo:GSE40142	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8g7	pgxind-kftx52ns	pgxcs-kftwg2bm		PGX_AM_BS_GSM986191	small cell Lung carcinoma [cell line SBC-4]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM986191	geo:GSE40142	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8gb	pgxind-kftx52nw	pgxcs-kftwg2c4		PGX_AM_BS_GSM986192	small cell Lung carcinoma [cell line SBC-5]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM986192	geo:GSE40142	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvj8gc	pgxind-kftx52ny	pgxcs-kftwg2a4		PGX_AM_BS_GSM986188	small cell Lung carcinoma [cell line SBC-6]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Koeln	Germany	DEU	50.93	6.95					geo:GSM986188	geo:GSE40142	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfq9	pgxind-kftx5ba4	pgxcs-kftwi8cz		PGX_AM_BS_GSM720233	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720233	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfqc	pgxind-kftx5ba8	pgxcs-kftwi8dx		PGX_AM_BS_GSM720235	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720235	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfqe	pgxind-kftx5baa	pgxcs-kftwi8ef		PGX_AM_BS_GSM720236	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720236	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfqf	pgxind-kftx5bac	pgxcs-kftwi8ex		PGX_AM_BS_GSM720237	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720237	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfqh	pgxind-kftx5bae	pgxcs-kftwi8fe		PGX_AM_BS_GSM720238	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720238	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfqj	pgxind-kftx5bag	pgxcs-kftwi8fw		PGX_AM_BS_GSM720239	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720239	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfqp	pgxind-kftx5bao	pgxcs-kftwi8hw		PGX_AM_BS_GSM720243	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720243	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfqr	pgxind-kftx5baq	pgxcs-kftwi8ie		PGX_AM_BS_GSM720244	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720244	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfqt	pgxind-kftx5bas	pgxcs-kftwi8iv		PGX_AM_BS_GSM720245	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720245	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfqw	pgxind-kftx5baw	pgxcs-kftwi8ju		PGX_AM_BS_GSM720247	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720247	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfr3	pgxind-kftx5bb4	pgxcs-kftwi8lt		PGX_AM_BS_GSM720251	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720251	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfr4	pgxind-kftx5bb6	pgxcs-kftwi8mb		PGX_AM_BS_GSM720252	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720252	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfr9	pgxind-kftx5bbc	pgxcs-kftwi8z3		PGX_AM_BS_GSM720278	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720278	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfrd	pgxind-kftx5bbg	pgxcs-kftwi903		PGX_AM_BS_GSM720280	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720280	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfrg	pgxind-kftx5bbl	pgxcs-kftwi8pr		PGX_AM_BS_GSM720259	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720259	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfro	pgxind-kftx5bbv	pgxcs-kftwi8s7		PGX_AM_BS_GSM720264	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720264	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfrv	pgxind-kftx5bc3	pgxcs-kftwi8u6		PGX_AM_BS_GSM720268	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720268	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfry	pgxind-kftx5bc7	pgxcs-kftwi8v6		PGX_AM_BS_GSM720270	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720270	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfsc	pgxind-kftx5bcn	pgxcs-kftwi8ns		PGX_AM_BS_GSM720255	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720255	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfsi	pgxind-kftx5bcv	pgxcs-kftwi912		PGX_AM_BS_GSM720282	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720282	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjfsp	pgxind-kftx5bd3	pgxcs-kftwi931		PGX_AM_BS_GSM720286	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720286	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjft2	pgxind-kftx5bdj	pgxcs-kftwi96y		PGX_AM_BS_GSM720294	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720294	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjft5	pgxind-kftx5bdo	pgxcs-kftwi97w		PGX_AM_BS_GSM720296	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720296	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjft7	pgxind-kftx5bdq	pgxcs-kftwi9ai		PGX_AM_BS_GSM720298	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720298	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjftc	pgxind-kftx5bdw	pgxcs-kftwi9bj		PGX_AM_BS_GSM720300	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720300	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjftl	pgxind-kftx5be8	pgxcs-kftwi9ek		PGX_AM_BS_GSM720306	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720306	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjftn	pgxind-kftx5bea	pgxcs-kftwi9f2		PGX_AM_BS_GSM720307	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720307	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjftp	pgxind-kftx5bec	pgxcs-kftwi9fk		PGX_AM_BS_GSM720308	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Lund	Sweden	SWE	55.71	13.19					geo:GSM720308	geo:GSE29065	geo:GPL4723					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgbz	pgxind-kftx5c18	pgxcs-kftwif3c		PGX_AM_BS_GSM782033	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782033	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgc4	pgxind-kftx5c1e	pgxcs-kftwif4t		PGX_AM_BS_GSM782041	Bronchiolo-alveolar adenocarcinoma	NCIT:C2923	Bronchioloalveolar Carcinoma	pgx:icdom-82503	Bronchiolo-alveolar adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782041	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgco	pgxind-kftx5c22	pgxcs-kftwifaq		PGX_AM_BS_GSM782063	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782063	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgcu	pgxind-kftx5c2a	pgxcs-kftwifcm		PGX_AM_BS_GSM782067	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782067	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgd5	pgxind-kftx5c2p	pgxcs-kftwifg1		PGX_AM_BS_GSM782074	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782074	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgda	pgxind-kftx5c2v	pgxcs-kftwifjd		PGX_AM_BS_GSM782077	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782077	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgdh	pgxind-kftx5c33	pgxcs-kftwifld		PGX_AM_BS_GSM782081	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782081	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgdn	pgxind-kftx5c3b	pgxcs-kftwifnb		PGX_AM_BS_GSM782085	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782085	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgec	pgxind-kftx5c47	pgxcs-kftwifun		PGX_AM_BS_GSM782100	Bronchiolo-alveolar adenocarcinoma	NCIT:C2923	Bronchioloalveolar Carcinoma	pgx:icdom-82503	Bronchiolo-alveolar adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782100	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgef	pgxind-kftx5c4b	pgxcs-kftwifvm		PGX_AM_BS_GSM782102	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782102	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgeq	pgxind-kftx5c4q	pgxcs-kftwifyz		PGX_AM_BS_GSM782109	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Paris	France	FRA	48.85	2.35					geo:GSM782109	geo:GSE31483	geo:GPL6986					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjggj	pgxind-kftx5c6x	pgxcs-kftwight		PGX_AM_BS_GSM794783	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794783	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjggk	pgxind-kftx5c70	pgxcs-kftwigia		PGX_AM_BS_GSM794784	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794784	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjggm	pgxind-kftx5c72	pgxcs-kftwigis		PGX_AM_BS_GSM794785	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794785	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjggp	pgxind-kftx5c76	pgxcs-kftwigjs		PGX_AM_BS_GSM794787	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794787	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjggu	pgxind-kftx5c7c	pgxcs-kftwigl8		PGX_AM_BS_GSM794790	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794790	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjggw	pgxind-kftx5c7e	pgxcs-kftwiglp		PGX_AM_BS_GSM794791	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794791	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjggx	pgxind-kftx5c7g	pgxcs-kftwigm7		PGX_AM_BS_GSM794792	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794792	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjggz	pgxind-kftx5c7i	pgxcs-kftwigmp		PGX_AM_BS_GSM794793	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794793	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgh2	pgxind-kftx5c7m	pgxcs-kftwigno		PGX_AM_BS_GSM794795	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794795	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgh4	pgxind-kftx5c7o	pgxcs-kftwih1n		PGX_AM_BS_GSM794819	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794819	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgh7	pgxind-kftx5c7s	pgxcs-kftwigrb		PGX_AM_BS_GSM794798	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794798	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgh9	pgxind-kftx5c7u	pgxcs-kftwigru		PGX_AM_BS_GSM794799	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794799	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgha	pgxind-kftx5c7w	pgxcs-kftwigsd		PGX_AM_BS_GSM794800	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794800	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjghe	pgxind-kftx5c80	pgxcs-kftwigtd		PGX_AM_BS_GSM794802	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794802	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjghi	pgxind-kftx5c86	pgxcs-kftwiguu		PGX_AM_BS_GSM794805	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794805	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjghk	pgxind-kftx5c89	pgxcs-kftwigvc		PGX_AM_BS_GSM794806	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794806	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjghm	pgxind-kftx5c8b	pgxcs-kftwigvt		PGX_AM_BS_GSM794807	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794807	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjghn	pgxind-kftx5c8d	pgxcs-kftwigwb		PGX_AM_BS_GSM794808	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794808	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjghr	pgxind-kftx5c8h	pgxcs-kftwigx9		PGX_AM_BS_GSM794810	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794810	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjghs	pgxind-kftx5c8j	pgxcs-kftwigxr		PGX_AM_BS_GSM794811	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794811	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjghu	pgxind-kftx5c8l	pgxcs-kftwigy9		PGX_AM_BS_GSM794812	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794812	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgi0	pgxind-kftx5c8t	pgxcs-kftwih06		PGX_AM_BS_GSM794816	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794816	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgi3	pgxind-kftx5c8x	pgxcs-kftwih15		PGX_AM_BS_GSM794818	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794818	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgi5	pgxind-kftx5c8z	pgxcs-kftwigo5		PGX_AM_BS_GSM794796	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794796	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgi7	pgxind-kftx5c91	pgxcs-kftwih24		PGX_AM_BS_GSM794820	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794820	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgi8	pgxind-kftx5c93	pgxcs-kftwih2m		PGX_AM_BS_GSM794821	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794821	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgia	pgxind-kftx5c95	pgxcs-kftwih33		PGX_AM_BS_GSM794822	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794822	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgic	pgxind-kftx5c97	pgxcs-kftwih3m		PGX_AM_BS_GSM794823	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794823	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgip	pgxind-kftx5c9n	pgxcs-kftwih7l		PGX_AM_BS_GSM794831	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794831	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgit	pgxind-kftx5c9s	pgxcs-kftwih8l		PGX_AM_BS_GSM794833	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794833	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgiw	pgxind-kftx5c9w	pgxcs-kftwih9j		PGX_AM_BS_GSM794835	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794835	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgiz	pgxind-kftx5ca0	pgxcs-kftwihaj		PGX_AM_BS_GSM794837	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794837	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgj3	pgxind-kftx5ca4	pgxcs-kftwihbi		PGX_AM_BS_GSM794839	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794839	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgj4	pgxind-kftx5ca6	pgxcs-kftwihbz		PGX_AM_BS_GSM794840	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794840	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgj6	pgxind-kftx5ca8	pgxcs-kftwihch		PGX_AM_BS_GSM794841	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794841	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgj8	pgxind-kftx5caa	pgxcs-kftwihcz		PGX_AM_BS_GSM794842	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794842	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjgjb	pgxind-kftx5cae	pgxcs-kftwihdz		PGX_AM_BS_GSM794844	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Brisbane	Australia	AUS	-27.47	153.03					geo:GSM794844	geo:GSE32058	geo:GPL2879					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjicv	pgxind-kftx5ejm	pgxcs-kftwj1tr		PGX_AM_BS_GSM788664	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788664	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjidf	pgxind-kftx5ekb	pgxcs-kftwj2b5		PGX_AM_BS_GSM788699	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788699	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjie0	pgxind-kftx5el1	pgxcs-kftwj261		PGX_AM_BS_GSM788689	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788689	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjief	pgxind-kftx5elk	pgxcs-kftwj2an		PGX_AM_BS_GSM788698	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788698	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjiek	pgxind-kftx5elq	pgxcs-kftwj2c3		PGX_AM_BS_GSM788701	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788701	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjig9	pgxind-kftx5ent	pgxcs-kftwj2tt		PGX_AM_BS_GSM788738	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788738	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjigc	pgxind-kftx5enx	pgxcs-kftwj2ur		PGX_AM_BS_GSM788740	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788740	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjigh	pgxind-kftx5eo3	pgxcs-kftwj2w7		PGX_AM_BS_GSM788743	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788743	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjigt	pgxind-kftx5eoh	pgxcs-kftwj31k		PGX_AM_BS_GSM788750	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788750	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjihl	pgxind-kftx5epg	pgxcs-kftwj39s		PGX_AM_BS_GSM788767	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788767	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjiie	pgxind-kftx5eqh	pgxcs-kftwj3ig		PGX_AM_BS_GSM788785	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788785	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjiio	pgxind-kftx5eqt	pgxcs-kftwj3lb		PGX_AM_BS_GSM788791	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788791	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjije	pgxind-kftx5erp	pgxcs-kftwj3sz		PGX_AM_BS_GSM788807	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788807	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjijt	pgxind-kftx5es7	pgxcs-kftwj3xb		PGX_AM_BS_GSM788816	Non-small-cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788816	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjilu	pgxind-kftx5euo	pgxcs-kftwj4kn		PGX_AM_BS_GSM788860	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788860	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjima	pgxind-kftx5ev8	pgxcs-kftwj4pg		PGX_AM_BS_GSM788870	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788870	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjimz	pgxind-kftx5ew2	pgxcs-kftwj4wn		PGX_AM_BS_GSM788885	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788885	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjing	pgxind-kftx5ewp	pgxcs-kftwj51z		PGX_AM_BS_GSM788896	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788896	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjink	pgxind-kftx5ewt	pgxcs-kftwj52y		PGX_AM_BS_GSM788898	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788898	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjins	pgxind-kftx5ex3	pgxcs-kftwj55d		PGX_AM_BS_GSM788903	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788903	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjint	pgxind-kftx5ex5	pgxcs-kftwj55u		PGX_AM_BS_GSM788904	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788904	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjiol	pgxind-kftx5ey4	pgxcs-kftwj5e2		PGX_AM_BS_GSM788921	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788921	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjiop	pgxind-kftx5eya	pgxcs-kftwj5fj		PGX_AM_BS_GSM788924	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Vancouver	Canada	CAN	49.25	-123.12					geo:GSM788924	geo:GSE31798	geo:GPL14360					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjgp	pgxind-kftx5fwu	pgxcs-kftwje6u		PGX_AM_BS_GSM1857242	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857242	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjgr	pgxind-kftx5fww	pgxcs-kftwje7c		PGX_AM_BS_GSM1857243	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857243	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjgs	pgxind-kftx5fwy	pgxcs-kftwje7t		PGX_AM_BS_GSM1857244	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857244	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjgw	pgxind-kftx5fx2	pgxcs-kftwje8t		PGX_AM_BS_GSM1857246	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857246	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjgx	pgxind-kftx5fx4	pgxcs-kftwje9a		PGX_AM_BS_GSM1857247	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857247	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjh1	pgxind-kftx5fx8	pgxcs-kftwjeaa		PGX_AM_BS_GSM1857249	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857249	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjh4	pgxind-kftx5fxd	pgxcs-kftwjeb9		PGX_AM_BS_GSM1857251	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857251	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjh6	pgxind-kftx5fxf	pgxcs-kftwjebr		PGX_AM_BS_GSM1857252	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857252	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjh7	pgxind-kftx5fxh	pgxcs-kftwjec9		PGX_AM_BS_GSM1857253	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857253	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhb	pgxind-kftx5fxl	pgxcs-kftwjed8		PGX_AM_BS_GSM1857255	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857255	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhe	pgxind-kftx5fxp	pgxcs-kftwjepn		PGX_AM_BS_GSM1857280	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857280	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhf	pgxind-kftx5fxr	pgxcs-kftwjeq5		PGX_AM_BS_GSM1857281	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857281	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhh	pgxind-kftx5fxt	pgxcs-kftwjeqm		PGX_AM_BS_GSM1857282	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857282	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhj	pgxind-kftx5fxv	pgxcs-kftwjer3		PGX_AM_BS_GSM1857283	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857283	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhk	pgxind-kftx5fxx	pgxcs-kftwjerl		PGX_AM_BS_GSM1857284	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857284	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhm	pgxind-kftx5fxz	pgxcs-kftwjes3		PGX_AM_BS_GSM1857285	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857285	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjho	pgxind-kftx5fy1	pgxcs-kftwjesk		PGX_AM_BS_GSM1857286	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857286	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhr	pgxind-kftx5fy5	pgxcs-kftwjetj		PGX_AM_BS_GSM1857288	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857288	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhu	pgxind-kftx5fy9	pgxcs-kftwjeui		PGX_AM_BS_GSM1857290	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857290	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhw	pgxind-kftx5fyb	pgxcs-kftwjev0		PGX_AM_BS_GSM1857291	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857291	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjhx	pgxind-kftx5fyd	pgxcs-kftwjevi		PGX_AM_BS_GSM1857292	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857292	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjji1	pgxind-kftx5fyh	pgxcs-kftwjewi		PGX_AM_BS_GSM1857294	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857294	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjji2	pgxind-kftx5fyj	pgxcs-kftwjedq		PGX_AM_BS_GSM1857256	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857256	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjji4	pgxind-kftx5fyl	pgxcs-kftwjee8		PGX_AM_BS_GSM1857257	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857257	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjji5	pgxind-kftx5fyn	pgxcs-kftwjeeq		PGX_AM_BS_GSM1857258	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857258	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjji9	pgxind-kftx5fyr	pgxcs-kftwjefq		PGX_AM_BS_GSM1857260	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857260	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjia	pgxind-kftx5fyt	pgxcs-kftwjeg8		PGX_AM_BS_GSM1857261	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857261	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjic	pgxind-kftx5fyv	pgxcs-kftwjegr		PGX_AM_BS_GSM1857262	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857262	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjih	pgxind-kftx5fz1	pgxcs-kftwjei9		PGX_AM_BS_GSM1857265	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857265	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjii	pgxind-kftx5fz4	pgxcs-kftwjeir		PGX_AM_BS_GSM1857266	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857266	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjik	pgxind-kftx5fz6	pgxcs-kftwjej9		PGX_AM_BS_GSM1857267	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857267	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjim	pgxind-kftx5fz8	pgxcs-kftwjejr		PGX_AM_BS_GSM1857268	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857268	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjip	pgxind-kftx5fzc	pgxcs-kftwjekr		PGX_AM_BS_GSM1857270	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857270	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjiw	pgxind-kftx5fzk	pgxcs-kftwjemp		PGX_AM_BS_GSM1857274	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857274	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjj3	pgxind-kftx5fzs	pgxcs-kftwjeoo		PGX_AM_BS_GSM1857278	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857278	geo:GSE72192	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjj6	pgxind-kftx5fzw	pgxcs-kftwjexh		PGX_AM_BS_GSM1857296	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857296	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjj8	pgxind-kftx5fzy	pgxcs-kftwjexz		PGX_AM_BS_GSM1857297	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857297	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjj9	pgxind-kftx5g00	pgxcs-kftwjeyh		PGX_AM_BS_GSM1857298	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857298	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjjd	pgxind-kftx5g04	pgxcs-kftwjezg		PGX_AM_BS_GSM1857300	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857300	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjje	pgxind-kftx5g06	pgxcs-kftwjezz		PGX_AM_BS_GSM1857301	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857301	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjjj	pgxind-kftx5g0c	pgxcs-kftwjf1h		PGX_AM_BS_GSM1857304	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857304	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjjl	pgxind-kftx5g0e	pgxcs-kftwjf1z		PGX_AM_BS_GSM1857305	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857305	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjjm	pgxind-kftx5g0g	pgxcs-kftwjf2h		PGX_AM_BS_GSM1857306	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857306	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjjq	pgxind-kftx5g0k	pgxcs-kftwjf3g		PGX_AM_BS_GSM1857308	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857308	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjjr	pgxind-kftx5g0m	pgxcs-kftwjf3y		PGX_AM_BS_GSM1857309	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857309	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjk0	pgxind-kftx5g0w	pgxcs-kftwjf6h		PGX_AM_BS_GSM1857314	squamous cell lung carcinoma	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857314	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjk5	pgxind-kftx5g12	pgxcs-kftwjf7z		PGX_AM_BS_GSM1857317	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				San Sebastian	Spain	ESP	43.31	-1.97					geo:GSM1857317	geo:GSE72192	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjk6	pgxind-kftx5g15	pgxcs-kftwjfjh		PGX_AM_BS_GSM1526628	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526628	geo:GSE62407	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjk8	pgxind-kftx5g17	pgxcs-kftwjfjz		PGX_AM_BS_GSM1526629	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526629	geo:GSE62407	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjka	pgxind-kftx5g19	pgxcs-kftwjfr6		PGX_AM_BS_GSM1526644	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526644	geo:GSE62407	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjkb	pgxind-kftx5g1b	pgxcs-kftwjfrn		PGX_AM_BS_GSM1526645	lung carcinoma	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526645	geo:GSE62407	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjl8	pgxind-kftx5g2f	pgxcs-kftwjft2		PGX_AM_BS_GSM1526648	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526648	geo:GSE62407	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjl9	pgxind-kftx5g2h	pgxcs-kftwjftl		PGX_AM_BS_GSM1526649	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526649	geo:GSE62407	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjlb	pgxind-kftx5g2j	pgxcs-kftwjg2u		PGX_AM_BS_GSM1526669	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526669	geo:GSE62407	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjlj	pgxind-kftx5g2t	pgxcs-kftwjfcj		PGX_AM_BS_GSM1526614	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526614	geo:GSE62407	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjlm	pgxind-kftx5g2y	pgxcs-kftwjfgk		PGX_AM_BS_GSM1526622	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526622	geo:GSE62407	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjlo	pgxind-kftx5g30	pgxcs-kftwjfh2		PGX_AM_BS_GSM1526623	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526623	geo:GSE62407	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjmf	pgxind-kftx5g3y	pgxcs-kftwjflf		PGX_AM_BS_GSM1526632	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526632	geo:GSE62407	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjmr	pgxind-kftx5g4c	pgxcs-kftwjflx		PGX_AM_BS_GSM1526633	small cell carcinoma [lung]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Mexico City	Mexico	MEX	19.43	-99.13					geo:GSM1526633	geo:GSE62407	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjn2	pgxind-kftx5g4r	pgxcs-kftwjg5r		PGX_AM_BS_GSM925738	lung adenocarcinoma [cell line PC-9/GR4]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM925738	geo:GSE37698	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjjn9	pgxind-kftx5g4z	pgxcs-kftwjg69		PGX_AM_BS_GSM925739	lung adenocarcinoma [cell line PC-9/WZR09]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM925739	geo:GSE37698	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjsx5	pgxind-kftx5r6j	pgxcs-kftwm7fr		PGX_AM_BS_GSM1153406	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1153406	geo:GSE47620	geo:GPL6983					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjsx8	pgxind-kftx5r6n	pgxcs-kftwm7gl		PGX_AM_BS_GSM1153408	lung adenocarcinoma [cell line HOP-62]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1153408	geo:GSE47620	geo:GPL6983					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjsxb	pgxind-kftx5r6r	pgxcs-kftwm7jd		PGX_AM_BS_GSM1153415	lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1153415	geo:GSE47620	geo:GPL6983					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjsxd	pgxind-kftx5r6t	pgxcs-kftwm7j1		PGX_AM_BS_GSM1153414	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1153414	geo:GSE47620	geo:GPL6983					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1g	pgxind-kftx5rbv	pgxcs-kftwm848		PGX_AM_BS_GSM1181254	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181254	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1h	pgxind-kftx5rbx	pgxcs-kftwm84m		PGX_AM_BS_GSM1181255	non-small cell Lung carcinoma [cell line EKVX]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181255	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1j	pgxind-kftx5rbz	pgxcs-kftwm851		PGX_AM_BS_GSM1181256	lung adenocarcinoma [cell line HOP-62]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181256	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1m	pgxind-kftx5rc3	pgxcs-kftwm8q4		PGX_AM_BS_GSM1181311	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181311	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1p	pgxind-kftx5rc7	pgxcs-kftwm8rc		PGX_AM_BS_GSM1181314	lung adenocarcinoma [cell line HOP-62]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181314	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1r	pgxind-kftx5rc9	pgxcs-kftwm93x		PGX_AM_BS_GSM1181344	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181344	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1s	pgxind-kftx5rcc	pgxcs-kftwm94b		PGX_AM_BS_GSM1181345	lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181345	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1u	pgxind-kftx5rce	pgxcs-kftwm94q		PGX_AM_BS_GSM1181346	lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181346	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1w	pgxind-kftx5rcg	pgxcs-kftwm969		PGX_AM_BS_GSM1181350	non-small cell Lung carcinoma [cell line EKVX]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181350	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1x	pgxind-kftx5rci	pgxcs-kftwm97h		PGX_AM_BS_GSM1181353	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181353	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt1z	pgxind-kftx5rck	pgxcs-kftwm97v		PGX_AM_BS_GSM1181354	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181354	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt21	pgxind-kftx5rcm	pgxcs-kftwm986		PGX_AM_BS_GSM1181355	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181355	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt22	pgxind-kftx5rco	pgxcs-kftwm98i		PGX_AM_BS_GSM1181356	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181356	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt24	pgxind-kftx5rcq	pgxcs-kftwm9bm		PGX_AM_BS_GSM1181364	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181364	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt29	pgxind-kftx5rcw	pgxcs-kftwm972		PGX_AM_BS_GSM1181352	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM1181352	geo:GSE48568	geo:GPL11068					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt4p	pgxind-kftx5rfy	pgxcs-kftwm9js		PGX_AM_BS_GSM750779	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM750779	geo:GSE30291	geo:GPL13786					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt4r	pgxind-kftx5rg0	pgxcs-kftwm9k7		PGX_AM_BS_GSM750780	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM750780	geo:GSE30291	geo:GPL13786					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt54	pgxind-kftx5rgg	pgxcs-kftwm9nb		PGX_AM_BS_GSM750788	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM750788	geo:GSE30291	geo:GPL13786					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt55	pgxind-kftx5rgi	pgxcs-kftwm9np		PGX_AM_BS_GSM750789	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM750789	geo:GSE30291	geo:GPL13786					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt58	pgxind-kftx5rgm	pgxcs-kftwm9oh		PGX_AM_BS_GSM750791	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1					geo:GSM750791	geo:GSE30291	geo:GPL13786					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt83	pgxind-kftx5rk7	pgxcs-kftwmakx		PGX_AM_BS_GSM799343	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Rochester	United Kingdom	GBR	51.39	0.51				NCI-H460	geo:GSM799343	geo:GSE32264	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt8j	pgxind-kftx5rks	pgxcs-kftwmahh		PGX_AM_BS_GSM799336	Lung adenocarcinoma [cell line A549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Rochester	United Kingdom	GBR	51.39	0.51				A549	geo:GSM799336	geo:GSE32264	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt8n	pgxind-kftx5rkw	pgxcs-kftwmaih		PGX_AM_BS_GSM799338	Lung adenocarcinoma [cell line HOP-62]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Rochester	United Kingdom	GBR	51.39	0.51				HOP-62	geo:GSM799338	geo:GSE32264	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt8q	pgxind-kftx5rl0	pgxcs-kftwmalf		PGX_AM_BS_GSM799344	Lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Rochester	United Kingdom	GBR	51.39	0.51				NCI-H522	geo:GSM799344	geo:GSE32264	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt92	pgxind-kftx5rle	pgxcs-kftwmbf4		PGX_AM_BS_GSM799399	Lung adenocarcinoma [cell line A549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Rochester	United Kingdom	GBR	51.39	0.51				A549	geo:GSM799399	geo:GSE32264	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt95	pgxind-kftx5rli	pgxcs-kftwmbg4		PGX_AM_BS_GSM799401	Lung adenocarcinoma [cell line HOP-62]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Rochester	United Kingdom	GBR	51.39	0.51				HOP-62	geo:GSM799401	geo:GSE32264	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjt98	pgxind-kftx5rln	pgxcs-kftwmbj5		PGX_AM_BS_GSM799407	Lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Rochester	United Kingdom	GBR	51.39	0.51				NCI-H522	geo:GSM799407	geo:GSE32264	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjtek	pgxind-kftx5rs7	pgxcs-kftwmcam		PGX_AM_BS_GSM1086289	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Muenster	Germany	DEU	51.96	7.63					geo:GSM1086289	geo:GSE44549	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjtel	pgxind-kftx5rs9	pgxcs-kftwmcb0		PGX_AM_BS_GSM1086290	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Muenster	Germany	DEU	51.96	7.63					geo:GSM1086290	geo:GSE44549	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjtep	pgxind-kftx5rsd	pgxcs-kftwmcbq		PGX_AM_BS_GSM1557132	Lung adenocarcinoma [cell line HCC827]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Freiburg	Germany	DEU	48.0	7.85					geo:GSM1557132	geo:GSE63784	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjteq	pgxind-kftx5rsf	pgxcs-kftwmcc5		PGX_AM_BS_GSM1557133	lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Freiburg	Germany	DEU	48.0	7.85					geo:GSM1557133	geo:GSE63784	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjtes	pgxind-kftx5rsh	pgxcs-kftwmccg		PGX_AM_BS_GSM1557134	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Freiburg	Germany	DEU	48.0	7.85					geo:GSM1557134	geo:GSE63784	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjujg	pgxind-kftx5t6o	pgxcs-kftwmlsi		PGX_AM_BS_GSM784193	Large cell lung carcinoma [cell line NCI-H460]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784193	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjulz	pgxind-kftx5t9r	pgxcs-kftwmmb0		PGX_AM_BS_GSM784249	Lung adenocarcinoma [cell line Calu-3]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784249	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjumh	pgxind-kftx5tad	pgxcs-kftwmmf0		PGX_AM_BS_GSM784226	lung adenocarcinoma [cell line SK-LU-1]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784226	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjunh	pgxind-kftx5tbm	pgxcs-kftwmmny		PGX_AM_BS_GSM784202	Small cell lung carcinoma [cell line CPC-N]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784202	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjutm	pgxind-kftx5tj3	pgxcs-kftwmo76		PGX_AM_BS_GSM784234	Large cell lung carcinoma [cell line LCLC-97TMI]	NCIT:C4450	Large cell lung carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784234	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjutn	pgxind-kftx5tj5	pgxcs-kftwmo7l		PGX_AM_BS_GSM784281	squamous cell lung carcinoma [cell line LK-2]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784281	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuu6	pgxind-kftx5tjs	pgxcs-kftwmoc2		PGX_AM_BS_GSM784222	Lung adenocarcinoma [cell line NCI-H1395]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784222	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuu9	pgxind-kftx5tjw	pgxcs-kftwmocw		PGX_AM_BS_GSM784247	small cell Lung carcinoma [cell line NCI-H146]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784247	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuua	pgxind-kftx5tjy	pgxcs-kftwmodb		PGX_AM_BS_GSM784195	Lung adenocarcinoma [cell line NCI-H1563]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784195	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuue	pgxind-kftx5tk2	pgxcs-kftwmoe4		PGX_AM_BS_GSM784268	Lung adenocarcinoma [cell line NCI-H1623]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784268	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuuh	pgxind-kftx5tk6	pgxcs-kftwmoex		PGX_AM_BS_GSM784264	small cell Lung carcinoma [cell line NCI-H1688]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784264	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuur	pgxind-kftx5tki	pgxcs-kftwmojr		PGX_AM_BS_GSM784224	lung adenocarcinoma [cell line NCI-H1838]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784224	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuuz	pgxind-kftx5tks	pgxcs-kftwmolt		PGX_AM_BS_GSM784272	Lung adenocarcinoma [cell line NCI-H2030]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784272	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuv1	pgxind-kftx5tku	pgxcs-kftwmom8		PGX_AM_BS_GSM784273	Non-small cell lung carcinoma [cell line NCI-H2085]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784273	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuv4	pgxind-kftx5tky	pgxcs-kftwmon1		PGX_AM_BS_GSM784209	small cell lung carcinoma [cell line NCI-H211]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784209	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuv6	pgxind-kftx5tl0	pgxcs-kftwmong		PGX_AM_BS_GSM784219	lung adenocarcinoma [cell line NCI-H2122]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784219	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuv7	pgxind-kftx5tl2	pgxcs-kftwmonv		PGX_AM_BS_GSM784235	Large cell lung carcinoma [cell line NCI-H2126]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784235	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuv9	pgxind-kftx5tl5	pgxcs-kftwmoo9		PGX_AM_BS_GSM784214	squamous cell lung carcinoma [cell line NCI-H2170]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784214	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuva	pgxind-kftx5tl7	pgxcs-kftwmooo		PGX_AM_BS_GSM482108	lung adenocarcinoma [cell line NCI-H23]	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482108	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuvt	pgxind-kftx5tlt	pgxcs-kftwmotb		PGX_AM_BS_GSM784233	lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784233	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuw6	pgxind-kftx5tm8	pgxcs-kftwmowl		PGX_AM_BS_GSM482517	small cell Lung carcinoma [cell line NCI-H82]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482517	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuw8	pgxind-kftx5tma	pgxcs-kftwmox0		PGX_AM_BS_GSM784220	small cell Lung carcinoma [cell line NCI-H82]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784220	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuxt	pgxind-kftx5to8	pgxcs-kftwmp8o		PGX_AM_BS_GSM784236	Lung carcinoma [cell line UMC-11]	NCIT:C4878	Lung Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784236	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjuz9	pgxind-kftx5tpy	pgxcs-kftwmpjx		PGX_AM_BS_GSM784275	Lung adenocarcinoma [cell line HCC78]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784275	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjv64	pgxind-kftx5tyb	pgxcs-kftwmr26		PGX_AM_BS_GSM784280	squamous cell lung carcinoma [cell line LC-1sq]	NCIT:C3493	Squamous Cell Lung Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784280	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjv7l	pgxind-kftx5u01	pgxcs-kftwmrf5		PGX_AM_BS_GSM784221	Small cell lung carcinoma [cell line SK-LC-17]	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784221	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvjv7n	pgxind-kftx5u03	pgxcs-kftwmrfk		PGX_AM_BS_GSM784256	Lung adenocarcinoma [cell line SK-LC-3]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784256	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2ut	pgxind-kftx6303	pgxcs-kftwohpe		PGX_AM_BS_GSM842540	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842540	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2vd	pgxind-kftx630r	pgxcs-kftwoht2		PGX_AM_BS_GSM842552	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842552	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2wi	pgxind-kftx6326	pgxcs-kftwoi0o		PGX_AM_BS_GSM842577	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842577	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2wm	pgxind-kftx632a	pgxcs-kftwoi1b		PGX_AM_BS_GSM842579	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842579	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2ws	pgxind-kftx632i	pgxcs-kftwoi2j		PGX_AM_BS_GSM842583	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842583	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2y3	pgxind-kftx6346	pgxcs-kftwoibi		PGX_AM_BS_GSM842612	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842612	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2yb	pgxind-kftx634g	pgxcs-kftwoid2		PGX_AM_BS_GSM842617	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842617	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2yt	pgxind-kftx6352	pgxcs-kftwoigl		PGX_AM_BS_GSM842628	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842628	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2z8	pgxind-kftx635k	pgxcs-kftwoijg		PGX_AM_BS_GSM842637	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842637	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2zb	pgxind-kftx635o	pgxcs-kftwoik2		PGX_AM_BS_GSM842639	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842639	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk2zs	pgxind-kftx6367	pgxcs-kftwoin6		PGX_AM_BS_GSM842649	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842649	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk30c	pgxind-kftx636w	pgxcs-kftwoiqz		PGX_AM_BS_GSM842661	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842661	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk31k	pgxind-kftx638e	pgxcs-kftwoj2n		PGX_AM_BS_GSM842688	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842688	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk31n	pgxind-kftx638i	pgxcs-kftwoj39		PGX_AM_BS_GSM842690	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842690	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk31p	pgxind-kftx638k	pgxcs-kftwoj3l		PGX_AM_BS_GSM842691	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842691	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk322	pgxind-kftx6390	pgxcs-kftwoj62		PGX_AM_BS_GSM842699	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842699	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk32c	pgxind-kftx639c	pgxcs-kftwoj7w		PGX_AM_BS_GSM842705	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842705	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk32r	pgxind-kftx639v	pgxcs-kftwojao		PGX_AM_BS_GSM842714	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842714	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk33e	pgxind-kftx63an	pgxcs-kftwojey		PGX_AM_BS_GSM842728	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842728	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk33g	pgxind-kftx63ap	pgxcs-kftwojfa		PGX_AM_BS_GSM842729	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842729	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk33l	pgxind-kftx63av	pgxcs-kftwojg7		PGX_AM_BS_GSM842732	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842732	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk33r	pgxind-kftx63b3	pgxcs-kftwojhf		PGX_AM_BS_GSM842736	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842736	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk34v	pgxind-kftx63cg	pgxcs-kftwojoy		PGX_AM_BS_GSM842760	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842760	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk358	pgxind-kftx63cw	pgxcs-kftwojrh		PGX_AM_BS_GSM842768	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842768	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk35n	pgxind-kftx63de	pgxcs-kftwojuc		PGX_AM_BS_GSM842777	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842777	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk35s	pgxind-kftx63dk	pgxcs-kftwojva		PGX_AM_BS_GSM842780	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842780	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk360	pgxind-kftx63du	pgxcs-kftwojwk		PGX_AM_BS_GSM842784	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842784	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk36d	pgxind-kftx63ea	pgxcs-kftwojzc		PGX_AM_BS_GSM842793	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842793	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk36f	pgxind-kftx63ed	pgxcs-kftwojzo		PGX_AM_BS_GSM842794	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842794	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk36h	pgxind-kftx63ef	pgxcs-kftwojzy		PGX_AM_BS_GSM842795	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842795	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk36i	pgxind-kftx63eh	pgxcs-kftwok0a		PGX_AM_BS_GSM842796	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842796	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk36p	pgxind-kftx63ep	pgxcs-kftwok1i		PGX_AM_BS_GSM842800	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842800	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk36x	pgxind-kftx63ez	pgxcs-kftwok32		PGX_AM_BS_GSM842805	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842805	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk381	pgxind-kftx63gc	pgxcs-kftwokag		PGX_AM_BS_GSM842829	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842829	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk383	pgxind-kftx63ge	pgxcs-kftwokas		PGX_AM_BS_GSM842830	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842830	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk388	pgxind-kftx63gk	pgxcs-kftwokbq		PGX_AM_BS_GSM842833	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842833	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk38b	pgxind-kftx63go	pgxcs-kftwokcd		PGX_AM_BS_GSM842835	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Boston	United States of America	USA	42.36	-71.06					geo:GSM842835	geo:GSE34140	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3gn	pgxind-kftx63qs	pgxcs-kftwolzb		PGX_AM_BS_GSM1018660	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018660	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3gt	pgxind-kftx63r0	pgxcs-kftwom0l		PGX_AM_BS_GSM1018664	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018664	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3hr	pgxind-kftx63s7	pgxcs-kftwom74		PGX_AM_BS_GSM1018685	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018685	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3ht	pgxind-kftx63s9	pgxcs-kftwom7y		PGX_AM_BS_GSM1018687	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018687	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3i1	pgxind-kftx63sj	pgxcs-kftwom9i		PGX_AM_BS_GSM1018692	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018692	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3ia	pgxind-kftx63st	pgxcs-kftwomb3		PGX_AM_BS_GSM1018697	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018697	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3id	pgxind-kftx63sx	pgxcs-kftwombq		PGX_AM_BS_GSM1018699	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018699	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3if	pgxind-kftx63sz	pgxcs-kftwomc2		PGX_AM_BS_GSM1018700	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018700	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3ig	pgxind-kftx63t1	pgxcs-kftwomcd		PGX_AM_BS_GSM1018701	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018701	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3ii	pgxind-kftx63t4	pgxcs-kftwomco		PGX_AM_BS_GSM1018702	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018702	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3in	pgxind-kftx63ta	pgxcs-kftwome4		PGX_AM_BS_GSM1018706	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018706	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3iq	pgxind-kftx63te	pgxcs-kftwomer		PGX_AM_BS_GSM1018708	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018708	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3ir	pgxind-kftx63tg	pgxcs-kftwomf3		PGX_AM_BS_GSM1018709	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018709	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3j0	pgxind-kftx63tq	pgxcs-kftwomh5		PGX_AM_BS_GSM1018715	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018715	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3j4	pgxind-kftx63tw	pgxcs-kftwomi3		PGX_AM_BS_GSM1018718	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018718	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3j6	pgxind-kftx63ty	pgxcs-kftwomie		PGX_AM_BS_GSM1018719	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018719	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3j8	pgxind-kftx63u0	pgxcs-kftwomiq		PGX_AM_BS_GSM1018720	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018720	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3j9	pgxind-kftx63u2	pgxcs-kftwomj1		PGX_AM_BS_GSM1018721	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018721	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3jb	pgxind-kftx63u4	pgxcs-kftwomkc		PGX_AM_BS_GSM1018724	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018724	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3jh	pgxind-kftx63uc	pgxcs-kftwomm2		PGX_AM_BS_GSM1018729	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018729	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3jl	pgxind-kftx63ug	pgxcs-kftwommp		PGX_AM_BS_GSM1018731	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018731	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3jm	pgxind-kftx63ui	pgxcs-kftwomn0		PGX_AM_BS_GSM1018732	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018732	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3k3	pgxind-kftx63v2	pgxcs-kftwomq4		PGX_AM_BS_GSM1018742	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018742	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3l4	pgxind-kftx63wd	pgxcs-kftwomx5		PGX_AM_BS_GSM1018774	lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018774	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3ll	pgxind-kftx63wx	pgxcs-kftwom7f		PGX_AM_BS_GSM1018686	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018686	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3lm	pgxind-kftx63wz	pgxcs-kftwomdb		PGX_AM_BS_GSM1018704	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018704	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3lo	pgxind-kftx63x1	pgxcs-kftwomg1		PGX_AM_BS_GSM1018712	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018712	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3lp	pgxind-kftx63x3	pgxcs-kftwomjd		PGX_AM_BS_GSM1018722	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018722	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3lr	pgxind-kftx63x5	pgxcs-kftwomjv		PGX_AM_BS_GSM1018723	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018723	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3lt	pgxind-kftx63x7	pgxcs-kftwomll		PGX_AM_BS_GSM1018728	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Tokyo	Japan	JPN	35.69	139.69					geo:GSM1018728	geo:GSE41536	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3vm	pgxind-kftx649a	pgxcs-kftws1zk		PGX_AM_BS_GSM2036735	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036735	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3vo	pgxind-kftx649c	pgxcs-kftws202		PGX_AM_BS_GSM2036736	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036736	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3vy	pgxind-kftx649o	pgxcs-kftws230		PGX_AM_BS_GSM2036742	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036742	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3w3	pgxind-kftx649u	pgxcs-kftws24h		PGX_AM_BS_GSM2036745	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036745	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3wh	pgxind-kftx64ac	pgxcs-kftwoovp		PGX_AM_BS_GSM2036754	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036754	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3wl	pgxind-kftx64ag	pgxcs-kftwoowh		PGX_AM_BS_GSM2036756	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036756	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3wr	pgxind-kftx64ao	pgxcs-kftwooy2		PGX_AM_BS_GSM2036760	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036760	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3wz	pgxind-kftx64ay	pgxcs-kftwop00		PGX_AM_BS_GSM2036765	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036765	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3x2	pgxind-kftx64b2	pgxcs-kftwop0t		PGX_AM_BS_GSM2036767	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036767	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3x7	pgxind-kftx64b8	pgxcs-kftwop1z		PGX_AM_BS_GSM2036770	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036770	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3y4	pgxind-kftx64cc	pgxcs-kftwopcn		PGX_AM_BS_GSM2036790	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036790	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3yh	pgxind-kftx64ct	pgxcs-kftwopfr		PGX_AM_BS_GSM2036798	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036798	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3ym	pgxind-kftx64cz	pgxcs-kftwopgx		PGX_AM_BS_GSM2036801	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036801	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3yv	pgxind-kftx64d9	pgxcs-kftwopiw		PGX_AM_BS_GSM2036806	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036806	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3yy	pgxind-kftx64dd	pgxcs-kftwopjp		PGX_AM_BS_GSM2036808	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036808	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk3zd	pgxind-kftx64dw	pgxcs-kftwopn8		PGX_AM_BS_GSM2036817	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036817	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk40c	pgxind-kftx64f2	pgxcs-kftwopvg		PGX_AM_BS_GSM2036838	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036838	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk40h	pgxind-kftx64f8	pgxcs-kftwopwn		PGX_AM_BS_GSM2036841	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036841	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk411	pgxind-kftx64fx	pgxcs-kftwoq1f		PGX_AM_BS_GSM2036853	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036853	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk41f	pgxind-kftx64gf	pgxcs-kftwoq4z		PGX_AM_BS_GSM2036862	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036862	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk41k	pgxind-kftx64gl	pgxcs-kftwoq66		PGX_AM_BS_GSM2036865	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036865	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk41s	pgxind-kftx64gw	pgxcs-kftwoq85		PGX_AM_BS_GSM2036870	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036870	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk420	pgxind-kftx64h6	pgxcs-kftwoqa5		PGX_AM_BS_GSM2036875	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036875	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk42m	pgxind-kftx64hw	pgxcs-kftwoqfd		PGX_AM_BS_GSM2036888	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036888	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk42x	pgxind-kftx64i9	pgxcs-kftwoqi5		PGX_AM_BS_GSM2036895	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036895	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk432	pgxind-kftx64ig	pgxcs-kftwoqjd		PGX_AM_BS_GSM2036898	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036898	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk43a	pgxind-kftx64iq	pgxcs-kftwoqnt		PGX_AM_BS_GSM2036903	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036903	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk43c	pgxind-kftx64is	pgxcs-kftwoqo7		PGX_AM_BS_GSM2036904	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036904	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk43m	pgxind-kftx64j4	pgxcs-kftwoqqj		PGX_AM_BS_GSM2036910	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036910	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk43w	pgxind-kftx64jg	pgxcs-kftwoqsw		PGX_AM_BS_GSM2036916	non-small cell lung cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Uppsala	Sweden	SWE	59.86	17.64					geo:GSM2036916	geo:GSE76730	geo:GPL3718					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk60i	pgxind-kftx66ur	pgxcs-kftwp9ub		PGX_AM_BS_GSM482111	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482111	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk60n	pgxind-kftx66ux	pgxcs-kftwp9v9		PGX_AM_BS_GSM482114	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482114	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk60q	pgxind-kftx66v1	pgxcs-kftwp9vw		PGX_AM_BS_GSM482116	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482116	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk60s	pgxind-kftx66v3	pgxcs-kftwp9w7		PGX_AM_BS_GSM482117	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482117	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk618	pgxind-kftx66vn	pgxcs-kftwp9za		PGX_AM_BS_GSM482127	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482127	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk61h	pgxind-kftx66vx	pgxcs-kftwpa0u		PGX_AM_BS_GSM482132	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482132	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk61p	pgxind-kftx66w8	pgxcs-kftwpa2e		PGX_AM_BS_GSM482137	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482137	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk61v	pgxind-kftx66wg	pgxcs-kftwpa3n		PGX_AM_BS_GSM482141	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482141	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk61x	pgxind-kftx66wi	pgxcs-kftwpa3y		PGX_AM_BS_GSM482142	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482142	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk61z	pgxind-kftx66wk	pgxcs-kftwpa49		PGX_AM_BS_GSM482143	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482143	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk620	pgxind-kftx66wm	pgxcs-kftwpa4l		PGX_AM_BS_GSM482144	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482144	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk62d	pgxind-kftx66x2	pgxcs-kftwpa71		PGX_AM_BS_GSM482152	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482152	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk62f	pgxind-kftx66x4	pgxcs-kftwpa7c		PGX_AM_BS_GSM482153	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482153	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk62r	pgxind-kftx66xi	pgxcs-kftwpad1		PGX_AM_BS_GSM482160	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482160	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk638	pgxind-kftx66y4	pgxcs-kftwpagi		PGX_AM_BS_GSM482171	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482171	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk64j	pgxind-kftx66zq	pgxcs-kftwpapa		PGX_AM_BS_GSM482199	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482199	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk65i	pgxind-kftx670x	pgxcs-kftwpavw		PGX_AM_BS_GSM482220	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482220	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk668	pgxind-kftx671t	pgxcs-kftwpb11		PGX_AM_BS_GSM482236	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482236	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk67f	pgxind-kftx6739	pgxcs-kftwpb9b		PGX_AM_BS_GSM482262	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482262	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk69z	pgxind-kftx676f	pgxcs-kftwpbqp		PGX_AM_BS_GSM482318	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482318	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk6h3	pgxind-kftx67f0	pgxcs-kftwpd54		PGX_AM_BS_GSM482518	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482518	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk6h8	pgxind-kftx67f6	pgxcs-kftwpd62		PGX_AM_BS_GSM482521	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482521	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk6hg	pgxind-kftx67fh	pgxcs-kftwpd7n		PGX_AM_BS_GSM482526	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482526	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvk6hm	pgxind-kftx67fp	pgxcs-kftwpd8x		PGX_AM_BS_GSM482530	small cell lung carcinoma	NCIT:C4917	Lung Small Cell Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11					geo:GSM482530	geo:GSE19399	geo:GPL3720					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkfkj	pgxind-kftx6ikh	pgxcs-kftwr723		PGX_AM_BS_GSM825023	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM825023	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkfkn	pgxind-kftx6ikl	pgxcs-kftwr732		PGX_AM_BS_GSM825031	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM825031	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkfkq	pgxind-kftx6ikp	pgxcs-kftwr742		PGX_AM_BS_GSM825045	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Taipei	Taiwan	TWN	25.05	121.53					geo:GSM825045	geo:GSE33355	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkft4	pgxind-kftx6iuz	pgxcs-kftwr9q0		PGX_AM_BS_GSM889595	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889595	geo:GSE36363	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkft8	pgxind-kftx6iv3	pgxcs-kftwr9qz		PGX_AM_BS_GSM889603	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889603	geo:GSE36363	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkftb	pgxind-kftx6iv7	pgxcs-kftwr9rz		PGX_AM_BS_GSM889605	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889605	geo:GSE36363	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkfte	pgxind-kftx6ivb	pgxcs-kftwr9sy		PGX_AM_BS_GSM889616	Lung adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Chapel Hill	United States of America	USA	35.91	-79.06					geo:GSM889616	geo:GSE36363	geo:GPL6801					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhf7	pgxind-kftx6kun	pgxcs-kftwro3n		PGX_AM_BS_GSM784320	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784320	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhgz	pgxind-kftx6kwu	pgxcs-kftwrofz		PGX_AM_BS_GSM784410	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784410	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhhi	pgxind-kftx6kxj	pgxcs-kftwrojq		PGX_AM_BS_GSM784422	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784422	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhhk	pgxind-kftx6kxl	pgxcs-kftwrok1		PGX_AM_BS_GSM784423	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784423	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhif	pgxind-kftx6kyn	pgxcs-kftwroq0		PGX_AM_BS_GSM784442	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784442	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhik	pgxind-kftx6kyt	pgxcs-kftwroqy		PGX_AM_BS_GSM784445	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784445	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhj1	pgxind-kftx6kzf	pgxcs-kftwrouh		PGX_AM_BS_GSM784456	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784456	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhjd	pgxind-kftx6kzu	pgxcs-kftwrowp		PGX_AM_BS_GSM784463	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784463	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhjf	pgxind-kftx6kzw	pgxcs-kftwroz3		PGX_AM_BS_GSM784464	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784464	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhji	pgxind-kftx6l00	pgxcs-kftwrozr		PGX_AM_BS_GSM784466	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784466	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhjq	pgxind-kftx6l0a	pgxcs-kftwrp1c		PGX_AM_BS_GSM784471	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784471	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhjs	pgxind-kftx6l0c	pgxcs-kftwrp1n		PGX_AM_BS_GSM784472	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784472	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhjt	pgxind-kftx6l0e	pgxcs-kftwrp1z		PGX_AM_BS_GSM784473	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784473	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhjv	pgxind-kftx6l0g	pgxcs-kftwrp2a		PGX_AM_BS_GSM784474	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784474	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhk2	pgxind-kftx6l0o	pgxcs-kftwrp3j		PGX_AM_BS_GSM784478	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784478	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhkb	pgxind-kftx6l10	pgxcs-kftwrp5e		PGX_AM_BS_GSM784484	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784484	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkhkd	pgxind-kftx6l12	pgxcs-kftwrp5p		PGX_AM_BS_GSM784485	non-small cell lung carcinoma	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Woodbury	United States of America	USA	44.92	-92.96					geo:GSM784485	geo:GSE31586	geo:GPL7313					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvki84	pgxind-kftx6lu6	pgxcs-kftwru8c		PGX_AM_BS_GSM417069	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01					geo:GSM417069	geo:GSE16597	geo:GPL8690					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvki8j	pgxind-kftx6luo	pgxcs-kftwruby		PGX_AM_BS_GSM417078	adenocarcinoma [lung]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01					geo:GSM417078	geo:GSE16597	geo:GPL8690					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkji3	pgxind-kftx6nfv	pgxcs-kftwst6l		PGX_AM_BS_GSM1568174	lung adenocarcinoma [Li-Fraumeni Syndrome]	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Salt Lake City	United States of America	USA	40.76	-111.89					geo:GSM1568174	geo:GSE64293	geo:GPL18602					EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvks9l	pgxind-kftx6y0s	pgxcs-kftwtxe4		PGX_AM_BS_CELLLINE_CCLE_BROAD-A549_LUNG	Lung adenocarcinoma [cell line A-549]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				A-549								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksc9	pgxind-kftx6y44	pgxcs-kftwty9a		PGX_AM_BS_CELLLINE_CCLE_BROAD-CALU1_LUNG	Lung squamous cell carcinoma [cell line Calu-1]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				Calu-1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkscb	pgxind-kftx6y46	pgxcs-kftwty9s		PGX_AM_BS_CELLLINE_CCLE_BROAD-CALU3_LUNG	Lung adenocarcinoma [cell line Calu-3]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				Calu-3								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkse7	pgxind-kftx6y6k	pgxcs-kftwtyuc		PGX_AM_BS_CELLLINE_CCLE_BROAD-CORL105_LUNG	Lung adenocarcinoma [cell line COR-L105]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				COR-L105								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksec	pgxind-kftx6y6q	pgxcs-kftwtyvv		PGX_AM_BS_CELLLINE_CCLE_BROAD-CORL279_LUNG	Lung small cell carcinoma [cell line COR-L279]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				COR-L279								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksee	pgxind-kftx6y6t	pgxcs-kftwtywd		PGX_AM_BS_CELLLINE_CCLE_BROAD-CORL311_LUNG	Lung small cell carcinoma [cell line COR-L311]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				COR-L311								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkseu	pgxind-kftx6y7d	pgxcs-kftwtz3h		PGX_AM_BS_CELLLINE_CCLE_BROAD-CPCN_LUNG	Lung small cell carcinoma [cell line CPC-N]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				CPC-N								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksfl	pgxind-kftx6y8c	pgxcs-kftwtzbq		PGX_AM_BS_CELLLINE_CCLE_BROAD-DMS454_LUNG	Lung small cell carcinoma [cell line DMS 454]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				DMS 454								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksfn	pgxind-kftx6y8e	pgxcs-kftwtzc8		PGX_AM_BS_CELLLINE_CCLE_BROAD-DMS53_LUNG	Lung small cell carcinoma [cell line DMS 53]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				DMS 53								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksfo	pgxind-kftx6y8g	pgxcs-kftwtzcq		PGX_AM_BS_CELLLINE_CCLE_BROAD-DMS79_LUNG	Lung small cell carcinoma [cell line DMS 79]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				DMS 79								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksgo	pgxind-kftx6y9p	pgxcs-kftwtzni		PGX_AM_BS_CELLLINE_CCLE_BROAD-EPLC272H_LUNG	Lung mucoepidermoid carcinoma [cell line EPLC-272H]	NCIT:C45544	Lung mucoepidermoid carcinoma	pgx:icdom-84303	Mucoepidermoid carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				EPLC-272H								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksi9	pgxind-kftx6ybm	pgxcs-kftwu046		PGX_AM_BS_CELLLINE_CCLE_BROAD-HCC1171_LUNG	Lung adenocarcinoma [cell line HCC1171]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				HCC1171								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksic	pgxind-kftx6ybq	pgxcs-kftwu055		PGX_AM_BS_CELLLINE_CCLE_BROAD-HCC1195_LUNG	Lung adenosquamous carcinoma [cell line HCC1195]	NCIT:C9133	Lung adenosquamous carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				HCC1195								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksj0	pgxind-kftx6yck	pgxcs-kftwu0ex		PGX_AM_BS_CELLLINE_CCLE_BROAD-HCC2279_LUNG	Lung adenosquamous carcinoma [cell line HCC2279]	NCIT:C9133	Lung adenosquamous carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				HCC2279								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksj2	pgxind-kftx6ycm	pgxcs-kftwu0fe		PGX_AM_BS_CELLLINE_CCLE_BROAD-HCC2935_LUNG	Lung adenocarcinoma [cell line HCC2935]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				HCC2935								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksj3	pgxind-kftx6yco	pgxcs-kftwu0fw		PGX_AM_BS_CELLLINE_CCLE_BROAD-HCC33_LUNG	Lung small cell carcinoma [cell line HCC33]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				HCC33								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksja	pgxind-kftx6ycw	pgxcs-kftwu0hv		PGX_AM_BS_CELLLINE_CCLE_BROAD-HCC44_LUNG	Lung adenocarcinoma [cell line HCC44]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				HCC44								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksje	pgxind-kftx6yd1	pgxcs-kftwu0jc		PGX_AM_BS_CELLLINE_CCLE_BROAD-HCC78_LUNG	Lung adenocarcinoma [cell line HCC78]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				HCC78								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksjg	pgxind-kftx6yd3	pgxcs-kftwu0jt		PGX_AM_BS_CELLLINE_CCLE_BROAD-HCC827_LUNG	Lung adenocarcinoma [cell line HCC827]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				HCC827								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksji	pgxind-kftx6yd5	pgxcs-kftwu0kb		PGX_AM_BS_CELLLINE_CCLE_BROAD-HCC95_LUNG	Lung squamous cell carcinoma [cell line HCC95]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				HCC95								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkskm	pgxind-kftx6yek	pgxcs-kftwu0wg		PGX_AM_BS_CELLLINE_CCLE_BROAD-HLC1_LUNG	Lung adenocarcinoma [cell line HLC-1]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				HLC-1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkso7	pgxind-kftx6yj2	pgxcs-kftwu21c		PGX_AM_BS_CELLLINE_CCLE_BROAD-IALM_LUNG	Lung large cell carcinoma [cell line IA-LM]	NCIT:C4450	Lung large cell carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				IA-LM								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksrp	pgxind-kftx6yng	pgxcs-kftwu368		PGX_AM_BS_CELLLINE_CCLE_BROAD-KNS62_LUNG	Lung squamous cell carcinoma [cell line KNS-62]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				KNS-62								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkst8	pgxind-kftx6ypb	pgxcs-kftwu3mi		PGX_AM_BS_CELLLINE_CCLE_BROAD-LC1F_LUNG	Lung squamous cell carcinoma [cell line LC-1F]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				LC-1F								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkstb	pgxind-kftx6ypg	pgxcs-kftwu3ni		PGX_AM_BS_CELLLINE_CCLE_BROAD-LCLC103H_LUNG	Lung large cell carcinoma [cell line LCLC-103H]	NCIT:C4450	Lung large cell carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				LCLC-103H								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkstd	pgxind-kftx6ypi	pgxcs-kftwu3o0		PGX_AM_BS_CELLLINE_CCLE_BROAD-LCLC97TM1_LUNG	Lung large cell carcinoma [cell line LCLC-97TM1]	NCIT:C4450	Lung large cell carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				LCLC-97TM1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkstg	pgxind-kftx6ypm	pgxcs-kftwu3p0		PGX_AM_BS_CELLLINE_CCLE_BROAD-LK2_LUNG	Lung squamous cell carcinoma [cell line LK-2]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				LK-2								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksu5	pgxind-kftx6yqh	pgxcs-kftwu3yk		PGX_AM_BS_CELLLINE_CCLE_BROAD-LU65_LUNG	Lung giant cell carcinoma [cell line Lu-65]	NCIT:C4452	Lung giant cell carcinoma	pgx:icdom-80313	Giant cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				Lu-65								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksu6	pgxind-kftx6yqj	pgxcs-kftwu3z1		PGX_AM_BS_CELLLINE_CCLE_BROAD-LU99_LUNG	Lung giant cell carcinoma [cell line Lu-99]	NCIT:C4452	Lung giant cell carcinoma	pgx:icdom-80313	Giant cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				Lu-99								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksu8	pgxind-kftx6yql	pgxcs-kftwu3zj		PGX_AM_BS_CELLLINE_CCLE_BROAD-LUDLU1_LUNG	Lung squamous cell carcinoma [cell line LUDLU-1]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				LUDLU-1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksua	pgxind-kftx6yqn	pgxcs-kftwu401		PGX_AM_BS_CELLLINE_CCLE_BROAD-LXF289_LUNG	Lung adenocarcinoma [cell line LXF 289]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				LXF 289								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkswu	pgxind-kftx6ytv	pgxcs-kftwu4s2		PGX_AM_BS_CELLLINE_CCLE_BROAD-MORCPR_LUNG	Lung adenocarcinoma [cell line MOR/CPR]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				MOR/CPR								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksxf	pgxind-kftx6yum	pgxcs-kftwu4ye		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1048_LUNG	Lung small cell carcinoma [cell line NCI-H1048]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1048								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksxm	pgxind-kftx6yuu	pgxcs-kftwu52i		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1184_LUNG	Lung small cell carcinoma [cell line NCI-H1184]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1184								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksxu	pgxind-kftx6yv4	pgxcs-kftwu551		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1373_LUNG	Lung adenocarcinoma [cell line NCI-H1373]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1373								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksxv	pgxind-kftx6yv6	pgxcs-kftwu55m		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1385_LUNG	Lung squamous cell carcinoma [cell line NCI-H1385]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1385								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksxy	pgxind-kftx6yva	pgxcs-kftwu56m		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1435_LUNG	Lung adenocarcinoma [cell line NCI-H1435]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1435								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksy0	pgxind-kftx6yvc	pgxcs-kftwu574		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1436_LUNG	Lung small cell carcinoma [cell line NCI-H1436]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1436								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksy5	pgxind-kftx6yvi	pgxcs-kftwu58m		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1563_LUNG	Lung adenocarcinoma [cell line NCI-H1563]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1563								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksya	pgxind-kftx6yvp	pgxcs-kftwu5a4		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1581_LUNG	Lung large cell carcinoma [cell line NCI-H1581]	NCIT:C4450	Lung large cell carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1581								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksyb	pgxind-kftx6yvq	pgxcs-kftwu5am		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1618_LUNG	Lung small cell carcinoma [cell line NCI-H1618]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1618								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksyd	pgxind-kftx6yvs	pgxcs-kftwu5b4		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1623_LUNG	Lung adenocarcinoma [cell line NCI-H1623]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1623								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksye	pgxind-kftx6yvu	pgxcs-kftwu5bm		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1648_LUNG	Lung adenocarcinoma [cell line NCI-H1648]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1648								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksyj	pgxind-kftx6yw1	pgxcs-kftwu5d4		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1666_LUNG	Minimally invasive lung adenocarcinoma [cell line NCI-H1666]	NCIT:C2923	Minimally invasive lung adenocarcinoma	pgx:icdom-82503	Bronchiolo-alveolar adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1666								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksyl	pgxind-kftx6yw3	pgxcs-kftwu5dm		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1693_LUNG	Lung adenocarcinoma [cell line NCI-H1693]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1693								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksyn	pgxind-kftx6yw5	pgxcs-kftwu5e4		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1694_LUNG	Lung small cell carcinoma [cell line NCI-H1694]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1694								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksyo	pgxind-kftx6yw7	pgxcs-kftwu5el		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1703_LUNG	Lung squamous cell carcinoma [cell line NCI-H1703]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1703								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksyq	pgxind-kftx6yw9	pgxcs-kftwu5f4		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1734_LUNG	Lung adenocarcinoma [cell line NCI-H1734]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1734								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksyt	pgxind-kftx6ywd	pgxcs-kftwu5g4		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1781_LUNG	Minimally invasive lung adenocarcinoma [cell line NCI-H1781]	NCIT:C2923	Minimally invasive lung adenocarcinoma	pgx:icdom-82503	Bronchiolo-alveolar adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1781								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksz1	pgxind-kftx6ywn	pgxcs-kftwu5il		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH1869_LUNG	Lung squamous cell carcinoma [cell line NCI-H1869]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H1869								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvksze	pgxind-kftx6yx3	pgxcs-kftwu5mk		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2009_LUNG	Lung adenocarcinoma [cell line NCI-H2009]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2009								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkszg	pgxind-kftx6yx5	pgxcs-kftwu5n2		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2023_LUNG	Lung adenocarcinoma [cell line NCI-H2023]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2023								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkszj	pgxind-kftx6yx9	pgxcs-kftwu5o2		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2030_LUNG	Lung adenocarcinoma [cell line NCI-H2030]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2030								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkszm	pgxind-kftx6yxd	pgxcs-kftwu5p1		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2066_LUNG	Lung squamous cell carcinoma [cell line NCI-H2066]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2066								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkszq	pgxind-kftx6yxh	pgxcs-kftwu5q1		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2081_LUNG	Lung small cell carcinoma [cell line NCI-H2081]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2081								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkszr	pgxind-kftx6yxj	pgxcs-kftwu5qj		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2085_LUNG	Lung adenocarcinoma [cell line NCI-H2085]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2085								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkszy	pgxind-kftx6yxr	pgxcs-kftwu5si		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH211_LUNG	Lung small cell carcinoma [cell line NCI-H211]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H211								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt01	pgxind-kftx6yxv	pgxcs-kftwu5ti		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2122_LUNG	Lung adenocarcinoma [cell line NCI-H2122]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2122								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt04	pgxind-kftx6yxz	pgxcs-kftwu5ui		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2141_LUNG	Lung small cell carcinoma [cell line NCI-H2141]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2141								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt06	pgxind-kftx6yy1	pgxcs-kftwu5v0		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2170_LUNG	Lung squamous cell carcinoma [cell line NCI-H2170]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2170								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt0d	pgxind-kftx6yy9	pgxcs-kftwu5wz		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2227_LUNG	Lung small cell carcinoma [cell line NCI-H2227]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2227								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt0e	pgxind-kftx6yyc	pgxcs-kftwu5xh		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2228_LUNG	Lung adenocarcinoma [cell line NCI-H2228]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2228								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt0l	pgxind-kftx6yyk	pgxcs-kftwu5zg		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH23_LUNG	Lung adenocarcinoma [cell line NCI-H23]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H23								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt0m	pgxind-kftx6yym	pgxcs-kftwu5zy		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2342_LUNG	Lung adenocarcinoma [cell line NCI-H2342]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2342								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt0o	pgxind-kftx6yyo	pgxcs-kftwu60f		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH2347_LUNG	Lung adenocarcinoma [cell line NCI-H2347]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H2347								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt12	pgxind-kftx6yz6	pgxcs-kftwu658		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH441_LUNG	Lung papillary adenocarcinoma [cell line NCI-H441]	NCIT:C5650	Lung papillary adenocarcinoma	pgx:icdom-82603	Papillary adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H441								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt16	pgxind-kftx6yza	pgxcs-kftwu667		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH460_LUNG	Lung large cell carcinoma [cell line NCI-H460]	NCIT:C4450	Lung large cell carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H460								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt1b	pgxind-kftx6yzg	pgxcs-kftwu69y		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH520_LUNG	Lung squamous cell carcinoma [cell line NCI-H520]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H520								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt1c	pgxind-kftx6yzi	pgxcs-kftwu6ag		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH522_LUNG	Lung adenocarcinoma [cell line NCI-H522]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H522								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt1e	pgxind-kftx6yzk	pgxcs-kftwu6az		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH524_LUNG	Lung small cell carcinoma [cell line NCI-H524]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H524								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt1j	pgxind-kftx6yzq	pgxcs-kftwu6ch		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH647_LUNG	Lung adenosquamous carcinoma [cell line NCI-H647]	NCIT:C9133	Lung adenosquamous carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H647								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt1l	pgxind-kftx6yzs	pgxcs-kftwu6d0		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH650_LUNG	Lung adenocarcinoma [cell line NCI-H650]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H650								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt1w	pgxind-kftx6z07	pgxcs-kftwu6gh		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH810_LUNG	Lung large cell carcinoma [cell line NCI-H810]	NCIT:C4450	Lung large cell carcinoma	pgx:icdom-80123	Large cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H810								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt1y	pgxind-kftx6z09	pgxcs-kftwu6gz		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH82_LUNG	Lung small cell carcinoma [cell line NCI-H82]	NCIT:C4917	Lung small cell carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H82								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt1z	pgxind-kftx6z0b	pgxcs-kftwu6hh		PGX_AM_BS_CELLLINE_CCLE_BROAD-NCIH838_LUNG	Lung adenocarcinoma [cell line NCI-H838]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				NCI-H838								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt6c	pgxind-kftx6z5r	pgxcs-kftwu7vo		PGX_AM_BS_CELLLINE_CCLE_BROAD-RERFLCSQ1_LUNG	Lung squamous cell carcinoma [cell line RERF-LC-Sq1]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				RERF-LC-Sq1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt8d	pgxind-kftx6z8c	pgxcs-kftwu8ho		PGX_AM_BS_CELLLINE_CCLE_BROAD-SKLU1_LUNG	Lung adenocarcinoma [cell line SK-LU-1]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				SK-LU-1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkt8u	pgxind-kftx6z8w	pgxcs-kftwu8ou		PGX_AM_BS_CELLLINE_CCLE_BROAD-SKMES1_LUNG	Lung squamous cell carcinoma [cell line SK-MES-1]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				SK-MES-1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvktc2	pgxind-kftx6zd0	pgxcs-kftwu9o1		PGX_AM_BS_CELLLINE_CCLE_BROAD-SQ1_LUNG	Lung squamous cell carcinoma [cell line Sq-1]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				Sq-1								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvktd2	pgxind-kftx6ze9	pgxcs-kftwua17		PGX_AM_BS_CELLLINE_CCLE_BROAD-SW1573_LUNG	Minimally invasive lung adenocarcinoma [cell line SW1573]	NCIT:C2923	Minimally invasive lung adenocarcinoma	pgx:icdom-82503	Bronchiolo-alveolar adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				SW1573								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvktgf	pgxind-kftx6zih	pgxcs-kftwub44		PGX_AM_BS_CELLLINE_CCLE_BROAD-VMRCLCD_LUNG	Lung adenocarcinoma [cell line VMRC-LCD]	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				VMRC-LCD								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvktgh	pgxind-kftx6zij	pgxcs-kftwub4m		PGX_AM_BS_CELLLINE_CCLE_BROAD-VMRCLCP_LUNG	Lung squamous cell carcinoma [cell line VMRC-LCP]	NCIT:C3493	Lung squamous cell carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Cambridge	United States of America	USA	42.38	-71.11				VMRC-LCP								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkthg	pgxind-kftx6zjs	pgxcs-kftwubfb		PGX_AM_BS_CELLLINE_NCI60-A549	Non-Small Cell Lung Cancer	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1				A-549								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkti0	pgxind-kftx6zkg	pgxcs-kftwubl1		PGX_AM_BS_CELLLINE_NCI60-HOP_62	Non-Small Cell Lung Cancer	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1				HOP-62								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvktix	pgxind-kftx6zll	pgxcs-kftwubup		PGX_AM_BS_CELLLINE_NCI60-NCI_H522	Non-Small Cell Lung Cancer	NCIT:C3512	Lung adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				Bethesda	United States of America	USA	38.98	-77.1				NCI-H522								EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv53	pgxind-kftx71od	pgxcs-kftwuugy		PGX_AM_BS_LUNG_MSK_2017-P_0000149_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv55	pgxind-kftx71of	pgxcs-kftwuuhg		PGX_AM_BS_LUNG_MSK_2017-P_0000149_T02_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv5b	pgxind-kftx71on	pgxcs-kftwuuky		PGX_AM_BS_LUNG_MSK_2017-P_0000205_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv5g	pgxind-kftx71ot	pgxcs-kftwuumf		PGX_AM_BS_LUNG_MSK_2017-P_0000219_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv5x	pgxind-kftx71pd	pgxcs-kftwuur6		PGX_AM_BS_LUNG_MSK_2017-P_0000316_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv60	pgxind-kftx71ph	pgxcs-kftwuus5		PGX_AM_BS_LUNG_MSK_2017-P_0000347_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv6a	pgxind-kftx71pt	pgxcs-kftwuuv1		PGX_AM_BS_LUNG_MSK_2017-P_0000390_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv6b	pgxind-kftx71pv	pgxcs-kftwuuvi		PGX_AM_BS_LUNG_MSK_2017-P_0000395_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv6v	pgxind-kftx71qk	pgxcs-kftwuv19		PGX_AM_BS_LUNG_MSK_2017-P_0000571_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv6w	pgxind-kftx71qm	pgxcs-kftwuv1q		PGX_AM_BS_LUNG_MSK_2017-P_0000580_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv6z	pgxind-kftx71qq	pgxcs-kftwuv2p		PGX_AM_BS_LUNG_MSK_2017-P_0000594_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv71	pgxind-kftx71qs	pgxcs-kftwuv36		PGX_AM_BS_LUNG_MSK_2017-P_0000602_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv7b	pgxind-kftx71r4	pgxcs-kftwuv61		PGX_AM_BS_LUNG_MSK_2017-P_0000628_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv7f	pgxind-kftx71ra	pgxcs-kftwuv7h		PGX_AM_BS_LUNG_MSK_2017-P_0000636_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv7m	pgxind-kftx71ri	pgxcs-kftwuv9f		PGX_AM_BS_LUNG_MSK_2017-P_0000671_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv7o	pgxind-kftx71rk	pgxcs-kftwuv9w		PGX_AM_BS_LUNG_MSK_2017-P_0000676_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv7v	pgxind-kftx71rv	pgxcs-kftwuvca		PGX_AM_BS_LUNG_MSK_2017-P_0000702_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv80	pgxind-kftx71s1	pgxcs-kftwuvdq		PGX_AM_BS_LUNG_MSK_2017-P_0000731_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv84	pgxind-kftx71s5	pgxcs-kftwuvep		PGX_AM_BS_LUNG_MSK_2017-P_0000756_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv87	pgxind-kftx71s9	pgxcs-kftwuvfo		PGX_AM_BS_LUNG_MSK_2017-P_0000774_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv88	pgxind-kftx71sb	pgxcs-kftwuvg5		PGX_AM_BS_LUNG_MSK_2017-P_0000785_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv8f	pgxind-kftx71sj	pgxcs-kftwuvi3		PGX_AM_BS_LUNG_MSK_2017-P_0000809_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv8h	pgxind-kftx71sl	pgxcs-kftwuvik		PGX_AM_BS_LUNG_MSK_2017-P_0000819_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv8r	pgxind-kftx71sx	pgxcs-kftwuvlg		PGX_AM_BS_LUNG_MSK_2017-P_0000894_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv93	pgxind-kftx71td	pgxcs-kftwuvpa		PGX_AM_BS_LUNG_MSK_2017-P_0000978_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv9q	pgxind-kftx71u6	pgxcs-kftwuvxn		PGX_AM_BS_LUNG_MSK_2017-P_0001154_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv9x	pgxind-kftx71ue	pgxcs-kftwuvzk		PGX_AM_BS_LUNG_MSK_2017-P_0001171_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkv9y	pgxind-kftx71ug	pgxcs-kftwuw02		PGX_AM_BS_LUNG_MSK_2017-P_0001189_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkva0	pgxind-kftx71ui	pgxcs-kftwuw0j		PGX_AM_BS_LUNG_MSK_2017-P_0001199_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkva1	pgxind-kftx71uk	pgxcs-kftwuw11		PGX_AM_BS_LUNG_MSK_2017-P_0001208_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkva3	pgxind-kftx71um	pgxcs-kftwuw1i		PGX_AM_BS_LUNG_MSK_2017-P_0001224_T02_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkva9	pgxind-kftx71uu	pgxcs-kftwuw3f		PGX_AM_BS_LUNG_MSK_2017-P_0001257_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvaj	pgxind-kftx71v7	pgxcs-kftwuw6b		PGX_AM_BS_LUNG_MSK_2017-P_0001303_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvao	pgxind-kftx71vd	pgxcs-kftwuw7r		PGX_AM_BS_LUNG_MSK_2017-P_0001309_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvaq	pgxind-kftx71vf	pgxcs-kftwuw89		PGX_AM_BS_LUNG_MSK_2017-P_0001314_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvaw	pgxind-kftx71vn	pgxcs-kftwuwa6		PGX_AM_BS_LUNG_MSK_2017-P_0001365_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvaz	pgxind-kftx71vr	pgxcs-kftwuwb5		PGX_AM_BS_LUNG_MSK_2017-P_0001368_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvbc	pgxind-kftx71w7	pgxcs-kftwuwex		PGX_AM_BS_LUNG_MSK_2017-P_0001397_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvbo	pgxind-kftx71wl	pgxcs-kftwuwia		PGX_AM_BS_LUNG_MSK_2017-P_0001550_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvbr	pgxind-kftx71wq	pgxcs-kftwuwj8		PGX_AM_BS_LUNG_MSK_2017-P_0001553_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvbs	pgxind-kftx71ws	pgxcs-kftwuwjq		PGX_AM_BS_LUNG_MSK_2017-P_0001571_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvbz	pgxind-kftx71x0	pgxcs-kftwuwln		PGX_AM_BS_LUNG_MSK_2017-P_0001613_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvco	pgxind-kftx71xw	pgxcs-kftwuwtb		PGX_AM_BS_LUNG_MSK_2017-P_0001813_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvd4	pgxind-kftx71yh	pgxcs-kftwuwzs		PGX_AM_BS_LUNG_MSK_2017-P_0001840_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvd6	pgxind-kftx71yj	pgxcs-kftwux09		PGX_AM_BS_LUNG_MSK_2017-P_0001840_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvdh	pgxind-kftx71yx	pgxcs-kftwux3m		PGX_AM_BS_LUNG_MSK_2017-P_0001955_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvdn	pgxind-kftx71z5	pgxcs-kftwux5k		PGX_AM_BS_LUNG_MSK_2017-P_0001987_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvdr	pgxind-kftx71z9	pgxcs-kftwux6j		PGX_AM_BS_LUNG_MSK_2017-P_0002000_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvdu	pgxind-kftx71zd	pgxcs-kftwux7i		PGX_AM_BS_LUNG_MSK_2017-P_0002016_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkved	pgxind-kftx7202	pgxcs-kftwuxd9		PGX_AM_BS_LUNG_MSK_2017-P_0002091_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvef	pgxind-kftx7204	pgxcs-kftwuxdr		PGX_AM_BS_LUNG_MSK_2017-P_0002091_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkveh	pgxind-kftx7206	pgxcs-kftwuxe8		PGX_AM_BS_LUNG_MSK_2017-P_0002105_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvei	pgxind-kftx7208	pgxcs-kftwuxeq		PGX_AM_BS_LUNG_MSK_2017-P_0002117_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkveq	pgxind-kftx720i	pgxcs-kftwuxh5		PGX_AM_BS_LUNG_MSK_2017-P_0002160_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkveu	pgxind-kftx720m	pgxcs-kftwuxi4		PGX_AM_BS_LUNG_MSK_2017-P_0002187_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvf7	pgxind-kftx7212	pgxcs-kftwuxlx		PGX_AM_BS_LUNG_MSK_2017-P_0002278_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvfc	pgxind-kftx7219	pgxcs-kftwuxnd		PGX_AM_BS_LUNG_MSK_2017-P_0002320_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvfi	pgxind-kftx721h	pgxcs-kftwuxp9		PGX_AM_BS_LUNG_MSK_2017-P_0002403_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvfv	pgxind-kftx721x	pgxcs-kftwuxt3		PGX_AM_BS_LUNG_MSK_2017-P_0002446_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvg0	pgxind-kftx7223	pgxcs-kftwuxuj		PGX_AM_BS_LUNG_MSK_2017-P_0002459_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvhl	pgxind-kftx7242	pgxcs-kftwuycy		PGX_AM_BS_LUNG_MSK_2017-P_0002783_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvi4	pgxind-kftx724r	pgxcs-kftwuyio		PGX_AM_BS_LUNG_MSK_2017-P_0002873_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvi6	pgxind-kftx724t	pgxcs-kftwuyj6		PGX_AM_BS_LUNG_MSK_2017-P_0002874_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvih	pgxind-kftx7257	pgxcs-kftwuymj		PGX_AM_BS_LUNG_MSK_2017-P_0002905_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkviw	pgxind-kftx725p	pgxcs-kftwuyqv		PGX_AM_BS_LUNG_MSK_2017-P_0002957_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvj7	pgxind-kftx7263	pgxcs-kftwuyu7		PGX_AM_BS_LUNG_MSK_2017-P_0003030_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvja	pgxind-kftx7267	pgxcs-kftwuyv5		PGX_AM_BS_LUNG_MSK_2017-P_0003055_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvjm	pgxind-kftx726l	pgxcs-kftwuyyj		PGX_AM_BS_LUNG_MSK_2017-P_0003129_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvjn	pgxind-kftx726n	pgxcs-kftwuyz1		PGX_AM_BS_LUNG_MSK_2017-P_0003156_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvjy	pgxind-kftx7271	pgxcs-kftwuz2e		PGX_AM_BS_LUNG_MSK_2017-P_0003207_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvk3	pgxind-kftx7277	pgxcs-kftwuz3t		PGX_AM_BS_LUNG_MSK_2017-P_0003229_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvk8	pgxind-kftx727d	pgxcs-kftwuz59		PGX_AM_BS_LUNG_MSK_2017-P_0003247_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvkq	pgxind-kftx727z	pgxcs-kftwuzah		PGX_AM_BS_LUNG_MSK_2017-P_0003316_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvks	pgxind-kftx7281	pgxcs-kftwuzaz		PGX_AM_BS_LUNG_MSK_2017-P_0003322_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvlg	pgxind-kftx728v	pgxcs-kftwuzjp		PGX_AM_BS_LUNG_MSK_2017-P_0003505_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvlj	pgxind-kftx7290	pgxcs-kftwuzkn		PGX_AM_BS_LUNG_MSK_2017-P_0003527_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvll	pgxind-kftx7292	pgxcs-kftwuzl5		PGX_AM_BS_LUNG_MSK_2017-P_0003531_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvlt	pgxind-kftx729c	pgxcs-kftwuznk		PGX_AM_BS_LUNG_MSK_2017-P_0003573_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvlw	pgxind-kftx729g	pgxcs-kftwuzoj		PGX_AM_BS_LUNG_MSK_2017-P_0003586_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvly	pgxind-kftx729i	pgxcs-kftwuzp0		PGX_AM_BS_LUNG_MSK_2017-P_0003595_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvm3	pgxind-kftx729o	pgxcs-kftwuzqg		PGX_AM_BS_LUNG_MSK_2017-P_0003635_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvmc	pgxind-kftx72a0	pgxcs-kftwuztb		PGX_AM_BS_LUNG_MSK_2017-P_0003714_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvmn	pgxind-kftx72af	pgxcs-kftwuzwq		PGX_AM_BS_LUNG_MSK_2017-P_0003750_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvmr	pgxind-kftx72ai	pgxcs-kftwuzxo		PGX_AM_BS_LUNG_MSK_2017-P_0003752_T03_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvmz	pgxind-kftx72as	pgxcs-kftwv002		PGX_AM_BS_LUNG_MSK_2017-P_0003863_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvna	pgxind-kftx72b6	pgxcs-kftwv03f		PGX_AM_BS_LUNG_MSK_2017-P_0003967_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvnc	pgxind-kftx72b8	pgxcs-kftwv03w		PGX_AM_BS_LUNG_MSK_2017-P_0003970_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvnh	pgxind-kftx72bf	pgxcs-kftwv05c		PGX_AM_BS_LUNG_MSK_2017-P_0004020_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvnk	pgxind-kftx72bj	pgxcs-kftwv06b		PGX_AM_BS_LUNG_MSK_2017-P_0004045_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvnl	pgxind-kftx72bl	pgxcs-kftwv06t		PGX_AM_BS_LUNG_MSK_2017-P_0004054_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvnu	pgxind-kftx72bv	pgxcs-kftwv09a		PGX_AM_BS_LUNG_MSK_2017-P_0004099_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvo3	pgxind-kftx72c7	pgxcs-kftwv0c6		PGX_AM_BS_LUNG_MSK_2017-P_0004117_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvof	pgxind-kftx72cl	pgxcs-kftwv0fm		PGX_AM_BS_LUNG_MSK_2017-P_0004146_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvok	pgxind-kftx72cr	pgxcs-kftwv0h3		PGX_AM_BS_LUNG_MSK_2017-P_0004207_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvov	pgxind-kftx72d6	pgxcs-kftwv0m1		PGX_AM_BS_LUNG_MSK_2017-P_0004315_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvp0	pgxind-kftx72dc	pgxcs-kftwv0ni		PGX_AM_BS_LUNG_MSK_2017-P_0004327_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvpg	pgxind-kftx72dw	pgxcs-kftwv0sa		PGX_AM_BS_LUNG_MSK_2017-P_0004395_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvpn	pgxind-kftx72e4	pgxcs-kftwv0u8		PGX_AM_BS_LUNG_MSK_2017-P_0004432_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvpq	pgxind-kftx72e8	pgxcs-kftwv0v6		PGX_AM_BS_LUNG_MSK_2017-P_0004442_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvpy	pgxind-kftx72ei	pgxcs-kftwv0xk		PGX_AM_BS_LUNG_MSK_2017-P_0004496_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvq5	pgxind-kftx72er	pgxcs-kftwv0zh		PGX_AM_BS_LUNG_MSK_2017-P_0004591_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvq6	pgxind-kftx72et	pgxcs-kftwv0zy		PGX_AM_BS_LUNG_MSK_2017-P_0004607_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvq8	pgxind-kftx72ev	pgxcs-kftwv10g		PGX_AM_BS_LUNG_MSK_2017-P_0004607_T03_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvqa	pgxind-kftx72ex	pgxcs-kftwv10x		PGX_AM_BS_LUNG_MSK_2017-P_0004612_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvqb	pgxind-kftx72ez	pgxcs-kftwv11f		PGX_AM_BS_LUNG_MSK_2017-P_0004613_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvqz	pgxind-kftx72ft	pgxcs-kftwv18m		PGX_AM_BS_LUNG_MSK_2017-P_0004739_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvrc	pgxind-kftx72g9	pgxcs-kftwv1cf		PGX_AM_BS_LUNG_MSK_2017-P_0004861_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvrk	pgxind-kftx72gk	pgxcs-kftwv1et		PGX_AM_BS_LUNG_MSK_2017-P_0004934_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvrs	pgxind-kftx72gu	pgxcs-kftwv1h7		PGX_AM_BS_LUNG_MSK_2017-P_0005002_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvrz	pgxind-kftx72h2	pgxcs-kftwv1j4		PGX_AM_BS_LUNG_MSK_2017-P_0005034_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvsh	pgxind-kftx72hp	pgxcs-kftwv1od		PGX_AM_BS_LUNG_MSK_2017-P_0005178_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvsi	pgxind-kftx72hr	pgxcs-kftwv1ov		PGX_AM_BS_LUNG_MSK_2017-P_0005179_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvsx	pgxind-kftx72i9	pgxcs-kftwv1uq		PGX_AM_BS_LUNG_MSK_2017-P_0005282_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvt4	pgxind-kftx72ih	pgxcs-kftwv1wm		PGX_AM_BS_LUNG_MSK_2017-P_0005316_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvt7	pgxind-kftx72il	pgxcs-kftwv1xk		PGX_AM_BS_LUNG_MSK_2017-P_0005321_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvt9	pgxind-kftx72in	pgxcs-kftwv1y1		PGX_AM_BS_LUNG_MSK_2017-P_0005337_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvtc	pgxind-kftx72ir	pgxcs-kftwv1yz		PGX_AM_BS_LUNG_MSK_2017-P_0005393_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvti	pgxind-kftx72iz	pgxcs-kftwv20x		PGX_AM_BS_LUNG_MSK_2017-P_0005483_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvtp	pgxind-kftx72j7	pgxcs-kftwv22u		PGX_AM_BS_LUNG_MSK_2017-P_0005533_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvtq	pgxind-kftx72j9	pgxcs-kftwv23b		PGX_AM_BS_LUNG_MSK_2017-P_0005537_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvtu	pgxind-kftx72jd	pgxcs-kftwv24a		PGX_AM_BS_LUNG_MSK_2017-P_0005562_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvuf	pgxind-kftx72k4	pgxcs-kftwv2ah		PGX_AM_BS_LUNG_MSK_2017-P_0005849_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvum	pgxind-kftx72kc	pgxcs-kftwv2ce		PGX_AM_BS_LUNG_MSK_2017-P_0005871_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvup	pgxind-kftx72kg	pgxcs-kftwv2dc		PGX_AM_BS_LUNG_MSK_2017-P_0005895_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvus	pgxind-kftx72kk	pgxcs-kftwv2eb		PGX_AM_BS_LUNG_MSK_2017-P_0005903_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvv0	pgxind-kftx72ku	pgxcs-kftwv2go		PGX_AM_BS_LUNG_MSK_2017-P_0005974_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvv2	pgxind-kftx72kw	pgxcs-kftwv2h5		PGX_AM_BS_LUNG_MSK_2017-P_0005981_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvv3	pgxind-kftx72ky	pgxcs-kftwv2hm		PGX_AM_BS_LUNG_MSK_2017-P_0005985_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvv8	pgxind-kftx72l4	pgxcs-kftwv2j2		PGX_AM_BS_LUNG_MSK_2017-P_0006046_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvvf	pgxind-kftx72lc	pgxcs-kftwv2l0		PGX_AM_BS_LUNG_MSK_2017-P_0006084_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvvk	pgxind-kftx72lj	pgxcs-kftwv2mg		PGX_AM_BS_LUNG_MSK_2017-P_0006105_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvvt	pgxind-kftx72lv	pgxcs-kftwv2pa		PGX_AM_BS_LUNG_MSK_2017-P_0006149_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvvv	pgxind-kftx72lx	pgxcs-kftwv2pr		PGX_AM_BS_LUNG_MSK_2017-P_0006151_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvvw	pgxind-kftx72lz	pgxcs-kftwv2q9		PGX_AM_BS_LUNG_MSK_2017-P_0006171_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvvy	pgxind-kftx72m1	pgxcs-kftwv2qq		PGX_AM_BS_LUNG_MSK_2017-P_0006175_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvw0	pgxind-kftx72m3	pgxcs-kftwv2r8		PGX_AM_BS_LUNG_MSK_2017-P_0006198_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvw3	pgxind-kftx72m7	pgxcs-kftwv2s7		PGX_AM_BS_LUNG_MSK_2017-P_0006199_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvwz	pgxind-kftx72nb	pgxcs-kftwv33b		PGX_AM_BS_LUNG_MSK_2017-P_0006457_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvxb	pgxind-kftx72nq	pgxcs-kftwv36n		PGX_AM_BS_LUNG_MSK_2017-P_0006588_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvxc	pgxind-kftx72ns	pgxcs-kftwv374		PGX_AM_BS_LUNG_MSK_2017-P_0006596_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvxl	pgxind-kftx72o2	pgxcs-kftwv39k		PGX_AM_BS_LUNG_MSK_2017-P_0006642_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvxt	pgxind-kftx72oc	pgxcs-kftwv3by		PGX_AM_BS_LUNG_MSK_2017-P_0006718_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvxw	pgxind-kftx72og	pgxcs-kftwv3cx		PGX_AM_BS_LUNG_MSK_2017-P_0006724_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvy4	pgxind-kftx72oq	pgxcs-kftwv3fc		PGX_AM_BS_LUNG_MSK_2017-P_0006810_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvyi	pgxind-kftx72p8	pgxcs-kftwv3jn		PGX_AM_BS_LUNG_MSK_2017-P_0006896_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvyk	pgxind-kftx72pb	pgxcs-kftwv3k5		PGX_AM_BS_LUNG_MSK_2017-P_0006913_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvym	pgxind-kftx72pd	pgxcs-kftwv3km		PGX_AM_BS_LUNG_MSK_2017-P_0006915_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvyv	pgxind-kftx72pp	pgxcs-kftwv3nh		PGX_AM_BS_LUNG_MSK_2017-P_0006964_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvyx	pgxind-kftx72pr	pgxcs-kftwv3ny		PGX_AM_BS_LUNG_MSK_2017-P_0006979_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvz0	pgxind-kftx72pv	pgxcs-kftwv3ox		PGX_AM_BS_LUNG_MSK_2017-P_0006995_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvz6	pgxind-kftx72q3	pgxcs-kftwv3qu		PGX_AM_BS_LUNG_MSK_2017-P_0007051_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvz8	pgxind-kftx72q5	pgxcs-kftwv3rc		PGX_AM_BS_LUNG_MSK_2017-P_0007054_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvzb	pgxind-kftx72q9	pgxcs-kftwv3sa		PGX_AM_BS_LUNG_MSK_2017-P_0007082_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvzd	pgxind-kftx72qb	pgxcs-kftwv3sr		PGX_AM_BS_LUNG_MSK_2017-P_0007084_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvzg	pgxind-kftx72qf	pgxcs-kftwv3tq		PGX_AM_BS_LUNG_MSK_2017-P_0007099_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvzh	pgxind-kftx72qh	pgxcs-kftwv3u7		PGX_AM_BS_LUNG_MSK_2017-P_0007101_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvzj	pgxind-kftx72qj	pgxcs-kftwv3up		PGX_AM_BS_LUNG_MSK_2017-P_0007108_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvzr	pgxind-kftx72qt	pgxcs-kftwv3x2		PGX_AM_BS_LUNG_MSK_2017-P_0007131_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkvzz	pgxind-kftx72r4	pgxcs-kftwv3zg		PGX_AM_BS_LUNG_MSK_2017-P_0007211_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw04	pgxind-kftx72ra	pgxcs-kftwv40x		PGX_AM_BS_LUNG_MSK_2017-P_0007239_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw0k	pgxind-kftx72ru	pgxcs-kftwv479		PGX_AM_BS_LUNG_MSK_2017-P_0007418_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw15	pgxind-kftx72sl	pgxcs-kftwv4dk		PGX_AM_BS_LUNG_MSK_2017-P_0007582_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw16	pgxind-kftx72sn	pgxcs-kftwv4e2		PGX_AM_BS_LUNG_MSK_2017-P_0007583_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw1k	pgxind-kftx72t3	pgxcs-kftwv4hw		PGX_AM_BS_LUNG_MSK_2017-P_0007681_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw29	pgxind-kftx72u0	pgxcs-kftwv4pn		PGX_AM_BS_LUNG_MSK_2017-P_0007977_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw2e	pgxind-kftx72u6	pgxcs-kftwv4r3		PGX_AM_BS_LUNG_MSK_2017-P_0008101_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw2r	pgxind-kftx72un	pgxcs-kftwv4uy		PGX_AM_BS_LUNG_MSK_2017-P_0008161_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw2t	pgxind-kftx72up	pgxcs-kftwv4vf		PGX_AM_BS_LUNG_MSK_2017-P_0008161_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw31	pgxind-kftx72v0	pgxcs-kftwv4xu		PGX_AM_BS_LUNG_MSK_2017-P_0008291_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw33	pgxind-kftx72v2	pgxcs-kftwv4yb		PGX_AM_BS_LUNG_MSK_2017-P_0008295_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw3i	pgxind-kftx72vk	pgxcs-kftwv52r		PGX_AM_BS_LUNG_MSK_2017-P_0008404_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw3j	pgxind-kftx72vm	pgxcs-kftwv538		PGX_AM_BS_LUNG_MSK_2017-P_0008406_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw3n	pgxind-kftx72vq	pgxcs-kftwv547		PGX_AM_BS_LUNG_MSK_2017-P_0008426_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw3t	pgxind-kftx72vy	pgxcs-kftwv564		PGX_AM_BS_LUNG_MSK_2017-P_0008442_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw3x	pgxind-kftx72w2	pgxcs-kftwv573		PGX_AM_BS_LUNG_MSK_2017-P_0008472_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw43	pgxind-kftx72wb	pgxcs-kftwv58z		PGX_AM_BS_LUNG_MSK_2017-P_0008539_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw45	pgxind-kftx72wd	pgxcs-kftwv59g		PGX_AM_BS_LUNG_MSK_2017-P_0008549_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw4f	pgxind-kftx72wp	pgxcs-kftwv5cc		PGX_AM_BS_LUNG_MSK_2017-P_0008678_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw4u	pgxind-kftx72x7	pgxcs-kftwv5i8		PGX_AM_BS_LUNG_MSK_2017-P_0008786_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw4v	pgxind-kftx72x9	pgxcs-kftwv5iq		PGX_AM_BS_LUNG_MSK_2017-P_0008837_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw5j	pgxind-kftx72y4	pgxcs-kftwv5px		PGX_AM_BS_LUNG_MSK_2017-P_0008934_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw5o	pgxind-kftx72ya	pgxcs-kftwv5rd		PGX_AM_BS_LUNG_MSK_2017-P_0008947_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw5q	pgxind-kftx72yc	pgxcs-kftwv5rv		PGX_AM_BS_LUNG_MSK_2017-P_0008976_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw5t	pgxind-kftx72yg	pgxcs-kftwv5st		PGX_AM_BS_LUNG_MSK_2017-P_0009017_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw6i	pgxind-kftx72zb	pgxcs-kftwv600		PGX_AM_BS_LUNG_MSK_2017-P_0009243_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw6o	pgxind-kftx72zj	pgxcs-kftwv61x		PGX_AM_BS_LUNG_MSK_2017-P_0009261_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw6t	pgxind-kftx72zp	pgxcs-kftwv63c		PGX_AM_BS_LUNG_MSK_2017-P_0009274_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw6y	pgxind-kftx72zv	pgxcs-kftwv64s		PGX_AM_BS_LUNG_MSK_2017-P_0009293_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw79	pgxind-kftx7309	pgxcs-kftwv685		PGX_AM_BS_LUNG_MSK_2017-P_0009353_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw7o	pgxind-kftx730r	pgxcs-kftwv6cg		PGX_AM_BS_LUNG_MSK_2017-P_0009434_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw7w	pgxind-kftx7312	pgxcs-kftwv6eu		PGX_AM_BS_LUNG_MSK_2017-P_0009469_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw80	pgxind-kftx7318	pgxcs-kftwv6gb		PGX_AM_BS_LUNG_MSK_2017-P_0009505_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw82	pgxind-kftx731a	pgxcs-kftwv6gs		PGX_AM_BS_LUNG_MSK_2017-P_0009508_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw8g	pgxind-kftx731s	pgxcs-kftwv6mt		PGX_AM_BS_LUNG_MSK_2017-P_0009586_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw8i	pgxind-kftx731u	pgxcs-kftwv6nb		PGX_AM_BS_LUNG_MSK_2017-P_0009591_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw8p	pgxind-kftx7322	pgxcs-kftwv6p8		PGX_AM_BS_LUNG_MSK_2017-P_0009623_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw8u	pgxind-kftx7328	pgxcs-kftwv6qp		PGX_AM_BS_LUNG_MSK_2017-P_0009660_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw91	pgxind-kftx732g	pgxcs-kftwv6sm		PGX_AM_BS_LUNG_MSK_2017-P_0009708_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw94	pgxind-kftx732k	pgxcs-kftwv6tl		PGX_AM_BS_LUNG_MSK_2017-P_0009714_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw95	pgxind-kftx732m	pgxcs-kftwv6u2		PGX_AM_BS_LUNG_MSK_2017-P_0009715_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw97	pgxind-kftx732o	pgxcs-kftwv6uj		PGX_AM_BS_LUNG_MSK_2017-P_0009748_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw9c	pgxind-kftx732u	pgxcs-kftwv6vy		PGX_AM_BS_LUNG_MSK_2017-P_0009764_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw9h	pgxind-kftx7331	pgxcs-kftwv6xd		PGX_AM_BS_LUNG_MSK_2017-P_0009833_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkw9z	pgxind-kftx733n	pgxcs-kftwv72n		PGX_AM_BS_LUNG_MSK_2017-P_0010257_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwa8	pgxind-kftx733x	pgxcs-kftwv751		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX148B	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwa9	pgxind-kftx733z	pgxcs-kftwv75j		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX151	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwac	pgxind-kftx7343	pgxcs-kftwv76i		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX174	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwag	pgxind-kftx7347	pgxcs-kftwv77j		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX181	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwah	pgxind-kftx7349	pgxcs-kftwv780		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX189	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwan	pgxind-kftx734f	pgxcs-kftwv79g		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX206B	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwao	pgxind-kftx734h	pgxcs-kftwv79y		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX210	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwaq	pgxind-kftx734j	pgxcs-kftwv7af		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX212	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwav	pgxind-kftx734q	pgxcs-kftwv7bw		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX224	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwaw	pgxind-kftx734s	pgxcs-kftwv7cd		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX229	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkway	pgxind-kftx734u	pgxcs-kftwv7cv		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX234	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwb3	pgxind-kftx7350	pgxcs-kftwv7eb		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX25	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwb4	pgxind-kftx7352	pgxcs-kftwv7es		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX263	Combined Small Cell Lung Carcinoma	NCIT:C9137	Combined Lung Small Cell Carcinoma	pgx:icdom-80453	Combined small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwb8	pgxind-kftx7356	pgxcs-kftwv7fr		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX27	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwb9	pgxind-kftx7358	pgxcs-kftwv7g9		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX276	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwbc	pgxind-kftx735c	pgxcs-kftwv7h7		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX285	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwbe	pgxind-kftx735e	pgxcs-kftwv7hp		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX29	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwbk	pgxind-kftx735m	pgxcs-kftwv7jm		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX298	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwbo	pgxind-kftx735q	pgxcs-kftwv7kl		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX304	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwbp	pgxind-kftx735s	pgxcs-kftwv7l2		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX304B	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwbt	pgxind-kftx735w	pgxcs-kftwv7m2		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX317	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwbu	pgxind-kftx735y	pgxcs-kftwv7mk		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX318	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwbw	pgxind-kftx7361	pgxcs-kftwv7n1		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX323	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwbx	pgxind-kftx7363	pgxcs-kftwv7nj		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX326	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwc4	pgxind-kftx736b	pgxcs-kftwv7ph		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX369	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwc8	pgxind-kftx736h	pgxcs-kftwv7sr		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX376	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwca	pgxind-kftx736j	pgxcs-kftwv7ta		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX382B	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwcd	pgxind-kftx736n	pgxcs-kftwv7u9		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX40	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwcf	pgxind-kftx736p	pgxcs-kftwv7ur		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX408	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwcl	pgxind-kftx736x	pgxcs-kftwv7wp		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX462	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwcs	pgxind-kftx7376	pgxcs-kftwv7ym		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX489	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwct	pgxind-kftx7378	pgxcs-kftwv7z3		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX491	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwcy	pgxind-kftx737e	pgxcs-kftwv80k		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX515	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwd1	pgxind-kftx737i	pgxcs-kftwv81j		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX535	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwd3	pgxind-kftx737k	pgxcs-kftwv821		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX537	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwd7	pgxind-kftx737q	pgxcs-kftwv83h		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX59	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwd9	pgxind-kftx737s	pgxcs-kftwv840		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX6	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwdb	pgxind-kftx737u	pgxcs-kftwv84i		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX631	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwde	pgxind-kftx737y	pgxcs-kftwv85h		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX640	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwdh	pgxind-kftx7382	pgxcs-kftwv86h		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX666	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwdm	pgxind-kftx7389	pgxcs-kftwv87z		PGX_AM_BS_LUNG_MSK_PDX-MSK_LX95	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwds	pgxind-kftx738h	pgxcs-kftwv8a2		PGX_AM_BS_LUNG_MSK_PDX-P_0000636_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwe3	pgxind-kftx738v	pgxcs-kftwv8dg		PGX_AM_BS_LUNG_MSK_PDX-P_0004442_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwe5	pgxind-kftx738x	pgxcs-kftwv8dy		PGX_AM_BS_LUNG_MSK_PDX-P_0004860_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkweb	pgxind-kftx7396	pgxcs-kftwv8fx		PGX_AM_BS_LUNG_MSK_PDX-P_0005562_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkweq	pgxind-kftx739o	pgxcs-kftwv8kb		PGX_AM_BS_LUNG_MSK_PDX-P_0007870_T02_IM6	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwey	pgxind-kftx739z	pgxcs-kftwv8mp		PGX_AM_BS_LUNG_MSK_PDX-P_0009358_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwf3	pgxind-kftx73a5	pgxcs-kftwv8o6		PGX_AM_BS_LUNG_MSK_PDX-P_0010571_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwfe	pgxind-kftx73aj	pgxcs-kftwv8rk		PGX_AM_BS_LUNG_MSK_PDX-P_0012091_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwfg	pgxind-kftx73al	pgxcs-kftwv8s3		PGX_AM_BS_LUNG_MSK_PDX-P_0012092_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwfo	pgxind-kftx73av	pgxcs-kftwv8ui		PGX_AM_BS_LUNG_MSK_PDX-P_0012736_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwfv	pgxind-kftx73b3	pgxcs-kftwv8wf		PGX_AM_BS_LUNG_MSK_PDX-P_0014389_T01_IM6	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwfz	pgxind-kftx73ba	pgxcs-kftwv8xv		PGX_AM_BS_LUNG_MSK_PDX-P_0015759_T01_IM6	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwg3	pgxind-kftx73be	pgxcs-kftwv90w		PGX_AM_BS_LUNG_MSK_PDX-P_0016779_T01_IM6	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwg7	pgxind-kftx73bk	pgxcs-kftwv92e		PGX_AM_BS_LUNG_MSK_PDX-P_0018814_T01_IM6	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwic	pgxind-kftx73e8	pgxcs-kftwv9p5		PGX_AM_BS_MSK_IMPACT_2017-P_0000030_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwml	pgxind-kftx73jk	pgxcs-kftwvb13		PGX_AM_BS_MSK_IMPACT_2017-P_0000149_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwmn	pgxind-kftx73jm	pgxcs-kftwvb1m		PGX_AM_BS_MSK_IMPACT_2017-P_0000149_T02_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwo9	pgxind-kftx73ln	pgxcs-kftwvbl2		PGX_AM_BS_MSK_IMPACT_2017-P_0000190_T01_IM3	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwou	pgxind-kftx73me	pgxcs-kftwvbrb		PGX_AM_BS_MSK_IMPACT_2017-P_0000205_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwpi	pgxind-kftx73n8	pgxcs-kftwvbyi		PGX_AM_BS_MSK_IMPACT_2017-P_0000219_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwtg	pgxind-kftx73s5	pgxcs-kftwvd65		PGX_AM_BS_MSK_IMPACT_2017-P_0000316_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwu3	pgxind-kftx73sx	pgxcs-kftwvdcw		PGX_AM_BS_MSK_IMPACT_2017-P_0000329_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwuu	pgxind-kftx73tv	pgxcs-kftwvdl3		PGX_AM_BS_MSK_IMPACT_2017-P_0000347_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwv2	pgxind-kftx73u5	pgxcs-kftwvdni		PGX_AM_BS_MSK_IMPACT_2017-P_0000351_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwvm	pgxind-kftx73uu	pgxcs-kftwvdt8		PGX_AM_BS_MSK_IMPACT_2017-P_0000363_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwww	pgxind-kftx73wh	pgxcs-kftwve96		PGX_AM_BS_MSK_IMPACT_2017-P_0000387_T01_IM3	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwx0	pgxind-kftx73wm	pgxcs-kftwvea5		PGX_AM_BS_MSK_IMPACT_2017-P_0000390_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwx6	pgxind-kftx73wt	pgxcs-kftwvec1		PGX_AM_BS_MSK_IMPACT_2017-P_0000395_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkwy8	pgxind-kftx73y4	pgxcs-kftwven0		PGX_AM_BS_MSK_IMPACT_2017-P_0000418_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx0b	pgxind-kftx740s	pgxcs-kftwvfbk		PGX_AM_BS_MSK_IMPACT_2017-P_0000463_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx38	pgxind-kftx744f	pgxcs-kftwvg64		PGX_AM_BS_MSK_IMPACT_2017-P_0000527_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx4r	pgxind-kftx746b	pgxcs-kftwvgoa		PGX_AM_BS_MSK_IMPACT_2017-P_0000571_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx54	pgxind-kftx746r	pgxcs-kftwvgs6		PGX_AM_BS_MSK_IMPACT_2017-P_0000580_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx5r	pgxind-kftx747j	pgxcs-kftwvgyx		PGX_AM_BS_MSK_IMPACT_2017-P_0000594_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx64	pgxind-kftx7480	pgxcs-kftwvh2u		PGX_AM_BS_MSK_IMPACT_2017-P_0000602_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx7f	pgxind-kftx749n	pgxcs-kftwvhig		PGX_AM_BS_MSK_IMPACT_2017-P_0000628_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx7p	pgxind-kftx749z	pgxcs-kftwvhnd		PGX_AM_BS_MSK_IMPACT_2017-P_0000636_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx9i	pgxind-kftx74c8	pgxcs-kftwvi6l		PGX_AM_BS_MSK_IMPACT_2017-P_0000671_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkx9s	pgxind-kftx74ck	pgxcs-kftwvi9h		PGX_AM_BS_MSK_IMPACT_2017-P_0000676_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxb3	pgxind-kftx74e7	pgxcs-kftwvinf		PGX_AM_BS_MSK_IMPACT_2017-P_0000702_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxca	pgxind-kftx74fq	pgxcs-kftwvj2d		PGX_AM_BS_MSK_IMPACT_2017-P_0000731_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxdb	pgxind-kftx74h1	pgxcs-kftwvjdh		PGX_AM_BS_MSK_IMPACT_2017-P_0000756_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxe4	pgxind-kftx74i2	pgxcs-kftwvjm3		PGX_AM_BS_MSK_IMPACT_2017-P_0000774_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxek	pgxind-kftx74in	pgxcs-kftwvjqw		PGX_AM_BS_MSK_IMPACT_2017-P_0000785_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxfl	pgxind-kftx74jx	pgxcs-kftwvk41		PGX_AM_BS_MSK_IMPACT_2017-P_0000809_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxfz	pgxind-kftx74kf	pgxcs-kftwvk8d		PGX_AM_BS_MSK_IMPACT_2017-P_0000819_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxjc	pgxind-kftx74on	pgxcs-kftwvlae		PGX_AM_BS_MSK_IMPACT_2017-P_0000894_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxn8	pgxind-kftx74tm	pgxcs-kftwvmi9		PGX_AM_BS_MSK_IMPACT_2017-P_0000978_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxrk	pgxind-kftx74z1	pgxcs-kftwvnue		PGX_AM_BS_MSK_IMPACT_2017-P_0001084_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxui	pgxind-kftx752n	pgxcs-kftwvope		PGX_AM_BS_MSK_IMPACT_2017-P_0001154_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxv3	pgxind-kftx753e	pgxcs-kftwvoxw		PGX_AM_BS_MSK_IMPACT_2017-P_0001171_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxvw	pgxind-kftx754f	pgxcs-kftwvp6m		PGX_AM_BS_MSK_IMPACT_2017-P_0001189_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxwc	pgxind-kftx7550	pgxcs-kftwvpbe		PGX_AM_BS_MSK_IMPACT_2017-P_0001199_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxws	pgxind-kftx755k	pgxcs-kftwvpg7		PGX_AM_BS_MSK_IMPACT_2017-P_0001208_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxxk	pgxind-kftx756i	pgxcs-kftwvpob		PGX_AM_BS_MSK_IMPACT_2017-P_0001224_T02_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxz1	pgxind-kftx758e	pgxcs-kftwvq6b		PGX_AM_BS_MSK_IMPACT_2017-P_0001257_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkxzz	pgxind-kftx759l	pgxcs-kftwvqge		PGX_AM_BS_MSK_IMPACT_2017-P_0001283_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky0x	pgxind-kftx75as	pgxcs-kftwvqqh		PGX_AM_BS_MSK_IMPACT_2017-P_0001303_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky1a	pgxind-kftx75b7	pgxcs-kftwvqua		PGX_AM_BS_MSK_IMPACT_2017-P_0001309_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky1h	pgxind-kftx75be	pgxcs-kftwvqw8		PGX_AM_BS_MSK_IMPACT_2017-P_0001314_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky33	pgxind-kftx75df	pgxcs-kftwvrfq		PGX_AM_BS_MSK_IMPACT_2017-P_0001348_T01_IM3	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky3t	pgxind-kftx75eb	pgxcs-kftwvrnh		PGX_AM_BS_MSK_IMPACT_2017-P_0001365_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky3z	pgxind-kftx75ej	pgxcs-kftwvrpf		PGX_AM_BS_MSK_IMPACT_2017-P_0001368_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvky55	pgxind-kftx75g0	pgxcs-kftwvs1u		PGX_AM_BS_MSK_IMPACT_2017-P_0001397_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyb9	pgxind-kftx75np	pgxcs-kftwvtzt		PGX_AM_BS_MSK_IMPACT_2017-P_0001528_T02_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyba	pgxind-kftx75nr	pgxcs-kftwvu0b		PGX_AM_BS_MSK_IMPACT_2017-P_0001528_T03_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyca	pgxind-kftx75p0	pgxcs-kftwvuaz		PGX_AM_BS_MSK_IMPACT_2017-P_0001550_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyci	pgxind-kftx75pa	pgxcs-kftwvudd		PGX_AM_BS_MSK_IMPACT_2017-P_0001553_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkycl	pgxind-kftx75pe	pgxcs-kftwvuec		PGX_AM_BS_MSK_IMPACT_2017-P_0001555_T01_IM3	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyd9	pgxind-kftx75q9	pgxcs-kftwvull		PGX_AM_BS_MSK_IMPACT_2017-P_0001571_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyey	pgxind-kftx75se	pgxcs-kftwvv64		PGX_AM_BS_MSK_IMPACT_2017-P_0001613_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyfb	pgxind-kftx75sv	pgxcs-kftwvv9z		PGX_AM_BS_MSK_IMPACT_2017-P_0001622_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyms	pgxind-kftx762b	pgxcs-kftwvxmp		PGX_AM_BS_MSK_IMPACT_2017-P_0001790_T01_IM3	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkynt	pgxind-kftx763l	pgxcs-kftwvxxq		PGX_AM_BS_MSK_IMPACT_2017-P_0001813_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyp6	pgxind-kftx765a	pgxcs-kftwvyc2		PGX_AM_BS_MSK_IMPACT_2017-P_0001840_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyp7	pgxind-kftx765c	pgxcs-kftwvycj		PGX_AM_BS_MSK_IMPACT_2017-P_0001840_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkytr	pgxind-kftx76ax	pgxcs-kftwvzq7		PGX_AM_BS_MSK_IMPACT_2017-P_0001937_T01_IM3	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyui	pgxind-kftx76bu	pgxcs-kftww003		PGX_AM_BS_MSK_IMPACT_2017-P_0001955_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyvt	pgxind-kftx76di	pgxcs-kftww0dy		PGX_AM_BS_MSK_IMPACT_2017-P_0001987_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkywg	pgxind-kftx76ea	pgxcs-kftww0kn		PGX_AM_BS_MSK_IMPACT_2017-P_0002000_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyx9	pgxind-kftx76fb	pgxcs-kftww0tb		PGX_AM_BS_MSK_IMPACT_2017-P_0002016_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyyo	pgxind-kftx76h4	pgxcs-kftww1ar		PGX_AM_BS_MSK_IMPACT_2017-P_0002050_T01_IM3	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyyv	pgxind-kftx76hc	pgxcs-kftww1co		PGX_AM_BS_MSK_IMPACT_2017-P_0002054_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkyzq	pgxind-kftx76if	pgxcs-kftww1ls		PGX_AM_BS_MSK_IMPACT_2017-P_0002075_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkz0h	pgxind-kftx76jb	pgxcs-kftww1tf		PGX_AM_BS_MSK_IMPACT_2017-P_0002091_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkz0i	pgxind-kftx76jd	pgxcs-kftww1tx		PGX_AM_BS_MSK_IMPACT_2017-P_0002091_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkz14	pgxind-kftx76k4	pgxcs-kftww205		PGX_AM_BS_MSK_IMPACT_2017-P_0002105_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkz1j	pgxind-kftx76km	pgxcs-kftww24h		PGX_AM_BS_MSK_IMPACT_2017-P_0002117_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkz3n	pgxind-kftx76n8	pgxcs-kftww2sm		PGX_AM_BS_MSK_IMPACT_2017-P_0002160_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkz4o	pgxind-kftx76oh	pgxcs-kftww337		PGX_AM_BS_MSK_IMPACT_2017-P_0002183_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkz4v	pgxind-kftx76op	pgxcs-kftww354		PGX_AM_BS_MSK_IMPACT_2017-P_0002187_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkz9e	pgxind-kftx76uc	pgxcs-kftww4jm		PGX_AM_BS_MSK_IMPACT_2017-P_0002278_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzbb	pgxind-kftx76wp	pgxcs-kftww564		PGX_AM_BS_MSK_IMPACT_2017-P_0002320_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzee	pgxind-kftx770k	pgxcs-kftww64y		PGX_AM_BS_MSK_IMPACT_2017-P_0002394_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzeu	pgxind-kftx7714	pgxcs-kftww69r		PGX_AM_BS_MSK_IMPACT_2017-P_0002403_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzfr	pgxind-kftx7729	pgxcs-kftww6jc		PGX_AM_BS_MSK_IMPACT_2017-P_0002421_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzgq	pgxind-kftx773g	pgxcs-kftww6th		PGX_AM_BS_MSK_IMPACT_2017-P_0002444_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzgt	pgxind-kftx773k	pgxcs-kftww6uf		PGX_AM_BS_MSK_IMPACT_2017-P_0002446_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzhh	pgxind-kftx774e	pgxcs-kftww71q		PGX_AM_BS_MSK_IMPACT_2017-P_0002459_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzp7	pgxind-kftx77e1	pgxcs-kftww9fq		PGX_AM_BS_MSK_IMPACT_2017-P_0002637_T01_IM3	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzq7	pgxind-kftx77f9	pgxcs-kftww9sp		PGX_AM_BS_MSK_IMPACT_2017-P_0002658_T01_IM3	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzrj	pgxind-kftx77gw	pgxcs-kftwwa6n		PGX_AM_BS_MSK_IMPACT_2017-P_0002689_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzvj	pgxind-kftx77lx	pgxcs-kftwwbfg		PGX_AM_BS_MSK_IMPACT_2017-P_0002783_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzw4	pgxind-kftx77mn	pgxcs-kftwwblp		PGX_AM_BS_MSK_IMPACT_2017-P_0002797_T01_IM3	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzz7	pgxind-kftx77qk	pgxcs-kftwwclj		PGX_AM_BS_MSK_IMPACT_2017-P_0002865_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzzk	pgxind-kftx77r1	pgxcs-kftwwcpf		PGX_AM_BS_MSK_IMPACT_2017-P_0002873_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvkzzl	pgxind-kftx77r3	pgxcs-kftwwcpw		PGX_AM_BS_MSK_IMPACT_2017-P_0002874_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl016	pgxind-kftx77t2	pgxcs-kftwwd8u		PGX_AM_BS_MSK_IMPACT_2017-P_0002905_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl02x	pgxind-kftx77v9	pgxcs-kftwwdrt		PGX_AM_BS_MSK_IMPACT_2017-P_0002957_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl06m	pgxind-kftx77zy	pgxcs-kftwweya		PGX_AM_BS_MSK_IMPACT_2017-P_0003030_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl07u	pgxind-kftx781i	pgxcs-kftwwfbb		PGX_AM_BS_MSK_IMPACT_2017-P_0003055_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0ag	pgxind-kftx784u	pgxcs-kftwwg5t		PGX_AM_BS_MSK_IMPACT_2017-P_0003129_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0bh	pgxind-kftx7864	pgxcs-kftwwggu		PGX_AM_BS_MSK_IMPACT_2017-P_0003152_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0bo	pgxind-kftx786c	pgxcs-kftwwgir		PGX_AM_BS_MSK_IMPACT_2017-P_0003156_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0e2	pgxind-kftx789a	pgxcs-kftwwhab		PGX_AM_BS_MSK_IMPACT_2017-P_0003207_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0f0	pgxind-kftx78ah	pgxcs-kftwwhke		PGX_AM_BS_MSK_IMPACT_2017-P_0003229_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0ft	pgxind-kftx78bi	pgxcs-kftwwht2		PGX_AM_BS_MSK_IMPACT_2017-P_0003247_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0iv	pgxind-kftx78fb	pgxcs-kftwwire		PGX_AM_BS_MSK_IMPACT_2017-P_0003316_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0j3	pgxind-kftx78fl	pgxcs-kftwwits		PGX_AM_BS_MSK_IMPACT_2017-P_0003321_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0j4	pgxind-kftx78fn	pgxcs-kftwwiua		PGX_AM_BS_MSK_IMPACT_2017-P_0003322_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0k5	pgxind-kftx78gy	pgxcs-kftwwj5c		PGX_AM_BS_MSK_IMPACT_2017-P_0003347_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0m7	pgxind-kftx78jk	pgxcs-kftwwjtm		PGX_AM_BS_MSK_IMPACT_2017-P_0003402_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0oo	pgxind-kftx78mm	pgxcs-kftwwklr		PGX_AM_BS_MSK_IMPACT_2017-P_0003462_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0qr	pgxind-kftx78p6	pgxcs-kftwwl7n		PGX_AM_BS_MSK_IMPACT_2017-P_0003505_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0rv	pgxind-kftx78qk	pgxcs-kftwwlj6		PGX_AM_BS_MSK_IMPACT_2017-P_0003527_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0s2	pgxind-kftx78qt	pgxcs-kftwwll4		PGX_AM_BS_MSK_IMPACT_2017-P_0003531_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0uq	pgxind-kftx78u6	pgxcs-kftwwmfu		PGX_AM_BS_MSK_IMPACT_2017-P_0003586_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0v5	pgxind-kftx78uo	pgxcs-kftwwmk7		PGX_AM_BS_MSK_IMPACT_2017-P_0003595_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0x6	pgxind-kftx78xb	pgxcs-kftwwn8e		PGX_AM_BS_MSK_IMPACT_2017-P_0003635_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl0yw	pgxind-kftx78zi	pgxcs-kftwwnr1		PGX_AM_BS_MSK_IMPACT_2017-P_0003674_T01_IM5	Poorly Differentiated Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl10j	pgxind-kftx791l	pgxcs-kftwwoaz		PGX_AM_BS_MSK_IMPACT_2017-P_0003714_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl125	pgxind-kftx793n	pgxcs-kftwwosd		PGX_AM_BS_MSK_IMPACT_2017-P_0003750_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl12a	pgxind-kftx793t	pgxcs-kftwwott		PGX_AM_BS_MSK_IMPACT_2017-P_0003752_T03_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl17i	pgxind-kftx79aa	pgxcs-kftwwqfe		PGX_AM_BS_MSK_IMPACT_2017-P_0003863_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1ap	pgxind-kftx79e3	pgxcs-kftwwrf3		PGX_AM_BS_MSK_IMPACT_2017-P_0003943_T01_IM3	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1bt	pgxind-kftx79fg	pgxcs-kftwwrqp		PGX_AM_BS_MSK_IMPACT_2017-P_0003967_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1bw	pgxind-kftx79fk	pgxcs-kftwwrrn		PGX_AM_BS_MSK_IMPACT_2017-P_0003970_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1c2	pgxind-kftx79fr	pgxcs-kftwwrtk		PGX_AM_BS_MSK_IMPACT_2017-P_0003973_T01_IM3	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1d6	pgxind-kftx79h2	pgxcs-kftwws6w		PGX_AM_BS_MSK_IMPACT_2017-P_0004006_T01_IM3	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1dr	pgxind-kftx79hs	pgxcs-kftwwsdd		PGX_AM_BS_MSK_IMPACT_2017-P_0004020_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1ep	pgxind-kftx79iy	pgxcs-kftwwsns		PGX_AM_BS_MSK_IMPACT_2017-P_0004045_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1f2	pgxind-kftx79je	pgxcs-kftwwsrn		PGX_AM_BS_MSK_IMPACT_2017-P_0004054_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1h3	pgxind-kftx79lx	pgxcs-kftwwtff		PGX_AM_BS_MSK_IMPACT_2017-P_0004099_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1hw	pgxind-kftx79mx	pgxcs-kftwwto4		PGX_AM_BS_MSK_IMPACT_2017-P_0004117_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1jc	pgxind-kftx79oq	pgxcs-kftwwu3g		PGX_AM_BS_MSK_IMPACT_2017-P_0004146_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1m6	pgxind-kftx79sc	pgxcs-kftwwv0h		PGX_AM_BS_MSK_IMPACT_2017-P_0004207_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1pf	pgxind-kftx79wh	pgxcs-kftwww1s		PGX_AM_BS_MSK_IMPACT_2017-P_0004276_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1pj	pgxind-kftx79wl	pgxcs-kftwww2q		PGX_AM_BS_MSK_IMPACT_2017-P_0004278_T01_IM5	Poorly Differentiated Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1r2	pgxind-kftx79yh	pgxcs-kftwwwj5		PGX_AM_BS_MSK_IMPACT_2017-P_0004315_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1rk	pgxind-kftx79z3	pgxcs-kftwwwog		PGX_AM_BS_MSK_IMPACT_2017-P_0004327_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1sz	pgxind-kftx7a0w	pgxcs-kftwwx63		PGX_AM_BS_MSK_IMPACT_2017-P_0004359_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1ut	pgxind-kftx7a36	pgxcs-kftwwxpg		PGX_AM_BS_MSK_IMPACT_2017-P_0004395_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1wg	pgxind-kftx7a59	pgxcs-kftwwy9k		PGX_AM_BS_MSK_IMPACT_2017-P_0004432_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1ww	pgxind-kftx7a5u	pgxcs-kftwwyeh		PGX_AM_BS_MSK_IMPACT_2017-P_0004442_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl1yt	pgxind-kftx7a88	pgxcs-kftwwyyt		PGX_AM_BS_MSK_IMPACT_2017-P_0004496_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl22u	pgxind-kftx7add	pgxcs-kftwx08d		PGX_AM_BS_MSK_IMPACT_2017-P_0004591_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl23n	pgxind-kftx7aee	pgxcs-kftwx0j9		PGX_AM_BS_MSK_IMPACT_2017-P_0004607_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl23p	pgxind-kftx7aeg	pgxcs-kftwx0js		PGX_AM_BS_MSK_IMPACT_2017-P_0004607_T03_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl23x	pgxind-kftx7aeq	pgxcs-kftwx0m9		PGX_AM_BS_MSK_IMPACT_2017-P_0004612_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl23z	pgxind-kftx7aes	pgxcs-kftwx0ms		PGX_AM_BS_MSK_IMPACT_2017-P_0004613_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl28t	pgxind-kftx7aky	pgxcs-kftwx24m		PGX_AM_BS_MSK_IMPACT_2017-P_0004714_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl29j	pgxind-kftx7alv	pgxcs-kftwx2cb		PGX_AM_BS_MSK_IMPACT_2017-P_0004730_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl29p	pgxind-kftx7am3	pgxcs-kftwx2e8		PGX_AM_BS_MSK_IMPACT_2017-P_0004733_T02_IM5	Poorly Differentiated Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl29z	pgxind-kftx7amf	pgxcs-kftwx2h3		PGX_AM_BS_MSK_IMPACT_2017-P_0004739_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2fa	pgxind-kftx7at3	pgxcs-kftwx43u		PGX_AM_BS_MSK_IMPACT_2017-P_0004858_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2fe	pgxind-kftx7at7	pgxcs-kftwx46t		PGX_AM_BS_MSK_IMPACT_2017-P_0004860_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2ff	pgxind-kftx7at9	pgxcs-kftwx47c		PGX_AM_BS_MSK_IMPACT_2017-P_0004861_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2fs	pgxind-kftx7atp	pgxcs-kftwx4b6		PGX_AM_BS_MSK_IMPACT_2017-P_0004869_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2iz	pgxind-kftx7axq	pgxcs-kftwx598		PGX_AM_BS_MSK_IMPACT_2017-P_0004934_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2li	pgxind-kftx7b0y	pgxcs-kftwx62o		PGX_AM_BS_MSK_IMPACT_2017-P_0004996_T02_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2lq	pgxind-kftx7b18	pgxcs-kftwx652		PGX_AM_BS_MSK_IMPACT_2017-P_0005002_T01_IM5	Poorly Differentiated Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2n7	pgxind-kftx7b33	pgxcs-kftwx6n0		PGX_AM_BS_MSK_IMPACT_2017-P_0005034_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2tq	pgxind-kftx7bb8	pgxcs-kftwx8mw		PGX_AM_BS_MSK_IMPACT_2017-P_0005178_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2ts	pgxind-kftx7bba	pgxcs-kftwx8nd		PGX_AM_BS_MSK_IMPACT_2017-P_0005179_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2y5	pgxind-kftx7bgp	pgxcs-kftwxa00		PGX_AM_BS_MSK_IMPACT_2017-P_0005282_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2zq	pgxind-kftx7bip	pgxcs-kftwxajf		PGX_AM_BS_MSK_IMPACT_2017-P_0005316_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl2zy	pgxind-kftx7biz	pgxcs-kftwxalu		PGX_AM_BS_MSK_IMPACT_2017-P_0005321_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl30s	pgxind-kftx7bjz	pgxcs-kftwxauf		PGX_AM_BS_MSK_IMPACT_2017-P_0005337_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl33a	pgxind-kftx7bn4	pgxcs-kftwxbxs		PGX_AM_BS_MSK_IMPACT_2017-P_0005393_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl36x	pgxind-kftx7brl	pgxcs-kftwxe6n		PGX_AM_BS_MSK_IMPACT_2017-P_0005483_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl36y	pgxind-kftx7brn	pgxcs-kftwxe7m		PGX_AM_BS_MSK_IMPACT_2017-P_0005483_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl37b	pgxind-kftx7bs3	pgxcs-kftwxefc		PGX_AM_BS_MSK_IMPACT_2017-P_0005492_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl37h	pgxind-kftx7bsb	pgxcs-kftwxej6		PGX_AM_BS_MSK_IMPACT_2017-P_0005496_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl395	pgxind-kftx7bue	pgxcs-kftwxfl6		PGX_AM_BS_MSK_IMPACT_2017-P_0005533_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl39a	pgxind-kftx7buk	pgxcs-kftwxfo2		PGX_AM_BS_MSK_IMPACT_2017-P_0005537_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3a4	pgxind-kftx7bvm	pgxcs-kftwxg60		PGX_AM_BS_MSK_IMPACT_2017-P_0005554_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3af	pgxind-kftx7bw1	pgxcs-kftwxgf1		PGX_AM_BS_MSK_IMPACT_2017-P_0005562_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3ga	pgxind-kftx7c3e	pgxcs-kftwxk3x		PGX_AM_BS_MSK_IMPACT_2017-P_0005700_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3gj	pgxind-kftx7c3q	pgxcs-kftwxka7		PGX_AM_BS_MSK_IMPACT_2017-P_0005707_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3hn	pgxind-kftx7c57	pgxcs-kftwxkxy		PGX_AM_BS_MSK_IMPACT_2017-P_0005732_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3kh	pgxind-kftx7c8s	pgxcs-kftwxmr9		PGX_AM_BS_MSK_IMPACT_2017-P_0005792_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3l2	pgxind-kftx7c9h	pgxcs-kftwxn2x		PGX_AM_BS_MSK_IMPACT_2017-P_0005805_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3le	pgxind-kftx7c9u	pgxcs-kftwxn9o		PGX_AM_BS_MSK_IMPACT_2017-P_0005813_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3mw	pgxind-kftx7cbp	pgxcs-kftwxo7s		PGX_AM_BS_MSK_IMPACT_2017-P_0005845_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3n2	pgxind-kftx7cby	pgxcs-kftwxobm		PGX_AM_BS_MSK_IMPACT_2017-P_0005849_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3n4	pgxind-kftx7cc0	pgxcs-kftwxock		PGX_AM_BS_MSK_IMPACT_2017-P_0005850_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3nz	pgxind-kftx7cd2	pgxcs-kftwxoum		PGX_AM_BS_MSK_IMPACT_2017-P_0005871_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3oz	pgxind-kftx7cec	pgxcs-kftwxpi8		PGX_AM_BS_MSK_IMPACT_2017-P_0005895_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3pe	pgxind-kftx7ceu	pgxcs-kftwxpqx		PGX_AM_BS_MSK_IMPACT_2017-P_0005903_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3q4	pgxind-kftx7cfr	pgxcs-kftwxq8q		PGX_AM_BS_MSK_IMPACT_2017-P_0005920_T01_IM5	Lung Carcinoid	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3so	pgxind-kftx7cj0	pgxcs-kftwxru7		PGX_AM_BS_MSK_IMPACT_2017-P_0005974_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3sy	pgxind-kftx7cjd	pgxcs-kftwxrzz		PGX_AM_BS_MSK_IMPACT_2017-P_0005981_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3t3	pgxind-kftx7cjj	pgxcs-kftwxs2w		PGX_AM_BS_MSK_IMPACT_2017-P_0005985_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3tx	pgxind-kftx7ckk	pgxcs-kftwxslp		PGX_AM_BS_MSK_IMPACT_2017-P_0006003_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3uy	pgxind-kftx7clu	pgxcs-kftwxt7r		PGX_AM_BS_MSK_IMPACT_2017-P_0006028_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3vp	pgxind-kftx7cmt	pgxcs-kftwxtoi		PGX_AM_BS_MSK_IMPACT_2017-P_0006046_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3wb	pgxind-kftx7cnl	pgxcs-kftwxu3r		PGX_AM_BS_MSK_IMPACT_2017-P_0006060_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3xc	pgxind-kftx7cou	pgxcs-kftwxuou		PGX_AM_BS_MSK_IMPACT_2017-P_0006084_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3y7	pgxind-kftx7cpx	pgxcs-kftwxv9q		PGX_AM_BS_MSK_IMPACT_2017-P_0006105_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl3yt	pgxind-kftx7cqp	pgxcs-kftwxvmo		PGX_AM_BS_MSK_IMPACT_2017-P_0006115_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl409	pgxind-kftx7csj	pgxcs-kftwxwjq		PGX_AM_BS_MSK_IMPACT_2017-P_0006149_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl40d	pgxind-kftx7csn	pgxcs-kftwxwlo		PGX_AM_BS_MSK_IMPACT_2017-P_0006151_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl40g	pgxind-kftx7csr	pgxcs-kftwxwno		PGX_AM_BS_MSK_IMPACT_2017-P_0006153_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl41c	pgxind-kftx7ctt	pgxcs-kftwxx5y		PGX_AM_BS_MSK_IMPACT_2017-P_0006171_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl41j	pgxind-kftx7cu1	pgxcs-kftwxx9s		PGX_AM_BS_MSK_IMPACT_2017-P_0006175_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl425	pgxind-kftx7cuu	pgxcs-kftwxxpv		PGX_AM_BS_MSK_IMPACT_2017-P_0006191_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl42h	pgxind-kftx7cv8	pgxcs-kftwxxwl		PGX_AM_BS_MSK_IMPACT_2017-P_0006198_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl42k	pgxind-kftx7cvc	pgxcs-kftwxxyi		PGX_AM_BS_MSK_IMPACT_2017-P_0006199_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl468	pgxind-kftx7czw	pgxcs-kftwy083		PGX_AM_BS_MSK_IMPACT_2017-P_0006280_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4ec	pgxind-kftx7d9w	pgxcs-kftwy56b		PGX_AM_BS_MSK_IMPACT_2017-P_0006457_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4ef	pgxind-kftx7da0	pgxcs-kftwy588		PGX_AM_BS_MSK_IMPACT_2017-P_0006459_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4el	pgxind-kftx7da8	pgxcs-kftwy5c3		PGX_AM_BS_MSK_IMPACT_2017-P_0006463_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4k7	pgxind-kftx7dhb	pgxcs-kftwy8vf		PGX_AM_BS_MSK_IMPACT_2017-P_0006588_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4kk	pgxind-kftx7dhr	pgxcs-kftwy935		PGX_AM_BS_MSK_IMPACT_2017-P_0006596_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4mq	pgxind-kftx7dkg	pgxcs-kftwyafc		PGX_AM_BS_MSK_IMPACT_2017-P_0006642_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4ms	pgxind-kftx7dki	pgxcs-kftwyagb		PGX_AM_BS_MSK_IMPACT_2017-P_0006643_T01_IM5	Sarcomatoid Carcinoma of the Lung	NCIT:C45540	Lung Sarcomatoid Carcinoma	pgx:icdom-80103	Carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4p6	pgxind-kftx7dni	pgxcs-kftwybxr		PGX_AM_BS_MSK_IMPACT_2017-P_0006696_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4q7	pgxind-kftx7dot	pgxcs-kftwycmi		PGX_AM_BS_MSK_IMPACT_2017-P_0006718_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4qh	pgxind-kftx7dp5	pgxcs-kftwycse		PGX_AM_BS_MSK_IMPACT_2017-P_0006724_T01_IM5	Poorly Differentiated Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4sf	pgxind-kftx7drk	pgxcs-kftwydzo		PGX_AM_BS_MSK_IMPACT_2017-P_0006768_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4sk	pgxind-kftx7drp	pgxcs-kftwye2m		PGX_AM_BS_MSK_IMPACT_2017-P_0006771_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4ud	pgxind-kftx7dtx	pgxcs-kftwyf7o		PGX_AM_BS_MSK_IMPACT_2017-P_0006810_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4x7	pgxind-kftx7dxh	pgxcs-kftwygy8		PGX_AM_BS_MSK_IMPACT_2017-P_0006873_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4y8	pgxind-kftx7dys	pgxcs-kftwyhmo		PGX_AM_BS_MSK_IMPACT_2017-P_0006896_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4yz	pgxind-kftx7dzp	pgxcs-kftwyi20		PGX_AM_BS_MSK_IMPACT_2017-P_0006912_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4z0	pgxind-kftx7dzr	pgxcs-kftwyi2z		PGX_AM_BS_MSK_IMPACT_2017-P_0006913_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4z2	pgxind-kftx7dzt	pgxcs-kftwyi3x		PGX_AM_BS_MSK_IMPACT_2017-P_0006914_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4z3	pgxind-kftx7dzv	pgxcs-kftwyi4w		PGX_AM_BS_MSK_IMPACT_2017-P_0006915_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl4zc	pgxind-kftx7e05	pgxcs-kftwyi9r		PGX_AM_BS_MSK_IMPACT_2017-P_0006920_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl513	pgxind-kftx7e2c	pgxcs-kftwyjdk		PGX_AM_BS_MSK_IMPACT_2017-P_0006964_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl514	pgxind-kftx7e2e	pgxcs-kftwyjej		PGX_AM_BS_MSK_IMPACT_2017-P_0006965_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl51s	pgxind-kftx7e39	pgxcs-kftwyjvd		PGX_AM_BS_MSK_IMPACT_2017-P_0006979_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl52h	pgxind-kftx7e43	pgxcs-kftwyka0		PGX_AM_BS_MSK_IMPACT_2017-P_0006995_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl53x	pgxind-kftx7e5z	pgxcs-kftwyl8n		PGX_AM_BS_MSK_IMPACT_2017-P_0007029_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl54x	pgxind-kftx7e78	pgxcs-kftwylu0		PGX_AM_BS_MSK_IMPACT_2017-P_0007051_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl552	pgxind-kftx7e7e	pgxcs-kftwylwy		PGX_AM_BS_MSK_IMPACT_2017-P_0007054_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl56c	pgxind-kftx7e90	pgxcs-kftwymqi		PGX_AM_BS_MSK_IMPACT_2017-P_0007082_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl56e	pgxind-kftx7e92	pgxcs-kftwymrg		PGX_AM_BS_MSK_IMPACT_2017-P_0007084_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl56p	pgxind-kftx7e9g	pgxcs-kftwymy9		PGX_AM_BS_MSK_IMPACT_2017-P_0007091_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl572	pgxind-kftx7e9x	pgxcs-kftwyn60		PGX_AM_BS_MSK_IMPACT_2017-P_0007099_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl575	pgxind-kftx7ea1	pgxcs-kftwynac		PGX_AM_BS_MSK_IMPACT_2017-P_0007101_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl57g	pgxind-kftx7eaf	pgxcs-kftwynh4		PGX_AM_BS_MSK_IMPACT_2017-P_0007108_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl58j	pgxind-kftx7ebs	pgxcs-kftwyo4d		PGX_AM_BS_MSK_IMPACT_2017-P_0007131_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl59w	pgxind-kftx7edj	pgxcs-kftwyoz3		PGX_AM_BS_MSK_IMPACT_2017-P_0007160_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5bl	pgxind-kftx7efn	pgxcs-kftwyq1b		PGX_AM_BS_MSK_IMPACT_2017-P_0007211_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5ct	pgxind-kftx7eh6	pgxcs-kftwyqrk		PGX_AM_BS_MSK_IMPACT_2017-P_0007239_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5ff	pgxind-kftx7ekg	pgxcs-kftwysg0		PGX_AM_BS_MSK_IMPACT_2017-P_0007318_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5jv	pgxind-kftx7eq2	pgxcs-kftwyv8h		PGX_AM_BS_MSK_IMPACT_2017-P_0007418_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5kb	pgxind-kftx7eqm	pgxcs-kftwyvi8		PGX_AM_BS_MSK_IMPACT_2017-P_0007427_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5lt	pgxind-kftx7esi	pgxcs-kftwywgv		PGX_AM_BS_MSK_IMPACT_2017-P_0007513_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5ou	pgxind-kftx7ewd	pgxcs-kftwyyfm		PGX_AM_BS_MSK_IMPACT_2017-P_0007582_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5ov	pgxind-kftx7ewf	pgxcs-kftwyygm		PGX_AM_BS_MSK_IMPACT_2017-P_0007583_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5sq	pgxind-kftx7f19	pgxcs-kftwz0wq		PGX_AM_BS_MSK_IMPACT_2017-P_0007681_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl5zt	pgxind-kftx7fai	pgxcs-kftwz5cl		PGX_AM_BS_MSK_IMPACT_2017-P_0007901_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl61y	pgxind-kftx7fdc	pgxcs-kftwz6pt		PGX_AM_BS_MSK_IMPACT_2017-P_0007977_T01_IM5	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl64h	pgxind-kftx7fgk	pgxcs-kftwz8cy		PGX_AM_BS_MSK_IMPACT_2017-P_0008032_T01_IM5	Lung Adenosquamous Carcinoma	NCIT:C9133	Lung Adenosquamous Carcinoma	pgx:icdom-85603	Adenosquamous carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl67b	pgxind-kftx7fk3	pgxcs-kftwza39		PGX_AM_BS_MSK_IMPACT_2017-P_0008101_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl69g	pgxind-kftx7fms	pgxcs-kftwzbfq		PGX_AM_BS_MSK_IMPACT_2017-P_0008161_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl69i	pgxind-kftx7fmu	pgxcs-kftwzbgq		PGX_AM_BS_MSK_IMPACT_2017-P_0008161_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6dk	pgxind-kftx7fs0	pgxcs-kftwze1s		PGX_AM_BS_MSK_IMPACT_2017-P_0008291_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6dn	pgxind-kftx7fs4	pgxcs-kftwze3p		PGX_AM_BS_MSK_IMPACT_2017-P_0008295_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6ie	pgxind-kftx7fy6	pgxcs-kftwzh6k		PGX_AM_BS_MSK_IMPACT_2017-P_0008404_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6ii	pgxind-kftx7fya	pgxcs-kftwzh8i		PGX_AM_BS_MSK_IMPACT_2017-P_0008406_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6j1	pgxind-kftx7fyy	pgxcs-kftwzhk3		PGX_AM_BS_MSK_IMPACT_2017-P_0008426_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6js	pgxind-kftx7fzx	pgxcs-kftwzi0n		PGX_AM_BS_MSK_IMPACT_2017-P_0008442_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6l0	pgxind-kftx7g1h	pgxcs-kftwzit0		PGX_AM_BS_MSK_IMPACT_2017-P_0008472_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6n8	pgxind-kftx7g49	pgxcs-kftwzk6w		PGX_AM_BS_MSK_IMPACT_2017-P_0008539_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6nq	pgxind-kftx7g4u	pgxcs-kftwzkhn		PGX_AM_BS_MSK_IMPACT_2017-P_0008549_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6ob	pgxind-kftx7g5l	pgxcs-kftwzkwl		PGX_AM_BS_MSK_IMPACT_2017-P_0008562_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6qb	pgxind-kftx7g84	pgxcs-kftwzm5h		PGX_AM_BS_MSK_IMPACT_2017-P_0008601_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6qs	pgxind-kftx7g8q	pgxcs-kftwzmg7		PGX_AM_BS_MSK_IMPACT_2017-P_0008650_T02_IM5	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6ry	pgxind-kftx7ga6	pgxcs-kftwzn6i		PGX_AM_BS_MSK_IMPACT_2017-P_0008675_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6s3	pgxind-kftx7gac	pgxcs-kftwzn9e		PGX_AM_BS_MSK_IMPACT_2017-P_0008678_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6wd	pgxind-kftx7gfp	pgxcs-kftwzpx9		PGX_AM_BS_MSK_IMPACT_2017-P_0008786_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6ws	pgxind-kftx7gg8	pgxcs-kftwzq61		PGX_AM_BS_MSK_IMPACT_2017-P_0008796_T01_IM5	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6xv	pgxind-kftx7ghl	pgxcs-kftwzqvm		PGX_AM_BS_MSK_IMPACT_2017-P_0008837_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl6ym	pgxind-kftx7gij	pgxcs-kftwzrc3		PGX_AM_BS_MSK_IMPACT_2017-P_0008854_T01_IM5	Spindle Cell Carcinoma of the Lung	NCIT:C45541	Lung Spindle Cell Carcinoma	pgx:icdom-80323	Spindle cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl71k	pgxind-kftx7gm8	pgxcs-kftwzt9l		PGX_AM_BS_MSK_IMPACT_2017-P_0008934_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl725	pgxind-kftx7gmz	pgxcs-kftwztok		PGX_AM_BS_MSK_IMPACT_2017-P_0008947_T01_IM5	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl72l	pgxind-kftx7gnj	pgxcs-kftwztya		PGX_AM_BS_MSK_IMPACT_2017-P_0008957_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl73g	pgxind-kftx7gom	pgxcs-kftwzugs		PGX_AM_BS_MSK_IMPACT_2017-P_0008976_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl74m	pgxind-kftx7gq3	pgxcs-kftwzv8f		PGX_AM_BS_MSK_IMPACT_2017-P_0009017_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7ay	pgxind-kftx7gxz	pgxcs-kftwzz6c		PGX_AM_BS_MSK_IMPACT_2017-P_0009184_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7cy	pgxind-kftx7h0f	pgxcs-kftx00e6		PGX_AM_BS_MSK_IMPACT_2017-P_0009243_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7do	pgxind-kftx7h1b	pgxcs-kftx00w7		PGX_AM_BS_MSK_IMPACT_2017-P_0009261_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7dx	pgxind-kftx7h1m	pgxcs-kftx010z		PGX_AM_BS_MSK_IMPACT_2017-P_0009266_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7e9	pgxind-kftx7h22	pgxcs-kftx018o		PGX_AM_BS_MSK_IMPACT_2017-P_0009274_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7em	pgxind-kftx7h2i	pgxcs-kftx01ge		PGX_AM_BS_MSK_IMPACT_2017-P_0009293_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7ey	pgxind-kftx7h2w	pgxcs-kftx01n5		PGX_AM_BS_MSK_IMPACT_2017-P_0009300_T01_IM5	Atypical Lung Carcinoid	NCIT:C45551	Lung Atypical Carcinoid Tumor	pgx:icdom-82493	Atypical carcinoid tumor	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7h8	pgxind-kftx7h5t	pgxcs-kftx032s		PGX_AM_BS_MSK_IMPACT_2017-P_0009353_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7hd	pgxind-kftx7h5z	pgxcs-kftx0387		PGX_AM_BS_MSK_IMPACT_2017-P_0009357_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7hf	pgxind-kftx7h61	pgxcs-kftx0397		PGX_AM_BS_MSK_IMPACT_2017-P_0009358_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7k6	pgxind-kftx7has	pgxcs-kftx04yn		PGX_AM_BS_MSK_IMPACT_2017-P_0009434_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7ln	pgxind-kftx7hcl	pgxcs-kftx05wu		PGX_AM_BS_MSK_IMPACT_2017-P_0009468_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7lo	pgxind-kftx7hcn	pgxcs-kftx05xu		PGX_AM_BS_MSK_IMPACT_2017-P_0009469_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7m1	pgxind-kftx7hd2	pgxcs-kftx065o		PGX_AM_BS_MSK_IMPACT_2017-P_0009477_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7my	pgxind-kftx7he5	pgxcs-kftx06on		PGX_AM_BS_MSK_IMPACT_2017-P_0009505_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7n2	pgxind-kftx7hea	pgxcs-kftx06rk		PGX_AM_BS_MSK_IMPACT_2017-P_0009508_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7p0	pgxind-kftx7hgq	pgxcs-kftx0830		PGX_AM_BS_MSK_IMPACT_2017-P_0009560_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7ph	pgxind-kftx7hha	pgxcs-kftx08cc		PGX_AM_BS_MSK_IMPACT_2017-P_0009586_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7pq	pgxind-kftx7hhm	pgxcs-kftx08i6		PGX_AM_BS_MSK_IMPACT_2017-P_0009591_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7r4	pgxind-kftx7hjc	pgxcs-kftx09en		PGX_AM_BS_MSK_IMPACT_2017-P_0009623_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7rb	pgxind-kftx7hjk	pgxcs-kftx09ik		PGX_AM_BS_MSK_IMPACT_2017-P_0009627_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7sr	pgxind-kftx7hla	pgxcs-kftx0aci		PGX_AM_BS_MSK_IMPACT_2017-P_0009660_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7t4	pgxind-kftx7hlr	pgxcs-kftx0amo		PGX_AM_BS_MSK_IMPACT_2017-P_0009684_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7u7	pgxind-kftx7hn2	pgxcs-kftx0b9w		PGX_AM_BS_MSK_IMPACT_2017-P_0009708_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7ug	pgxind-kftx7hne	pgxcs-kftx0bfn		PGX_AM_BS_MSK_IMPACT_2017-P_0009714_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7ui	pgxind-kftx7hng	pgxcs-kftx0bgl		PGX_AM_BS_MSK_IMPACT_2017-P_0009715_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7vn	pgxind-kftx7hox	pgxcs-kftx0c8a		PGX_AM_BS_MSK_IMPACT_2017-P_0009748_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7wd	pgxind-kftx7hpt	pgxcs-kftx0cnl		PGX_AM_BS_MSK_IMPACT_2017-P_0009764_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl7y4	pgxind-kftx7hrz	pgxcs-kftx0dq0		PGX_AM_BS_MSK_IMPACT_2017-P_0009833_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl83j	pgxind-kftx7hyp	pgxcs-kftx0fny		PGX_AM_BS_MSK_IMPACT_2017-P_0009963_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl83w	pgxind-kftx7hz6	pgxcs-kftx0frq		PGX_AM_BS_MSK_IMPACT_2017-P_0009970_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl84c	pgxind-kftx7hzq	pgxcs-kftx0fwi		PGX_AM_BS_MSK_IMPACT_2017-P_0009986_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl84u	pgxind-kftx7i0d	pgxcs-kftx0g1r		PGX_AM_BS_MSK_IMPACT_2017-P_0009997_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl868	pgxind-kftx7i24	pgxcs-kftx0ggk		PGX_AM_BS_MSK_IMPACT_2017-P_0010030_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl86z	pgxind-kftx7i33	pgxcs-kftx0gqs		PGX_AM_BS_MSK_IMPACT_2017-P_0010054_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl872	pgxind-kftx7i37	pgxcs-kftx0grr		PGX_AM_BS_MSK_IMPACT_2017-P_0010056_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl889	pgxind-kftx7i4q	pgxcs-kftx0h4l		PGX_AM_BS_MSK_IMPACT_2017-P_0010083_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl88g	pgxind-kftx7i4z	pgxcs-kftx0h6i		PGX_AM_BS_MSK_IMPACT_2017-P_0010087_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl89z	pgxind-kftx7i6w	pgxcs-kftx0hmr		PGX_AM_BS_MSK_IMPACT_2017-P_0010126_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8bo	pgxind-kftx7i92	pgxcs-kftx0i6y		PGX_AM_BS_MSK_IMPACT_2017-P_0010172_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8ex	pgxind-kftx7id7	pgxcs-kftx0j81		PGX_AM_BS_MSK_IMPACT_2017-P_0010257_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8fe	pgxind-kftx7ids	pgxcs-kftx0jct		PGX_AM_BS_MSK_IMPACT_2017-P_0010267_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8g7	pgxind-kftx7iet	pgxcs-kftx0jle		PGX_AM_BS_MSK_IMPACT_2017-P_0010300_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8hf	pgxind-kftx7igb	pgxcs-kftx0jyc		PGX_AM_BS_MSK_IMPACT_2017-P_0010332_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8hg	pgxind-kftx7ige	pgxcs-kftx0jyt		PGX_AM_BS_MSK_IMPACT_2017-P_0010333_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8hi	pgxind-kftx7igg	pgxcs-kftx0jzb		PGX_AM_BS_MSK_IMPACT_2017-P_0010334_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8ho	pgxind-kftx7igo	pgxcs-kftx0k18		PGX_AM_BS_MSK_IMPACT_2017-P_0010338_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8ii	pgxind-kftx7ihq	pgxcs-kftx0kby		PGX_AM_BS_MSK_IMPACT_2017-P_0010355_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8k8	pgxind-kftx7ijy	pgxcs-kftx0kuu		PGX_AM_BS_MSK_IMPACT_2017-P_0010404_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8ka	pgxind-kftx7ik0	pgxcs-kftx0kvc		PGX_AM_BS_MSK_IMPACT_2017-P_0010405_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8qq	pgxind-kftx7ip8	pgxcs-kftx0m62		PGX_AM_BS_MSK_IMPACT_2017-P_0010554_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8r3	pgxind-kftx7ipo	pgxcs-kftx0m9x		PGX_AM_BS_MSK_IMPACT_2017-P_0010561_T01_IM5	Lung Carcinoid	NCIT:C4038	Lung Carcinoid Tumor	pgx:icdom-82403	Carcinoid tumor, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8r6	pgxind-kftx7ips	pgxcs-kftx0maw		PGX_AM_BS_MSK_IMPACT_2017-P_0010563_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8rj	pgxind-kftx7iq9	pgxcs-kftx0mes		PGX_AM_BS_MSK_IMPACT_2017-P_0010571_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8ss	pgxind-kftx7iru	pgxcs-kftx0mui		PGX_AM_BS_MSK_IMPACT_2017-P_0010602_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8tu	pgxind-kftx7it5	pgxcs-kftx0n5l		PGX_AM_BS_MSK_IMPACT_2017-P_0010636_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8tv	pgxind-kftx7it7	pgxcs-kftx0n62		PGX_AM_BS_MSK_IMPACT_2017-P_0010637_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8uf	pgxind-kftx7itw	pgxcs-kftx0nbt		PGX_AM_BS_MSK_IMPACT_2017-P_0010648_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8y5	pgxind-kftx7iyp	pgxcs-kftx0oig		PGX_AM_BS_MSK_IMPACT_2017-P_0010740_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8yl	pgxind-kftx7iza	pgxcs-kftx0on9		PGX_AM_BS_MSK_IMPACT_2017-P_0010750_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl8zz	pgxind-kftx7j0z	pgxcs-kftx0p1n		PGX_AM_BS_MSK_IMPACT_2017-P_0010793_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl90w	pgxind-kftx7j23	pgxcs-kftx0pde		PGX_AM_BS_MSK_IMPACT_2017-P_0010813_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl92s	pgxind-kftx7j4h	pgxcs-kftx0pxm		PGX_AM_BS_MSK_IMPACT_2017-P_0010855_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl92v	pgxind-kftx7j4l	pgxcs-kftx0pyt		PGX_AM_BS_MSK_IMPACT_2017-P_0010857_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl93p	pgxind-kftx7j5o	pgxcs-kftx0q84		PGX_AM_BS_MSK_IMPACT_2017-P_0010894_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl946	pgxind-kftx7j68	pgxcs-kftx0qf2		PGX_AM_BS_MSK_IMPACT_2017-P_0010904_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl94w	pgxind-kftx7j74	pgxcs-kftx0qmw		PGX_AM_BS_MSK_IMPACT_2017-P_0010927_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl94x	pgxind-kftx7j76	pgxcs-kftx0qnd		PGX_AM_BS_MSK_IMPACT_2017-P_0010927_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl94z	pgxind-kftx7j78	pgxcs-kftx0qnv		PGX_AM_BS_MSK_IMPACT_2017-P_0010928_T01_IM5	Lung Neuroendocrine Tumor	NCIT:C5670	Lung Neuroendocrine Neoplasm	pgx:icdom-82463	Neuroendocrine carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl973	pgxind-kftx7j9x	pgxcs-kftx0rbr		PGX_AM_BS_MSK_IMPACT_2017-P_0010978_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl975	pgxind-kftx7j9z	pgxcs-kftx0rc8		PGX_AM_BS_MSK_IMPACT_2017-P_0010978_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl97a	pgxind-kftx7ja5	pgxcs-kftx0rdp		PGX_AM_BS_MSK_IMPACT_2017-P_0010980_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl97j	pgxind-kftx7jai	pgxcs-kftx0rgm		PGX_AM_BS_MSK_IMPACT_2017-P_0010986_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl98u	pgxind-kftx7jc5	pgxcs-kftx0rwq		PGX_AM_BS_MSK_IMPACT_2017-P_0011016_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl98x	pgxind-kftx7jc9	pgxcs-kftx0rxq		PGX_AM_BS_MSK_IMPACT_2017-P_0011018_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl99f	pgxind-kftx7jcv	pgxcs-kftx0s33		PGX_AM_BS_MSK_IMPACT_2017-P_0011033_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl99k	pgxind-kftx7jd1	pgxcs-kftx0s4l		PGX_AM_BS_MSK_IMPACT_2017-P_0011036_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl99n	pgxind-kftx7jd5	pgxcs-kftx0s5l		PGX_AM_BS_MSK_IMPACT_2017-P_0011038_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9d1	pgxind-kftx7jhf	pgxcs-kftx0t8g		PGX_AM_BS_MSK_IMPACT_2017-P_0011126_T01_IM5	Poorly Differentiated Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9dk	pgxind-kftx7ji3	pgxcs-kftx0tea		PGX_AM_BS_MSK_IMPACT_2017-P_0011138_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9dt	pgxind-kftx7jie	pgxcs-kftx0tgp		PGX_AM_BS_MSK_IMPACT_2017-P_0011142_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9e5	pgxind-kftx7jit	pgxcs-kftx0tkk		PGX_AM_BS_MSK_IMPACT_2017-P_0011150_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9ec	pgxind-kftx7jj1	pgxcs-kftx0tmk		PGX_AM_BS_MSK_IMPACT_2017-P_0011154_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9en	pgxind-kftx7jjg	pgxcs-kftx0tq2		PGX_AM_BS_MSK_IMPACT_2017-P_0011161_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9f5	pgxind-kftx7jk2	pgxcs-kftx0tve		PGX_AM_BS_MSK_IMPACT_2017-P_0011181_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9fv	pgxind-kftx7jl0	pgxcs-kftx0u54		PGX_AM_BS_MSK_IMPACT_2017-P_0011197_T01_IM5	Atypical Lung Carcinoid	NCIT:C45551	Lung Atypical Carcinoid Tumor	pgx:icdom-82493	Atypical carcinoid tumor	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9hc	pgxind-kftx7jmw	pgxcs-kftx0ul3		PGX_AM_BS_MSK_IMPACT_2017-P_0011236_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9ks	pgxind-kftx7jr6	pgxcs-kftx0vnn		PGX_AM_BS_MSK_IMPACT_2017-P_0011326_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9ky	pgxind-kftx7jrf	pgxcs-kftx0vpl		PGX_AM_BS_MSK_IMPACT_2017-P_0011331_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9l3	pgxind-kftx7jrl	pgxcs-kftx0vr1		PGX_AM_BS_MSK_IMPACT_2017-P_0011334_T01_IM5	Poorly Differentiated Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9li	pgxind-kftx7js3	pgxcs-kftx0vve		PGX_AM_BS_MSK_IMPACT_2017-P_0011343_T01_IM5	Lung Neuroendocrine Tumor	NCIT:C5670	Lung Neuroendocrine Neoplasm	pgx:icdom-82463	Neuroendocrine carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9n2	pgxind-kftx7ju3	pgxcs-kftx0wc9		PGX_AM_BS_MSK_IMPACT_2017-P_0011378_T01_IM5	Poorly Differentiated Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9o8	pgxind-kftx7jvk	pgxcs-kftx0wr2		PGX_AM_BS_MSK_IMPACT_2017-P_0011403_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9q9	pgxind-kftx7jy5	pgxcs-kftx0xct		PGX_AM_BS_MSK_IMPACT_2017-P_0011457_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9qu	pgxind-kftx7jyv	pgxcs-kftx0xj2		PGX_AM_BS_MSK_IMPACT_2017-P_0011471_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9ru	pgxind-kftx7k04	pgxcs-kftx0xw0		PGX_AM_BS_MSK_IMPACT_2017-P_0011508_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9t5	pgxind-kftx7k1r	pgxcs-kftx0y9y		PGX_AM_BS_MSK_IMPACT_2017-P_0011537_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9wh	pgxind-kftx7k5z	pgxcs-kftx0zbv		PGX_AM_BS_MSK_IMPACT_2017-P_0012036_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9x7	pgxind-kftx7k6w	pgxcs-kftx0zjl		PGX_AM_BS_MSK_IMPACT_2017-P_0012056_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9yf	pgxind-kftx7k8g	pgxcs-kftx0zwn		PGX_AM_BS_MSK_IMPACT_2017-P_0012084_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9yk	pgxind-kftx7k8m	pgxcs-kftx0zy4		PGX_AM_BS_MSK_IMPACT_2017-P_0012088_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9yo	pgxind-kftx7k8s	pgxcs-kftx0zzl		PGX_AM_BS_MSK_IMPACT_2017-P_0012091_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9yq	pgxind-kftx7k8u	pgxcs-kftx1002		PGX_AM_BS_MSK_IMPACT_2017-P_0012092_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvl9zz	pgxind-kftx7kaf	pgxcs-kftx10fo		PGX_AM_BS_MSK_IMPACT_2017-P_0012121_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvla5k	pgxind-kftx7khg	pgxcs-kftx125p		PGX_AM_BS_MSK_IMPACT_2017-P_0012280_T01_IM5	Small Cell Lung Cancer	NCIT:C4917	Small Cell Lung Carcinoma	pgx:icdom-80413	Small cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvla67	pgxind-kftx7ki9	pgxcs-kftx12ci		PGX_AM_BS_MSK_IMPACT_2017-P_0012306_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlagv	pgxind-kftx7kvm	pgxcs-kftx15o9		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0000012_T03_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlah5	pgxind-kftx7kvy	pgxcs-kftx15r5		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0000363_T01_IM3	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlahg	pgxind-kftx7kwd	pgxcs-kftx15uh		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0000731_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlahj	pgxind-kftx7kwh	pgxcs-kftx15vh		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0000894_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlahm	pgxind-kftx7kwl	pgxcs-kftx15wf		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0000978_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlahr	pgxind-kftx7kwr	pgxcs-kftx15xv		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0001171_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlai5	pgxind-kftx7kx7	pgxcs-kftx161t		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0001867_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlai6	pgxind-kftx7kx9	pgxcs-kftx162b		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0001955_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaid	pgxind-kftx7kxi	pgxcs-kftx1647		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0002160_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaim	pgxind-kftx7kxs	pgxcs-kftx166m		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0002320_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaip	pgxind-kftx7kxw	pgxcs-kftx167k		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0002444_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaiv	pgxind-kftx7ky4	pgxcs-kftx169h		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0002637_T01_IM3	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaja	pgxind-kftx7kym	pgxcs-kftx16fi		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0002874_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlajd	pgxind-kftx7kyq	pgxcs-kftx16gg		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0002905_T01_IM3	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlajv	pgxind-kftx7kzd	pgxcs-kftx16ls		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0003229_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlajy	pgxind-kftx7kzh	pgxcs-kftx16mq		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0003322_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlak0	pgxind-kftx7kzj	pgxcs-kftx16n7		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0003347_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlakk	pgxind-kftx7l07	pgxcs-kftx16sy		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0004020_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlakl	pgxind-kftx7l09	pgxcs-kftx16tg		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0004054_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaks	pgxind-kftx7l0h	pgxcs-kftx16ve		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0004442_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlalb	pgxind-kftx7l16	pgxcs-kftx1715		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0004996_T02_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlalr	pgxind-kftx7l1q	pgxcs-kftx175w		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0005792_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaly	pgxind-kftx7l1y	pgxcs-kftx177t		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0005981_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlam3	pgxind-kftx7l24	pgxcs-kftx1799		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0006084_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlamh	pgxind-kftx7l2n	pgxcs-kftx17dj		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0006642_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlamj	pgxind-kftx7l2p	pgxcs-kftx17e1		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0006724_T01_IM5	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlamr	pgxind-kftx7l2z	pgxcs-kftx17gg		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0007084_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlamu	pgxind-kftx7l33	pgxcs-kftx17hf		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0007101_T02_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlan0	pgxind-kftx7l3b	pgxcs-kftx17jc		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0007418_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlan5	pgxind-kftx7l3h	pgxcs-kftx17ml		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0007582_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlan7	pgxind-kftx7l3j	pgxcs-kftx17n2		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0007583_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlani	pgxind-kftx7l3y	pgxcs-kftx17qg		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0007977_T01_IM5	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlanp	pgxind-kftx7l46	pgxcs-kftx17sd		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0008295_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlanu	pgxind-kftx7l4c	pgxcs-kftx17tt		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0008406_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlany	pgxind-kftx7l4i	pgxcs-kftx17v9		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0008786_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlao6	pgxind-kftx7l4s	pgxcs-kftx17xn		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0008976_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaod	pgxind-kftx7l50	pgxcs-kftx17zk		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0009274_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaof	pgxind-kftx7l52	pgxcs-kftx1802		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0009293_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaon	pgxind-kftx7l5d	pgxcs-kftx182f		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0009469_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaor	pgxind-kftx7l5j	pgxcs-kftx183u		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0009505_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaot	pgxind-kftx7l5l	pgxcs-kftx184c		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0009521_T01_IM5	Non-Small Cell Lung Cancer	NCIT:C2926	Lung Non-Small Cell Carcinoma	pgx:icdom-80463	Non-small cell carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaov	pgxind-kftx7l5o	pgxcs-kftx184t		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0009586_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlap1	pgxind-kftx7l5w	pgxcs-kftx186q		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0009764_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlap3	pgxind-kftx7l5y	pgxcs-kftx1877		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0009833_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlape	pgxind-kftx7l6c	pgxcs-kftx18aj		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0010636_T01_IM5	Lung Squamous Cell Carcinoma	NCIT:C3493	Lung Squamous Cell Carcinoma	pgx:icdom-80703	Squamous cell carcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlapf	pgxind-kftx7l6e	pgxcs-kftx18b1		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0010648_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlapp	pgxind-kftx7l6q	pgxcs-kftx18dw		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0010986_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlapr	pgxind-kftx7l6s	pgxcs-kftx18ed		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0011033_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaps	pgxind-kftx7l6u	pgxcs-kftx18eu		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0011036_T01_IM5	Large Cell Neuroendocrine Carcinoma	NCIT:C5672	Lung Large Cell Neuroendocrine Carcinoma	pgx:icdom-80133	Large cell neuroendocrine carcinoma	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaqc	pgxind-kftx7l7j	pgxcs-kftx18kk		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0012427_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaqq	pgxind-kftx7l81	pgxcs-kftx18ou		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0013653_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaqs	pgxind-kftx7l83	pgxcs-kftx18pb		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0014172_T01_IM5	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlaqv	pgxind-kftx7l87	pgxcs-kftx18q9		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0014451_T01_IM6	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlar3	pgxind-kftx7l8h	pgxcs-kftx18un		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0015078_T01_IM6	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-kftvlari	pgxind-kftx7l90	pgxcs-kftx18z2		PGX_AM_BS_NSCLC_PD1_MSK_2018-P_0016033_T01_IM6	Lung Adenocarcinoma	NCIT:C3512	Lung Adenocarcinoma	pgx:icdom-81403	Adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung						EFO:0030039	no followup status				New York City	United States of America	USA	40.71	-74.01												EFO:0030039	no followup status	DUO:0000004	no restriction
pgxbs-l08ahvm4	pgxind-l08ahvm4		AEB-14595748-BAC9	AEB-14595748-BAC9	bronchioloalveolar carcinoma	NCIT:C2923	Bronchioloalveolar Carcinoma	pgx:icdom-82503	Bronchiolo-alveolar adenocarcinoma, NOS	pgx:icdot-C34.9	Lung, NOS	lung																														
